Crit Rev Toxicol by Kuempel, Eileen D. et al.
Evaluating the mechanistic evidence and key data gaps in 
assessing the potential carcinogenicity of carbon nanotubes 
and nanofibers in humans
Eileen D. Kuempela,†, Marie-Claude Jaurandb,c,d,e, Peter Møllerf, Yasuo Morimotog, Norihiro 
Kobayashih, Kent E. Pinkertoni, Linda M. Sargentj,‡, Roel C. H. Vermeulenk, Bice Fubinil,†, 
and Agnes B. Kanem,§,€
aNational Institute for Occupational Safety and Health, Cincinnati, OH, USA bInstitut National de la 
Santé et de la Recherche Médicale, Unité Mixte de Recherche, UMR 1162, Paris, France cLabex 
Immuno-Oncology, Sorbonne Paris Cité, University of Paris Descartes, Paris, France dUniversity 
Institute of Hematology, Sorbonne Paris Cité, University of Paris Diderot, Paris, France eUniversity 
of Paris 13, Sorbonne Paris Cité, Saint-Denis, France fDepartment of Public Health, University of 
Copenhagen, Copenhagen, Denmark gDepartment of Occupational Pneumology, University of 
Occupational and Environmental Health, Kitakyushu City, Japan hNational Institute of Health 
Sciences, Tokyo, Japan iCenter for Health and the Environment, University of California, Davis, 
California, USA jNational Institute for Occupational Safety and Health, Morgantown, West Virginia, 
USA kInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands 
lDepartment of Chemistry and “G.Scansetti” Interdepartmental Center, Università degli Studi di 
Torino, Torino, Italy mDepartment of Pathology and Laboratory Medicine, Brown University, 
Providence, RI, USA
Abstract
In an evaluation of carbon nanotubes (CNTs) for the IARC Monograph 111, the Mechanisms 
Subgroup was tasked with assessing the strength of evidence on the potential carcinogenicity of 
CNTs in humans. The mechanistic evidence was considered to be not strong enough to alter the 
evaluations based on the animal data. In this paper, we provide an extended, in-depth examination 
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of the in vivo and in vitro experimental studies according to current hypotheses on the 
carcinogenicity of inhaled particles and fibers. We cite additional studies of CNTs that were not 
available at the time of the IARC meeting in October 2014, and extend our evaluation to include 
carbon nanofibers (CNFs). Finally, we identify key data gaps and suggest research needs to reduce 
uncertainty. The focus of this review is on the cancer risk to workers exposed to airborne CNT or 
CNF during the production and use of these materials. The findings of this review, in general, 
affirm those of the original evaluation on the inadequate or limited evidence of carcinogenicity for 
most types of CNTs and CNFs at this time, and possible carcinogenicity of one type of CNT 
(MWCNT-7). The key evidence gaps to be filled by research include: investigation of possible 
associations between in vitro and early-stage in vivo events that may be predictive of lung cancer 
or mesothelioma, and systematic analysis of dose–response relationships across materials, 
including evaluation of the influence of physico-chemical properties and experimental factors on 
the observation of nonmalignant and malignant endpoints.
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Introduction
Scope and objectives
In October 2014, the International Agency for Research on Cancer (IARC) convened a 
monograph meeting of international experts on the carcinogenicity of three fiber or fiber-like 
materials, including fluoro-edenite, silicon carbide whiskers, and carbon nanotubes (CNTs) 
(Grosse et al. 2014). The monograph expert group included subgroups in epidemiology, 
animal studies, and mechanisms. Of the three substances evaluated, CNTs were the most 
diverse and heterogeneous group of materials, had the most extensive scientific literature, 
and yet also had the most uncertainty regarding the available evidence for specific types of 
CNTs. The Mechanisms Subgroup was tasked with examining the extensive mechanistic 
data and identifying key data gaps. CNT heterogeneity and data gaps for most types of 
CNTs resulted in a high degree of uncertainty with regard to assessing the potential 
carcinogenicity of the various types of CNTs to which people (especially workers) could 
potentially be exposed.
The purpose and scope of this critical review paper are to further examine the available 
evidence, including the additional studies on CNTs that were published after the IARC 
Monograph 111 meeting and the published studies on carbon nanofibers (CNF) (CNF was 
not evaluated in the IARC Monograph 111). In addition, some key areas of evidence such as 
the mechanisms of cell proliferation were examined in greater depth. A diversity of expert 
judgments was expressed within the subgroup, as summarized in the IARC 111 monograph 
(in press) and in this paper with regard to interpreting the strength of the mechanistic 
evidence on the potential carcinogenicity of CNTs. Agreement was generally achieved on 
the key areas of evidence needed to evaluate the potential carcinogenicity of CNTs and 
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CNFs, which are based on current hypotheses on the carcinogenicity of inhaled particles and 
fibers, as well as missing information concerning that evidence. This follow-on paper also 
examines whether the additional data evaluated since the monograph meeting provide any 
new insights on the physico-chemical and other factors that may be associated with the 
potential cancer risk of occupational exposure to airborne CNTs and/or CNFs. This review 
includes those studies that provide information on the doses and responses to CNTs or CNFs 
in rodent lungs, pleura, or peritoneum, as well as in vitro studies in human or rodent cells at 
relevant experimental conditions. Consideration is given to the dose–response relationships 
in the animal studies compared to the estimated equivalent pulmonary or pleural doses of 
CNTs or CNFs in humans with potential occupational airborne exposures.
The objective of this follow-on review (as in the original review for the IARC Monograph 
111 meeting on CNTs) is to critically evaluate the available evidence on the key steps in the 
development of cancer in the lungs or mesothelium associated with exposure to CNTs or 
CNFs. Studies were examined for the availability of relevant data across the various types of 
CNTs and CNFs and for consistency or differences in the results on cancer or precursor 
events. Data gaps in the key biological events are identified, as well as the research needs to 
strengthen the evidence for making decisions about the potential carcinogenicity of specific 
CNTs or CNFs or categories of materials.
Worker exposures and lung responses
Workers in facilities that produce or use CNTs and/or CNFs have the potential for inhalation 
exposure when these particles become airborne and enter the workers’ breathing zone. 
Workplace airborne exposure concentration measurements have been reported in several 
studies of single-walled or multi-walled CNTs (SWCNT, MWCNT, respectively) (Maynard 
et al. 2004; Han et al. 2008; Bello et al. 2008, 2009, 2010; Tsai et al. 2009; Johnson et al. 
2010; Lee et al. 2010; Cena & Peters 2011; Dahm et al. 2011, 2012) and CNFs (Methner et 
al. 2007, 2012; Evans et al. 2010; Birch et al. 2011; Dahm et al. 2015). For a complete 
review of the CNT occupational exposure studies, the reader is referred to the IARC 
monograph (in press). Pulmonary health effects studies in workers are extremely limited. No 
studies of health effects in workers exposed to CNTs or CNFs were available at the time of 
the Monograph 111 meeting. Since then, a few studies have reported biomonitoring 
endpoints associated with exposure to MWCNTs (Lee et al. 2015; Fatkhutdinova et al. 2016; 
Shvedova et al. 2016).
Lee et al. (2015) examined nine manufacturing workers and four office workers at a large-
scale manufacturing facility which produced MWCNT using a continuous thermal chemical 
vapor deposition (CVD) process. Noninvasive exhaled breath condensate (EBC) was used to 
monitor the potential effects of MWNCT exposures on inflammatory and oxidative stress in 
the respiratory tract. Particles in the inhalable, thoracic and alveolar sizes were all measured 
in the workplace air. Particle sizes ranged from approximately 8 to 300 nm in diameter, with 
the peak diameter at ~100–200 nm; lengths were not reported. Workers’ personal exposures, 
measured as the inhalable mass concentrations of elemental carbon, were 6.2–9.3 μg/m3. 
The respirable conentrations were estimated to be 1.6–2.3 mg/m3, assuming from other 
studies that the inhalable particle concentration included 25% respirable particles. No 
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significant differences were reported in the age, gender, smoking status, or working duration 
of manufacturing or office workers. The pulmonary function tests and hematology and blood 
biochemistry values in both office and manufacturing workers were reported to be in the 
normal ranges. Some of the EBC biomarkers of oxidative stress were significantly higher in 
the total manufacturing workers (i.e., malondialde-hyde (MDA), 4-hydroxy-2-hexanal (4-
HHE), and n-hexanal). Nonsignificant increases in blood molybdenum (Mo: used as a 
catalyst in MWCNT manufacturing) were also measured in the total manufacturing workers, 
and blood Mo was positively correlated with the EBC oxidative markers MDA and n-
hexanol.
Fatkhutdinova et al. (2016) reported significantly elevated pro-fibrotic inflammatory 
mediators, including IL-1β, IL-4, IL-10, and TNF-α, in sputum and serum samples in 
workers exposed to MWCNT (diameter 8–15 nm; length ≥2 μm; Ni and Co catalyst <5%) 
compared to unexposed control groups at a company in Tambov, Russia. In this small, cross-
sectional study, workers in the exposed group (n = 10) had potential exposures to MWCNT 
for more than one year, while the unexposed control group (n = 12) worked at the same 
facility. The exposure concentrations to respirable elemental carbon were 0.7–2.8 μg/m3 and 
inhalable fractions were 3.5–17.1 μg/m3 (8-h time-weighted average concentration) across 
occupations. Of the 22 workers, 18 were male and 4 female aged 19–63 years. Six of the 22 
workers were current smokers. MWCNTs caused significant increases in IL-1β, IL6, TNF-
α, inflammatory cytokines and KL-6, a serological biomarker for interstitial lung disease in 
collected sputum samples. Limited statistical analysis of the effects of age (years), sex 
(M/F), and smoking (Y/N) on the association between MWCNT exposure and inflammatory 
mediators was performed in generalized linear models with one each of the individual 
variables and the main effect variable of MWCNT exposure; and these models showed that 
only KL-6 in sputum was significantly elevated. Analyses of inflammatory cytokines in 
blood resulted in overall null results with the exception of a possible elevation of TGF-β1 in 
young workers (<30 years).
Shvedova et al. (2016) studied changes in global non-coding RNA (ncRNA), including long 
ncRNA and micro RNA and messenger RNA (mRNA) expression profiles in blood of 
workers exposed to MWCNTs at the same facility as reported by Fatkhutdinova et al. 
(2016). Eight MWCNT exposed workers and seven nonexposed controls were studied. 
Airborne elemental carbon concentrations in worker breathing zones were 0.54–6.11 μg/m3 
(respirable) or 0.71–29.6 μg/m3 (inhalable). Exposed workers were aged 18–60 years with 
~6–24 months exposure to MWCNT, while unexposed workers were aged 20–30 years. A 
number of changes in mRNA and ncRNA expression profiles that have been associated with 
pulmonary (inflammation, fibrosis), cardiovascular, or carcinogenic outcomes were observed 
in the MWCNT exposed workers. No evaluation was performed on the role of age, sex, 
smoking, or other factors on the changes in these expression profiles. These early studies 
suggest that measuring biomarkers in worker populations may provide further information 
on possible early-stage lung effects from CNT exposure. Other epidemiology studies on 
workers exposed to CNT or other nanomaterial are ongoing in the USA, Netherlands/
Belgium, France, and Australia (Liou et al. 2015).
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Worker populations have had fairly low exposure duration (e.g., compared to a full working 
lifetime of 45 years) due to the relatively recent start of global CNT and CNF production (in 
the past 10 or so years). Due to uncertainty about the potential for adverse lung effects, 
including cancer, an evaluation of all the relevant evidence including mechanistic data is 
needed to examine the extent to which the various types of CNTs and CNFs may be 
carcinogenic. At this time, due to the limited human data, experimental studies in rodents 
and cells provide the available data to assess the state of the evidence on the potential 
carcinogenicity of the various types of CNTs and CNFs. Such evaluations are important to 
identify the current state of the science and the key data gaps, for example, for consideration 
in developing evidence-based occupational health guidance.
Rodent cancer data on CNTs
Due to inadequate evidence in humans, the animal data on carcinogenicity of specific CNTs 
provided the evidence basis for the cancer classifications (Grosse et al. 2014; IARC, in 
press). The evidence considered in IARC cancer evaluations (IARC 2006) is summarized in 
Figure 1. Mechanistic evidence, if sufficiently strong, can support the modification (up or 
down) of the default classification based on the human and/or animal evidence (IARC 2006) 
(Figure 2). Mechanistic evidence can include “preneoplastic lesions, tumor pathology, 
genetic and related effects, structure–activity relationships, metabolism and toxicokinetics, 
physicochemical parameters and analogous biological agents” (IARC 2006). No mechanistic 
evidence in humans exposed to CNTs was available for IARC monograph 111 evaluation, 
and only limited data have been published subsequently (Section “Worker Exposures and 
Lung Responses”). Animal studies that provide mechanistic data on the potential 
carcinogenicity of CNTs and CNFs include sub-chronic or chronic studies in rats and mice, 
with exposure routes by inhalation, intratracheal instillation (including intratracheal 
spraying), oropharyngeal aspiration, intrapleural injection, or intraperitoneal (IP) injection 
(discussed in Sections “Deposition, Clearance, and Retention Kinetics Relevant to the 
Potential Carcinogenicity of CNTs and CNFs”; “Indirect Genotoxicity of CNTs and CNFs: 
Rodent Studies”; “Genotoxicity”; “Role of Physico-Chemical Properties of CNTs or CNFs 
on Genotoxic or Carcinogenic Effects”).
A total of 11 cancer studies of various types of MWCNTs and SWCNTs in rats or mice were 
available for evaluation at the monograph meeting (Tables 1 and 2). Sufficient evidence of 
cancer in animals (two or more adequate studies) was available for one type of CNT 
(MWCNT-7), and limited evidence in animals (one adequate study) was available for each 
of two other types of MWCNT with similar dimensions as MWCNT-7 (Grosse et al. 2014; 
IARC, in press). The evidence on the carcinogenicity of MWCNT-7 includes the increased 
incidence of peritoneal mesothelioma in rats following IP injection (Nagai et al. 2011) or 
intrascrotal injection (Sakamoto et al. 2009), along with evidence on tumor promotion and 
increased incidences of bronchiolo-alveolar and adenocarcinoma in mice at 17 weeks after a 
three-week inhalation exposure (Sargent et al. 2014) and mesothelioma in genetically 
modified (p53±) mice after IP injection (Takagi et al. 2008, 2012). Two other types of 
MWCNT (with similar dimensions to MWCNT-7) were associated with increased incidence 
of mesothelioma in rats in one experiment each (Nagai et al. 2011). The mechanistic 
evidence on carcinogenicity, as discussed in this paper, was considered by a majority of the 
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working group to be not strong enough to support modification of the classifications based 
on the animal evidence. The uncertainty in chronic endpoints, inconsistent evidence across 
the various types of CNTs, major gaps in the evidence in animals, and lack of information 
from exposed humans precluded the use of mechanistic data to classify specific CNTs as to 
their carcinogenicity or to generalize to other CNTs. Thus, the IARC overall evaluations 
were determined by the animal evidence available at the time. MWCNT-7 was classified as 
“possibly carcinogenic to humans (Group 2B)”; and SWCNT and all other MWCNT 
(excluding MWCNT-7) were considered “not classifiable as to their carcinogenicity to 
humans (Group 3)” (Grosse et al. 2014; IARC, in press).
An additional study (Rittinghausen et al. 2014) that investigated four additional types of 
MWCNTs, all of which were carcinogenic in rats by IP injection, was published after the 
IARC monograph meeting. A lack of adequate studies on the carcinogenicity of other types 
of CNTs, including SWCNTs, or CNFs remains a significant data gap. Summaries of the 
published cancer studies of MWCNTs and SWCNTs in rats or mice are provided in Tables 1 
and 2. No studies of carcinogenicity of CNFs were available at the time of the IARC 
evaluation or this review.
Most of the studies of CNT carcinogenicity in rodents use an IP injection route of exposure 
(Tables 1 and 2). The IP studies provide relevant qualitative information on the cancer 
hazard potential, as determined by international expert groups, including IARC. No chronic 
inhalation rodent bioassays are available (to date) for any CNTs or CNFs. One study of 
short-term (3-wk) inhalation exposure to MWCNT-7, followed by chronic post-exposure (17 
mo.), has been performed in mice (Sargent et al. 2014). At the time of the IARC Monograph 
111 meeting, all of the studies that showed an increased incidence of mesothelioma were IP 
studies in rats. A recent article (Suzui et al. 2016) reported mesothelioma in rats exposed to 
MWCNT-N by trans-tracheal intrapulmonary spraying (see Section “Overview of 
Mechanisms”).
For more information on the IARC evaluation of the rodent cancer studies, the reader is 
referred to IARC (in press) and Grosse et al. (2014). The focus of this review is on the 
mechanistic evidence and key data gaps in assessing the carcinogenicity of CNTs and CNFs 
in humans.
Substances and endpoints evaluated
Data that are especially useful in a cancer hazard assessment of CNTs and CNFs include: the 
physico-chemical characteristics of the particles, and the cellular responses in major steps in 
the carcinogenic process, particularly from in vivo (e.g., rodent) studies. Most of the in vivo 
and in vitro data available for the IARC evaluation and for this review were on MWCNTs 
and SWCNTs, with studies on CNF also evaluated in this review. The descriptions of the 
physico-chemical characteristics of these materials varied widely across study, making it 
difficult to assess the role of specific characteristics on the potential carcinogenicity. When 
such data were reported, the properties that related to toxicity (both cancer and noncancer 
endpoints) included the differences in the CNT wall number, diameter and length; form and 
entanglement, degree of and stability of agglomeration; purity (metal content); framework 
defects, and/or post-production treatment (functionalization). Studies of genotoxicity and 
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sustained cell proliferation provide clues to the cellular responses to carcinogenic agents. 
The disruption of the cell cycle control mechanisms results in sustained proliferation that 
does not resolve after the stimulus is removed. Chronically sustained proliferative signaling 
that persists after the stimulus disappears is a hallmark of cancer (Hanahan & Weinberg 
2011; Engstrom et al. 2015; Smith et al. 2016). Normal cells differ fundamentally from 
tumor cells by their “inherent capacity for unrestrained proliferation” (Engstrom et al. 2015). 
Normal cell proliferation is under tight control and ceases if the stimulus disappears or if 
cells are exposed to growth inhibitory signals (Hanahan & Weinberg 2011; Engstrom et al. 
2015). These responses can be investigated with different cell types including target 
respiratory cells, as discussed in this review. In vitro studies considered were those using 
human lung epithelial or mesothelial cells and examining genotoxicity endpoints.
Gentoxicity and cell proliferation/hyperplasia endpoints were reported in some rodent 
studies of CNTs or CNFs (Tables 4 and 6), which could indicate either direct or indirect 
(secondary) carcinogenic mechanisms (Section “Hypotheses on Mechanisms Related to 
Genotoxicity and Carcinogenicity of Inhaled Particles or Fibers”). Due to the complex 
nature of tumor development, understanding tumor biology requires studying both the 
individual specialized tumor cell types and the “tumor microenvironment,” which develops 
during the multistep tumorigenesis process (Hanahan & Weinberg 2011). Early development 
of a “tumor microenvironment” could involve the formation of a pro-inflammatory cellular 
milieu (e.g., due to oxidative stress and chronic inflammation from intrinsic or extrinsic 
stressors). In this review, these early endpoints are examined in rodents and cells exposed to 
CNTs or CNFs.
Hazard evaluations, including the IARC cancer hazard evaluations, are qualitative in nature, 
and typically do not take into account the quantitative nature of the dose–response 
relationships in the animal and/or human studies. Criteria for causality including strength, 
consistency, specificity, and other criteria (Hill 1965) are considered in these weight of 
evidence evaluations (IARC 2006). Observation of an association between the dose of a 
substance and the adverse response contributes to the evidence of a causal relationship 
(IARC 2006). Dose is also considered in a hazard review in the context of assessing whether 
multiple mechanisms could be involved in tumor development, including at different dose 
levels (IARC 2006). Qualitatively, dose is taken into account in evaluating the extent to 
which the materials in the experimental studies are similar to those to which humans could 
be exposed (IARC 2006). The quantitative target tissue dose might also be considered in 
extrapolating the hazard evidence from animals to humans and in interpreting in vitro 
findings (IARC 2006).
Initial literature searches for the Monographs are provided by IARC, and meeting 
participants are expected to supplement the initial searches with additional relevant studies 
(IARC 2006). Following the Monograph 111 meeting, the authors of this review identified 
additional relevant studies on CNF and any newly published studies on CNT that provide 
evidence on key mechanistic endpoints where data are especially limited (e.g., cancer, in 
vivo genotoxicity, and cell proliferation) and any subchronic or chronic studies, especially 
by inhalation. These studies were located through regular literature searching (using 
Pubmed, Embase, Toxline, Web of Science, and/or Google Scholar) and regular review of 
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professional journals. Additional references are also cited that discussed the general 
mechanisms on the carcinogenicity of inhaled particles and fibers. Study outcome was not a 
criterion for selection; i.e., studies with both positive and negative responses to CNTs or 
CNFs were considered for relevancy and adequacy of experimental design. The IARC 
(2006) guidelines were followed in this review; these guidelines do not provide specific 
experimental design criteria for mechanistic studies, but do require that any study limitations 
are clearly outlined. In IARC cancer evaluations, possible mechanisms are identified and “a 
representative selection of key data from humans and experimental systems is summarized” 
(IARC 2006). The studies that were added to this review since the IARC Monograph 111 
meeting are indicated in the respective sections and tables and summarized in the Discussion 
(Section “Overview of Mechanisms”). Only a few new in vivo studies were added; a larger 
number of in vitro studies were added. Only reports that have been published or accepted for 
publication in openly available scientific literature are reviewed (IARC 2006).
In the future, new studies that fill the data gaps identified in this paper in key mechanistic 
areas (Section “Research Needs and Recommendations”) (Table 6) will be especially useful 
in futher evaluations of the evidence on the potential carcinogenicity of CNTs and CNFs. 
The carcinogenic potential of inhalation exposure to CNTs and CNFs includes several key 
biological events in common with other inhaled particles or fibers, as shown in Figures 3 and 
4, and summarized in Table 6. These key events begin with airborne exposure to particulate 
substances in the breathing zone (e.g., workers).
Deposition, clearance, and retention kinetics relevant to potential 
carcinogenicity of CNTs and CNFs
Airborne exposure
The first step to evaluate workers’ potential cancer risk from CNTs and/or CNFs is to assess 
their possible routes of exposure. The respiratory tract is the target organ of inhaled particles 
(nonfibrous or fibrous), including CNTs or CNFs, and cancers can develop in the respiratory 
tract regions where particles or fibers deposit or translocate, especially the tissues and cells 
in the bronchial, pulmonary, and pleural regions (ICRP 1994) (Figure 5). Airborne CNTs 
and/or CNFs (e.g., in the workplace) could be inhaled and deposited in the respiratory tract, 
where the possible respiratory hazard depends on the dose. Airborne exposures to CNTs 
and/or CNFs in the work-place have been reported in facilities manufacturing or using CNTs 
and/or CNF in several countries, including the U.S.A. and S. Korea (Section “Worker 
Exposures and Lung Responses”). The airborne particle size distribution depends on the 
physical form of the material and the energy applied to it in a given process or task. In 
experimental studies of CNTs and CNFs, the particle size distribution delivered to the 
animal or cell can vary with the material preparation (e.g., milling, grinding, sieving, 
sonication), the suspension media (air or liquid), and/or particle aerosolization techniques. A 
comprehensive summary of the exposure generation methods used in rodent studies of CNTs 
and CNFs can be found in Oberdorster et al. (2015).
Kuempel et al. Page 8
Crit Rev Toxicol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Inhalation and deposition
Airborne particulate can potentially enter the respiratory tract through breathing and then be 
either exhaled or deposited in one of the regions of the respiratory tract (Figure 5). The 
probability that particles are inhaled and deposited in the respiratory tract depends on several 
factors including the particle’s aerodynamic (or thermodynamic) diameter (ICRP 1994; 
Maynard & Kuempel 2005; Kulkarni & Baron 2011). Shape and orientation are additional 
factors that can influence the deposition probability of nonspherical particles such as fibers 
(Schulz et al. 2000). “Inhalable” particles are defined as those capable of entering the nose 
or mouth and depositing anywhere in the respiratory tract; e.g., particles with aerodynamic 
diameter of 100 μm have an approximately 50% probability of being inhaled and deposited. 
“Thoracic” particles are those capable of reaching the thoracic region and depositing in the 
lung airways; e.g., 10 μm diameter particles have an ~50% probability of depositing in that 
region. “Respirable” particles are those capable of reaching and depositing in the pulmonary 
(alveolar) region of the lungs; e.g., 4 μm diameter particles have an ~50% probability of 
depositing in the gas-exchange region. These definitions are based on mathematical 
modeling and aerosol measurement devices that have been developed to replicate the particle 
deposition efficiencies (as aerosol mass fractions) in the human respiratory tract (ICRP 
1994; ISO 1995; ACGIH 2015).
Nanoparticles (<100 nm diameter) have an estimated deposition efficiency of up to 99% in 
the human respiratory tract, including up to 60% in the alveolar region (ICRP 1994; 
Maynard & Kuempel 2005). The inhalable and respirable particle mass fractions in rodents 
consist of smaller particle sizes than those in humans due to the differences in the size and 
geometry of the respiratory tract across species (Miller 2000). Airborne CNTs and CNFs are 
often agglomerated (Birch et al. 2011; Dahm et al. 2012, 2015; Chen et al. 2012); and as 
such their deposition efficiency in the rodent or human respiratory tract has been assumed to 
approximate that of spherical particles and estimated using spherical particle dosimetry 
models (e.g., Multiple-path Particle Dosimetry Model, MPPD) and data on CNT or CNF 
aerodynamic diameter and density (ARA 2009; NIOSH 2013).
CNT and CNF agglomerates can be less than unit density (1 g/ml) (Ma-Hock et al. 2009; 
Pauluhn 2010; NIOSH 2013), which results in a lower pulmonary deposition fraction, as 
estimated in the MPPD model (ARA 2009; NIOSH 2013). Airborne mass samples of CNT 
and CNF in the workplace are reported to consist mostly of agglomerates of CNT and CNF 
in the thoracic and inhalable size fractions, as well as a smaller mass fraction of respirable 
CNT and CNF; the observed size fractions can also depend on the specific material and 
process (Birch et al. 2011; Dahm et al. 2015).
The primary function of the respiratory tract in humans and rodents is gas exchange (oxygen 
uptake and carbon dioxide release), which takes place in the pulmonary (alveolar) region 
across the thin epithelial and endothelial cell layers in humans (Figure 5) and rodents. 
Although airborne inhalable and respirable CNT and CNF particles have been measured in 
the work-place (Dahm et al. 2012, 2015), no studies are currently available on the 
deposition, clearance, and retention of CNTs or CNFs in the respiratory tract or translocation 
to other organs in humans. On the other hand, there are a number of rodent studies of how 
MWCNTs are deposited, cleared, and retained in the lung, as well as translocated to the 
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liver, kidney, spleen, heart, and brain (as discussed below and in more detail in the IARC 
monograph 111 [IARC, in press]). The fraction of the inhaled MWCNTs that deposits in the 
rodent pulmonary region is estimated at 1–4% in mice (Shvedova et al. 2008; Mercer et al. 
2013a) and 5–20% in rats (Pauluhn 2010; Oyabu et al. 2011). Human pulmonary deposition 
fractions for MWCNTs or SWCNTs (of same aerodynamic diameter as those studied in 
rodents) were estimated to be 8–10% in workers (NIOSH 2013), based on the airborne 
particle size according to the MPPD model (ARA 2009). The degree of dispersion and 
disaggregation of MWCNT (Baytubes®) influenced the airborne particle sizes and therefore 
the pulmonary deposition fractions (Pauluhn & Rosenbruch 2015). The mass median 
aerodynamic diameter (MMAD) was 2.6 or 0.79 for dry- or wet-dispersed material, 
respectively, and the estimated pulmonary deposition fraction was 3.1% or 8.2%, 
respectively, using MPPD 2.11 (Pauluhn & Rosenbruch 2015). Thus, the smaller the particle 
size (more dispersed), the greater the pulmonary deposition.
Differences in airway branching patterns (bipodial or tripodial in humans vs. monopodial in 
rats) can result in differences in particle deposition patterns in the tracheobronchial region 
and the downstream alveolar region (Pinkerton et al. 1997). Particle deposition is dictated by 
physical mechanisms (impaction, interception, sedimentation, diffusion) that depend on the 
structure of the respiratory tract region and the particle size, shape, and orientation in the 
airstream (Miller 2000; Schulz et al. 2000). Fiber deposition depends on diameter because 
fibers tend to align with the airstream, which enables long fibers (>10 μm in length) to reach 
the alveolar region (Kulkarni & Baron 2011). Fiber length comes into play as it influences 
the interception with the airway, and enhanced fiber deposition at airway bifurcations has 
been observed in studies of asbestos (Schulz et al. 2000). The airborne characteristics of 
particles and the differences in respiratory tract structure and physiology have been taken 
into account in respiratory tract dosimetry models in rodents and humans, which allows for 
the reasonably accurate prediction of the deposited dose of particles in the respiratory tract 
(e.g., ICRP 1994; ARA 2009), including CNTs and CNFs with similar aerodynamic 
characteristics. However, clearance of CNTs and CNFs is not known in humans, and limited 
information is available in rodents (Section “Clearance and Retention”).
Although CNTs and CNFs have not been measured in the human respiratory tract, these 
particles have been measured in human respiratory tract replicas from the nasal airways to 
the fourth airway generation (Su & Cheng 2014, 2015) following aerosolization using a 
medical nebulizer (after 24 hr of ultrasonication). Su and Cheng used both stacked cup 
CNTs (SCCNTs) (Shenzhen Nanotech Co., Shenzhen, China) and SWCNTs (SWeNT®, 
Southwest NanoTechnologies, Norman, OK, USA). The SCCNTs were produced to >95% 
purity by a chemical vapor deposition process and had a 10–20 nm diameter and a 5–15 μm 
length before aerosolization. The SWCNTs had a 0.93 ± 0.27 nm diameter (>90% carbon by 
weight), with a length to diameter aspect ratio of >1000. Size-classified diameters of the 
aerosol were 51, 101, and 215 nm. The morphology of the size-classified SCCNTs included 
“curved, rope-like, circular loop, and bird nestlike” single structures or aggregates. The size 
classified SWCNTs showed “twisted rubber band and open cage-like structures of very thin 
nanotubes.” Both the SCCNTs and SWCNTs had physical dimensions that were generally 
much larger than their aerodynamic diameters (Su & Cheng 2014, 2015). The total 
deposition fraction in the human airway replica (which included nasal-pharyngeal, tracheal, 
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and four generations of airways) was approximately 7–19% for SCCNTs and 12–18% for 
SWCNTs Su and Cheng (2015). This implies that more than 80% of the structures with 
diameters in the range studied could penetrate beyond the fourth airway generation to the 
lower airways and alveoli and possibly deposit.
Clearance and retention
Some studies in rats and mice show reduced clearance of MWCNTs following inhalation 
exposure at lower lung particle doses (as mass or volume) than observed with other inhaled 
poorly-soluble respirable particles (Mercer et al. 2013a; Pauluhn 2010), while others have 
shown normal clearance rates in rats at the doses administered (Oyabu et al. 2011). A 
reduction in the normal lung clearance rate is important because it would result in an 
increased lung retention rate and greater lung burden for a given duration of exposure. 
Oyabu et al. (2011) reported a lung retention half time of approximately 50 days in rats 
exposed to 0.37 ± 0.18 mg/m3 of an aerosol of short MWCNTs (1.1 μm geometric mean 
length, almost all <10 μm; 2.7 GSD) and Triton X-100 by whole-body inhalation (6 h/d, 5 
d/wk for 4 wk). Pauluhn (2010) reported reduced pulmonary clearance rates compared to 
those in rats at non-overload conditions, i.e., normal retention half-times (t1/2) of ~60 d in 
rats (Snipes 1989) compared to 151, 350, 318, or 375 d in Wistar rats following subchronic 
inhalation to 0.1, 0.4, 1.5, or 6 mg/m3 of MWCNTs (Baytubes®) of relatively short lengths 
(median ~200–1000 nm); however, the retention half-time was reported to be unreliable at 
0.1 mg/m3 due to the lung dose measurements being at the limit of detection and to the 
potential binding of soluble cobalt (used to estimate the MWCNT lung burden) in the lung 
tissues. Subsequently, the estimated retention t1/2 was revised to 84–105 d in rats exposed to 
0.4 mg/m3 MWCNTs (Baytubes®) (Pauluhn & Rosenbruch 2015).
The pulmonary clearance rate of MWCNTs (Baytubes®) was shown to depend on the degree 
of dispersion and disaggregation (Pauluhn & Rosenbruch 2015). The retention t1/2 was 46 d 
for wet- or dry-dispersed MWCNT, respectively. Thus, the smaller MWCNT (MMAD = 
0.79 μm) was cleared from the lungs faster than the larger MWCNT (MMAD = 2.6 μm). 
The reason for the faster clearance from the lungs of the more highly dispersed MWCNT 
was suggested to be through the lymphatic system into the pleura, as seen by the “sustained 
black discoloration of the visceral surfaces of the lung and lung-associated lymph nodes” 
(Pauluhn & Rosenbruch 2015). Consistent with this observation is the greater septal 
thickening seen in rats exposed to the smaller airborne MWCNT particles. Thus, the shorter 
retention t1/2 of the smaller MWCNT from the lungs does not take into account the whole 
body retention including in the lymph nodes.
A study of well-dispersed MWCNT (geometric mean diameter and length: 48 nm and 2.5 
μm, respectively; Nikkisco Co. Ltd., Tokyo, Japan) administered to rats by IT instillation 
(0.20 or 0.55 mg doses) showed significant pulmonary retention at 364 days post-instillation 
(Shinohara et al. 2016). Approximately 30% of the MWCNT appeared to be cleared within 
24 h of administration, while the lung burden of MWCNT did change significantly one year 
later. MWCNT were observed inside alveolar macrophages, but were not detected by mass 
in the liver or brain at one year post-instillation (Shinohara et al. 2016).
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The rodent lung overloading mechanism has been well-studied for many types of poorly-
soluble particles (recently reviewed in Pauluhn 2014a; Morfeld et al. 2015; Borm et al. 
2015). At sufficiently high doses, the rodent (rat and mouse) alveolar macrophages become 
overloaded with engulfed particles, resulting in impaired pulmonary clearance and increased 
particle build-up and retention in the lungs (Bolton et al. 1983; Morrow 1988; Elder et al. 
2005). The effects of overloading involve a sequence of events including persistent 
pulmonary inflammation, fibrosis, and tumorigenesis (Oberdorster 1995). The degree of rat 
lung overloading has been associated with the total mass or volume of retained particles 
(Muhle et al. 1990; Bellmann et al. 1991). Reduced alveolar-macrophage mediated clearance 
was “regularly seen at particulate burdens above approximately 1–3 mg in the rat lung” 
(Oberdorster 1995), although nanoscale or highly toxic materials were associated with 
impaired pulmonary clearance at a lower mass or volumetric particle dose than for micro-
scale poorly-soluble low toxicity particles (Bellmann et al. 1991; Oberdorster et al. 1994). 
The studies on overloading of lung clearance in rodents were performed with particles like 
carbon black or TiO2, which have different characteristics than CNTs. For example, a recent 
paper illustrates that carbon black and TiO2 trigger toxicogenomic responses in mouse lungs 
that are different from those of CNTs (Nikota et al. 2016). In addition, some CNTs may 
undergo biodegradation (Section “Solubility/Degradation in Body or Cellular Fluids”) which 
could impact their clearance.
For nanoscale particles, some evidence suggests that the impairment of pulmonary clearance 
may be due to a different mechanism than macrophage volumetric overloading, such as 
altered alveolar macrophage function (phagocytosis or chemotaxis) (Renwick et al. 2001, 
2004) and/or greater ability to enter the lung interstitium (Oberdorster et al. 1994). Particle 
surface area has been shown to better describe the decreased clearance and pulmonary 
responses to nanoscale compared to microscale particles (Tran et al. 2000). Although 
environmental exposures may not result in lung burdens equivalent to those in overloaded 
rats, occupational exposures in dusty environments such as coal mining have resulted in 
human lung burdens exceeding 10 mg/g lung, and pulmonary clearance was very slow or not 
measureable in those miners (Freedman & Robinson 1988). Human long-term retention of 
respirable particles apparently involves the sequestration of some portion of the dust, even at 
low exposures, below overloading in rats (Kuempel et al. 2001; Gregoratto et al. 2010). 
Humans tend to retain a greater proportion of particles in the alveolar interstitium, while rats 
retain a greater proportion of particles in the alveolar spaces (Nikula et al. 2001).
The mechanistic pathways operating at lower (non-overloading) doses may differ from those 
operating at higher doses if the defenses of the cell or organism are overwhelmed 
(McClellan 1997; Oberdorster et al. 2005a). Dose rate can influence the occurrence and 
severity of acute or sub/chronic effects in rats exposed to CNTs or other particles (Pauluhn 
2014b; Baisch et al. 2014). In two studies of the same MWCNT, rats showed similar dose–
response relationships for pulmonary septal thickening at 90 days following a one-day (6-h) 
inhalation exposure (Ellinger-Ziegelbauer & Pauluhn 2009) and after 13-weeks of inhalation 
exposure (Pauluhn 2010), based on estimated deposited lung dose (NIOSH 2013). However, 
the collagen observed in rats (by Sirius red staining), at 90 days following exposure to 
MWCNT at 241 mg/m3 for 6-h, was interpreted to be due to chronic alveolitis rather than to 
interstitial fibrosis (Ellinger-Ziegelbauer & Pauluhn 2009). In contrast, in rats exposed to 
Kuempel et al. Page 12
Crit Rev Toxicol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
MWCNT at lower concentrations for 13 weeks, “increased interstitial collagen staining 
(Sirius red)” was reported at the 1.6 or 6 mg/m3 doses, and “focal areas of increased 
collagen staining were adjacent to sites of increased particle deposition and inflammatory 
infiltrates” in rats exposed at 0.4 mg/m3 or higher doses (Pauluhn 2010).
Particles (including CNTs or CNFs) that are not cleared from the lungs can move into the 
lung interstitial tissue (either alone or inside macrophages). Particle retention in the 
interstitium increases the risk of fibrosis for poorly-soluble particles including CNTs 
(NIOSH 2013). Rodent studies have shown that both MWCNTs and SWCNTs can enter the 
lung interstium, and SWCNTs appear to do so to a greater extent as individual structures 
rather than being transported by alveolar macrophages (Mercer et al. 2008, 2010, 2011). 
Some studies have reported the translocation of MWCNT from the lungs to the lung-
associated tissues and to systemic organs (discussed below); however investigation of 
translocation of SWCNT in vivo remains a research need.
In an inhalation study of mice (male C57BL/6) exposed to 5 mg/m3 of MWCNTs 
(MWCNT-7; mean length of 4.3 μm [Chen et al. 2012]) for 12 d (5 h/d, 3 wks), the lung 
burden measured on day 1 post-exposure was 28.1 μg (1321 × 109; fiber number estimate 
based on 47 million MWCNT fibers/μg [conversion reported in Chen et al. (2012)] (Mercer 
et al. 2013a,b). Of this lung burden, 84% was found in the alveolar (pulmonary) region of 
the lungs, and 16% was in the airways. The same group (Porter et al. 2010, 2013) observed a 
similar distribution of MWCNTs in two previous studies of MWCNTs in mice exposed by 
pharyngeal aspiration or acute inhalation, respectively. In the inhalation study (Mercer et al. 
2013a), of the MWCNTs that deposited in the alveolar region, 56% was observed in alveolar 
macrophages, 5.7% was in the alveolar airways, and 20% was in the alveolar tissue at day 1 
post-exposure (Mercer et al. 2013a). The distribution of MWCNTs in the lungs shifted over 
time from alveolar macrophages to the alveolar tissue (5.8–9.5 μg on day 1 and 168 post-
exposure, respectively). Thus, the alveolar interstitial lung burden increased as MWCNTs in 
the alveoli were cleared (Mercer et al. 2013a). At 336 days post-exposure, 65% of the initial 
MWCNT lung burden (28.1 μg, measured 1 day-post-inhalation exposure) was retained in 
the lungs (18.2 μg MWCNT), most of which was retained in the alveolar region (96%, 
including 4.8% in subpleural tissue); 4% (0.77 μg) was retained in the airways (Mercer et al. 
2013a). The number of larger or agglomerated MWCNT structures (>4 fibers/MWCNT) 
decreased over time – from 53 to 25% of the lung burden on 1 or 168 days post-exposure, 
respectively (Mercer et al. 2013a). The number of structures with 2, 3, or 4 fibers also 
decreased significantly. However, the percentage of single fibers in the MWCNT lung 
burden did not change significantly from 1 to 168 days post-exposure. Thus, the MWCNTs 
were decreasing in size, resulting in a relatively constant number of single MWCNTs in the 
lungs over time.
Inhaled MWCNTs were also observed in the pleural tissues at 1-day post-exposure (Mercer 
et al. 2013a). Approximately 1.2% (0.34 μg) of the MWCNT lung burden was observed as 
single fibers in the pleural compartment (including the subpleura and visceral pleura) at 1-
day post-exposure. In a study of the same type of MWCNT carried out in mice (male 
C57BL/6J) exposed to MWCNT-7 (49 nm in diameter; 3.9 μm in length) by pharyngeal 
aspiration (10, 20, 40 and 80 μg MWCNT or vehicle), 18% of the MWCNTs were observed 
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in airways, 81% in the alveolar region, and 0.6% in the subpleural tissue on d 1 post-
exposure (80 μg dose) (Mercer et al. 2010). At 56 days after pharyngeal aspiration of mice, 
8% of the total MWCNTs in the lungs were observed in the alveolar interstitial tissue; the 
subpleural tissue, “the region consisting of mesothelial cells of the visceral pleura and 
immediately adjacent Interstitium,” contained 1.6% of the total lung burden (Mercer et al. 
2011). No MWCNTs were found in the airways of mice at 7, 28, and 56 days post-aspiration 
exposure (Mercer et al. 2011).
Pleural clearance of MWCNT has been shown to depend on the length of structures. 
Clearance was reduced in mice administered longer MWCNT (mean length 13 μm) by IP 
injection, compared to the same mass dose (5 μg/mouse) of shorter MWCNT (0.5–5 μm 
lengths) (Murphy et al. 2011; Donaldson et al. 2013). The inflammatory and fibrotic 
responses were also related to the length of MWCNT, including at 6 weeks post-exposure 
following pharyngeal aspiration into the lungs (Murphy et al. 2013). Clearance and retention 
studies of CNT and CNF following long-term inhalation exposure have not been reported.
Cell uptake and interaction
Airborne CNTs or CNFs deposited in the respiratory tract may enter cells by various 
mechanisms, such as passive internalization (diffusion or penetration of cell membrane) or 
active internalization (phagocytosis or other types of endocytosis) (Kunzmann et al. 2011; 
Ye et al. 2013). The mechanisms of cell uptake depend on the surface properties of the 
CNTs, the cell type encountered and the cell’s activation state. SWCNTs are poorly 
recognized by alveolar macrophages, and uptake is low (10% in murine alveolar 
macrophages) (Shvedova et al. 2005), increasing the likelihood of SWCNTs becoming 
interstitialized. In another study, 90% of dispersed SWCNT structures were observed in the 
lung interstitium of mice (Mercer et al. 2008).
MWCNTs are reportedly more effectively taken up by macrophages than SWCNTs (Mercer 
et al. 2010, 2011; Treumann et al. 2013), suggesting an increased likelihood of being cleared 
from the pulmonary region to the tracheobronchial region (via macrophage movement to the 
mucociliary escalator) and cleared from the lungs by cough or expectoration. Alveolar 
macrophage uptake is significantly increased by carboxylic acid functionalized (F) 
MWCNTs compared to original (O) or purified (P) MWCNTs (Silva et al. 2014). 
Dimensions of these MWCNTs were 20–30 nm diameter and 10–30 μm length. The residual 
metal catalysts contents were: O-MWCNT (4.49% Ni, 0.76% Fe); P-MWCNT (1.8% Ni, 
0.08% Fe); and F-MWCNTs (non-detectable levels of Ni or Fe). The differences in these 
MWCNTs also influenced their location and their structural forms within the alveolar 
macrophages. In one experiment, rats were exposed by single (6-h) inhalation to O-, P-, or 
F-MWCNT at ~30 mg/m3 (by nebulization); aerodynamic diameters were MMAD (GSD) of 
3.7 (2.5), 4.8 (2.0), and 3.3 (3.1) for O-, P-, and F-MWCNT, respectively. On day 1 after 
exposure, O-MWCNT and P-MWCNT were observed inside the phagolysosomes of the 
macrophages, and F-MWCNT was seen in the cytosol and protruding from the cell 
membrane. On day 21, the O- and P-MWCNT were no longer inside the phagolysosomes, 
but were observed in the cytosol as larger focal agglomerates; F-MWCNTs remained in the 
cytosol as smaller, dispersed aggregates. The acidic functional groups on the F-MWCNT 
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increased the hydrophilicity, which has been “generally linked to easier clearance from the 
body” along with some evidence of reduced toxicity (Silva et al. 2014). The F-MWCNT 
were considered to reduce toxicity by preventing uptake into phagolysosomes and 
subsequent NLRP3 inflammasome activation (Silva et al. 2014).
In mice exposed to MWCNT-7 by pharyngeal aspiration, MWCNT penetrations were 
observed at day 1 post-exposure Mercer et al. (2010) to be most frequently in alveolar 
macrophages, followed by alveolar type II epithelial cells (which make up approximately 
2% of normal epithelial surface), and less frequently in alveolar interstitial cells (where they 
were typically observed as fibers passing through adjacent epithelial cells). The investigators 
found that MWCNTs inside cells were not confined to phagolysosomes and extended from 
the cell surface through the nuclei and other organelles. In the airways, the MWCNTs were 
observed in the mucous layer above airway epithelial cells and in airway macrophages in the 
cilia-mucous lining; penetrations by MWCNTs in the airways were rare. At the 20 μg dose, 
a total of 15 million MWCNT penetrations were observed in the 11 million alveolar type I 
epithelial cells in mouse lungs (Mercer et al. 2010).
As observed for asbestos and other fibers, rigid MWCNTs that exceed the length of alveolar 
macrophages can pierce the macrophage membrane and release reactive oxygen species 
(ROS) in the lungs, causing “frustrated phagocytosis” (Donaldson et al. 2013). The threshold 
fiber length resulting in pulmonary inflammation (14 μm) in mice after aspiration exposure 
to silver nanowires was found to be greater than the threshold length causing pleural 
inflammation (5 μm) (Schinwald et al. 2012), which is consistent with observations with 
asbestos (Davis et al. 1986; Donaldson et al. 2010). Differences in threshold fiber length 
have been attributed to different clearance mechanisms in the lung and the pleural space, i.e., 
macrophage-mediated clearance of particles or fibers to the mucociliary escalator in the 
airways or through the pleural stomata, respectively (Schinwald et al. 2012). The size of the 
parietal pleural stomata, through which the pleural fluid flows, was reported to range from 
0.8–10 μm in mammalian species from mice to humans, respectively (Schinwald et al. 
2012).
Translocation from the lungs to other organs
Several studies have reported translocation of MWCNTs from the lungs of rodents to the 
systemic circulation and to other organs. MWCNTs translocated from the lungs of mice 
were found in blood samples (Ingle et al. 2013). MWCNTs of two sizes (60–80 nm or 90–
150 nm diameter) were observed as black pigments in liver tissue 1-day post-intratracheal 
instillation, and dose-dependent toxicity and necrosis were observed in the liver and kidney 
(Reddy et al. 2010). MWCNTs seen by transmission electron microscopy were located in 
alveolar macrophages in the subpleural region two weeks after inhalation exposure of 30 
mg/m3 in mice (Ryman-Rasmussen et al. 2009). MWCNTs administered to rats by 
intrapulmonary spraying directly penetrated the pleural cavity from the lungs through the 
visceral pleura, which had visceral pleural cell proliferation at the end of the 9-day exposure 
(Xu et al. 2012). After a 90-day inhalation exposure in rats, MWCNTs (CM-100; diameter 
~10–15 nm, length ~20 μm) were detected in the pleura at 28 days post-exposure (Kim et al. 
2014). As discussed in Broaddus et al. (2011), the anatomy of the visceral pleural differs in 
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rodents and humans, which may impact the translocation of particles from the lungs to the 
pleural space.
After inhalation exposure to 5 mg/m3 of MWCNTs (MWCNT-7) in mice (5 h/d, for 12 d, 
during 3 wk), most of the MWCNTs that translocated from the lungs were found in the tra-
cheobronchial lymph nodes (1.08% on post-exposure day 1 and 7.34% on post-exposure day 
336, as a percentage of the post-exposure day 1 lung burden) (Mercer et al. 2013b). The next 
highest extrapulmonary tissue burdens of MWCNTs were reported in the liver (0.0028% and 
0.027% on post-exposure days 1 and 336, respectively) and kidneys (0.0010% and 0.0052% 
on post-exposure days 1 and 336, respectively). Lower amounts of MWCNTs were detected 
in the heart, brain, chest wall, and diaphragm (with higher amounts at post-exposure days 1 
and 336 than in all tissues except the chest wall). In the lung, 54% of the MWCNT burden 
was agglomerated, while only single MWCNT structures (average length 6.9 μm) were 
observed in the liver, kidney, heart, brain, chest wall, and diaphragm (Mercer et al. 2013b). 
The MWCNT tissue concentration in extrapulmonary organs increased after the 3-wk 
inhalation exposure, from 1 to 7% of the lung burden (by mass) on post-exposure days 1 or 
336 (Mercer et al. 2013b).
In another study of mice, 14C-radiolabeled MWCNTs (also administered by pharyngeal 
aspiration) were detected in the spleen and liver at 1 day post-exposure; the percentage of 
the administered dose in the spleen and liver increased from 0.1% to 1% at 6 and 12 months 
post-exposure, respectively, while the lung dose decreased to 20% and 10% of the 
administered dose at 6 and 12 months post-exposure, respectively (Czarny et al. 2014). To 
date, there are no reports of in vivo translocation studies of other types of CNTs, including 
SWCNTs, or CNFs.
Hypotheses on the mechanistic events related to genotoxicity and 
carcinogenicity of inhaled particles or fibers
Carcinogenicity is a multistep process that occurs at the cellular level, and genetic damage 
can occur at several steps in the pathway. Initiation is an irreversible first step in which 
mutation(s) become permanently integrated into the DNA. The initiated cell can remain 
quiescent or can undergo autonomous proliferation and clonal expansion by not responding 
to control signals for normal growth, or undergo senescence (Collado & Serrano 2005; 
Kilbey et al. 2008). Promoting agents (chemical, physiological, or physical stresses) can also 
result in cell proliferation, which can be sustained as long as the stimulus remains.
The hallmarks of cancer pathways include the following key biological events: sustained 
proliferative signaling, evasion of growth suppression, activation of invasion and metastasis, 
enabled replicative immortality, induction of angiogenesis; and resistance to cell death 
(Hanahan & Weinberg 2000; Hanahan & Weinberg 2011; Engstrom et al. 2015). Genomic 
instability and inflammation underlie these hallmarks (Hanahan & Weinberg 2011; 
Engstrom et al. 2015). Reprograming of energy metabolism and evading immune destruction 
are considered enabling characteristics (Hanahan & Weinberg 2011). Particle-induced 
persistent inflammation and inflammatory factors, which may be released in the tumor 
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microenvironment by neighboring cells, can indirectly participate in the neoplastic process 
(Table 7).
Simplistically, carcinogenic agents including particles can be broadly grouped as either 
directly or indirectly genotoxic (Velazquez et al. 1996; Schins & Knaapen 2007). Genotoxic 
agents can cause permanent changes in cellular DNA by direct interaction (or via metabolic 
activation), whereas nongenotoxic agents do not interact with DNA in a biologically 
significant way but act indirectly through other pathways such as persistent inflammation 
and cell proliferation (Velazquez et al. 1996). Relatively few chemicals are complete 
carcinogens, i.e., capable of enabling all of the hallmarks on their own (Engstrom et al. 
2015; Smith et al. 2016). Yet, exposure to individual or multiple agents can activate the 
hallmark mechanisms of cancer and disrupt normal cell function, thereby enabling the 
cancer pathways (Engstrom et al. 2015). For example, agents that activate the Ras oncogene 
or inhibit the tumor suppressor p53 gene act on the cell cycle and cell proliferation 
(Engstrom et al. 2015).
Persistent inflammation, oxidative stress, epithelial or mesothelial injury, cell proliferation, 
and genotoxicity are considered to be key events on the pathway(s) to the development of 
lung cancer and mesothelioma from exposure to poorly-soluble particles or fibers, including 
CNTs and CNFs (Figures 3 and 4) (Table 7). Cell proliferation and hyperplasia resulting 
from sustained inflammatory response and apoptosis (programmed cell death) have been 
reported for asbestos (Buder-Hoffmann et al. 2001; Heintz et al. 2010; Smith et al. 2016). 
Sustained inflammatory response can be triggered by repeated exposures and/or 
biopersistent substances at sufficient doses, as observed for CNTs and CNFs in some animal 
studies (Tables 3 and 6). Cell proliferation alone was not predictive of carcinogenesis for 
chemicals (Melnick et al. 1993).
The mechanism of cell proliferation was examined in more depth in this review since it is a 
hallmark of cancer observed for other poorly-soluble particles and fibers, and relatively few 
such data are available to date for CNTs and CNFs. For example, a study showing focal 
adenomatous hyperplasia in alveolar epithelial tissues in mice inhaling MWCNT-7 (Sargent 
et al. 2014) is examined in greater detail (in Section “Epithelial cell proliferation and 
hyperplasia–MWCNT”) since that is the only study to date to report lesions that resemble 
the human preneoplastic lesion of atypical adenomatous hyperplasia (AAH) (Brambilla et al. 
2001), although the incidence of spontaneous lung tumor in the control group is high 
(>20%). Smith et al. (2016) describe three scenarios involving alterations in cellular 
replication and/or cell-cycle control that are related to carcinogenesis – i.e., sustained 
replication, unrepaired DNA damage, and escape from normal cell-cycle control 
(Characteristic 10 of Table 7).
In general, it is recognized that different agents could act at different stages in the 
carcinogenic process, and that more than one mechanism may be involved (IARC 2006). 
Attention is given to key gaps in the data and to the relevance of the mechanisms to humans, 
especially when data are derived from experimental systems, as for CNTs and CNFs. In 
addition, consideration is given to current understanding and data gaps in the mechanisms of 
particle- and fiber-induced carcinogenesis in rodents and humans.
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In vivo (rodent) effects associated with indirect genotoxicity
Biological events that can contribute to carcinogenicity without direct interaction of the 
toxicant with DNA include persistent inflammation, oxidative stress, and deregulation of 
pathways involved in stress response signaling, apoptosis, and cell proliferation. In this 
review and the IARC monograph (in press), in vivo studies in rodents were considered the 
most relevant assays currently available to assess these endpoints. In order to evaluate the 
strength of the evidence regarding the potential carcinogenicity of CNTs, we examined the 
available evidence on the key steps in the hypothesized cancer pathways, as shown in 
Figures 3 and 4. Inhaled particles and fibers deposited in the lung can induce transient or 
persistent pulmonary inflammation and fibrosis. Deposited particles that are not cleared can 
be translocated towards the pleura. When particles and fibers are retained in the lung, 
persistent inflammatory responses may occur. As a result, persistent lung injury and 
inflammation can trigger secondary genotoxicity due to oxidative stress and frustrated 
phagocytosis of long, rigid fibers or nanotubes. Cell proliferation is triggered in response to 
lung cell injury as well as by cytokines and growth factors released from inflammatory cells 
(Colotta et al. 2009; Guerard et al. 2015). Persistent inflammation, oxidative stress, and 
epithelial or mesothelial injury and cell proliferation are considered to play important roles 
in the development of lung cancer and mesothelioma. The role of fibrosis in carcinogenesis 
has been debated, and in a recent IARC review, the proposed mechanism for carcinogenicity 
of asbestos fibers considered fibrosis as a separate pathological response to pulmonary 
inflammatory events (Figure 4.2 in vol. 100C of IARC 2012). Studies on pulmonary 
inflammation, fibrosis and injury that investigated persistent responses in the lungs and 
pleura following inhalation or instillation of CNTs or CNFs were selected for evaluation. A 
summary of these studies is provided in Table 3, and the key events are discussed further 
below.
Inhalation of poorly-soluble particles or fibers into the lung is associated with persistent 
inflammation, oxidative stress, fibrosis, and cancer in rodents (Borm et al. 2004; Madl & 
Pinkerton 2009; Mossman et al. 2011, 2013). In the absence of regulatory exposure limits 
specific to CNTs or CNFs, these materials are by default grouped in the class of poorly-
soluble respirable particles by regulatory agencies; moreover, CNTs and CNFs are high-
aspect ratio nanomaterials similar to asbestos fibers (Section “Evidence on possible steps in 
pathway(s) to lung cancer”), and concern about potential carcinogenicity relates to the 
fibrous structure as well as biopersistence of CNTs and CNFs. Acute and persistent release 
of proinflammatory mediators from lung target cells have been used as a biomarker for 
inflammation induced by exposure to CNTs, as well as asbestos fibers (IARC 2012; Boyles 
et al. 2014). Studies on pulmonary inflammatory effects of CNTs in experimental animals 
are summarized in Table 3.
Inflammation—Three mechanisms have been proposed for the release of proinflammatory 
mediators from lung macrophages following uptake of CNTs and other high-aspect ratio 
nanomaterials: (1) frustrated phagocytosis elicited by long, high-aspect ratio nanomaterials 
(Johnston et al. 2010); (2) activation of the NLRP3 inflammasome leading to release of two 
key cytokines, IL-1β and IL-18 (Hamilton et al. 2009; Palomaki et al. 2011; Biswas et al. 
2011); and (3) release of alarmins, including IL-1α, IL-33, and high mobility group box 
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protein (HMGB1) following cell necrosis (Chan et al. 2012; Jessop & Holian 2014; Rabolli 
et al. 2014). These proinflammatory mediators trigger continued recruitment of 
inflammatory cells and persistent inflammation (Grivennikov et al. 2010). Elevated 
neutrophils in BALF (bronchioalveolar lavage fluid) have been measured in workers with 
respiratory impairment who had exposure to asbestos, coal, or silica (Rom 1991), in coal 
miners with pneumoconiosis (Vallyathan et al. 2000), and in patients with acute silicosis 
(Goodman et al. 1992; Lapp & Castranova 1993). Constitutive upregulation of intracellular 
signaling pathways, e.g., NF-κB, STAT-3, and AP-1, amplifies release of additional 
proinflammatory mediators, including chemokines, prostaglandins, and heat shock proteins 
(Laskin et al. 2011; Kundu & Surh 2012; DiDonato et al. 2012; Fan et al. 2013). The 
combination of persistent recruitment and activation of inflammatory cells, ongoing tissue 
injury, and impaired tissue regeneration has been viewed as a tumor-promoting environment 
(Kuriashy et al. 2011; Trinchieri 2012). Persistent inflammation has been viewed as the 
“seventh hallmark of cancer” and has been linked to the development of genetic instability 
(Colotta et al. 2009; Hanahan & Weinberg 2011). Persistent release of reactive oxygen and 
nitrogen species is associated with DNA and chromosomal damage, impaired DNA repair, 
and aberrant methylation and gene silencing via epigenetic alterations (O’Hagan et al. 2011; 
Baylin 2012; Kidane et al. 2014).
Recent studies using genetically-engineered mice that are deficient in key proinflammatory 
mediators or their receptors or in components of the NLRP3 inflammasome provide 
evidence for a mechanistic link between the generation of ROS and acute inflammation 
following exposure to asbestos fibers (Dostert et al. 2008) or CNTs (Girtsman et al. 2014; 
Sun et al. 2015). However, acute inflammatory responses assessed 24 h post-exposure may 
not be sustained at later time points depending on the physico-chemical properties of the 
CNTs, dose, and route of delivery (Silva et al. 2014). Mice genetically deficient for the IL-1 
receptor were found to have an initial inflammatory response to CNTs that was blocked, 
while the response 28 days post-exposure was elevated (Girtsman et al. 2014). It is 
anticipated that biopersistent CNTs would be associated with persistent inflammation. Only 
a few studies have quantitated CNT clearance or retention (Mercer et al. 2013a,b; Silva et al. 
2014); in one of the studies, persistent inflammation (on day 21 post-exposure) was not 
induced by somewhat biopersistent MWCNTs (i.e., at least 10% of the ~200 μg instilled 
MWCNT mass in male Sprague-Dawley rats was still present in the caudal lobes at day 21; 
the primary length of the MWCNT was 10–30 μm in dry bulk form, but the hydrodynamic 
size was generally <1 μm in length; as-produced MWCNT was more inflammogenic than 
the purified or carboxylic acid functionalized forms) (Silva et al. 2014).
A causal association between inflammasome activation, acute inflammation, and induction 
of malignant mesothelioma by asbestos fibers was not confirmed in NLRP3-deficient mice 
(Chow et al. 2012) despite the postulated links between persistent inflammation and chronic 
lung diseases associated with inhalation of crystalline silica or asbestos fibers (Chaput et al. 
2013; De Nardo et al. 2014). Inflammasome activation may have different pathological 
outcomes depending on the initiating agent, stage in tumor development and progression, 
and the target tissue (Kolb et al. 2014). While there is experimental evidence linking 
persistent inflammation with genetic and epigenetic alterations in asbestos-induced lung 
cancer and malignant mesothelioma (Mossman et al. 2011; Broaddus et al. 2011; Mossman 
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et al. 2013), there are no chronic studies linking persistent inflammation, genetic and 
epigenetic alterations, and cancer following exposure to CNTs.
Fibrosis—Lung granulomas accompanied by fibrosis are observed in most, but not all, 
studies of rodents exposed to CNTs (Landsiedel et al. 2014) (Table 3). In humans, 
granulomas are induced in response to biopersistent stimuli, such as aspirated foreign 
materials and fungal or mycobacterial infections. Sarcoidosis is a systemic disease of 
unknown etiology that can also induce lung granulomas (Mukhopadhyay et al. 2012). 
Granulomas may become fibrotic and calcified and may be confused with lung cancer on 
radiographic images; however, granulomas are not neoplastic (Borczuk 2012). There is 
limited evidence for a causal association between sarcoidosis and the development of lung 
cancer (Artinian and Kvale 2004; Bonifazi et al. 2015; Chopra & Judson 2015).
A potential causal association between pulmonary fibrosis and lung cancer is controversial. 
Interstitial pulmonary fibrosis in humans encompasses a range of diseases that may be 
idiopathic or secondary to dust inhalation, cigarette smoking, or exposure to radiation or 
drugs (Raghu et al. 2004; Katzenstein et al. 2010; Vassallo 2012). These diseases are 
characterized by repeated episodes of lung epithelial injury with impaired repair and 
attempted healing by fibrosis. Human epidemiological studies linking interstitial pulmonary 
fibrosis and lung cancer have shown different results depending on the patient population 
and geographic location (Sharma & Lamb 2003). Humans with lung diseases characterized 
by chronic inflammation and dysplasia (which includes idiopathic pulmonary fibrosis and 
diffuse interstitial fibrosis associated with pneumoconiosis, not related to asbestos exposure) 
are reported to have an increased risk of lung cancer in a cohort of 563 patients without 
asbestos exposure (Katabami et al. 2000).
In studies of other poorly-soluble particles or fibers, lung fibrosis is induced following 
inhalation of crystalline silica or asbestos fibers in animals and humans (Mossman et al. 
2011; Leung et al. 2012) and may be linked to the development of lung cancer (IARC 2002; 
Laskin et al. 2011; IARC 2012). Some types of CNTs have also been shown to induce 
fibrosis in rodents following intratracheal instillation, pharyngeal aspiration, or inhalation 
(Bonner 2010 and summarized in Table 3). An in vitro study of well-dispersed SWCNTs 
suggested that individual CNT structures can mimic lung basement membrane substrate, 
enhancing fibroblast proliferation and collagen production (Wang et al. 2010). Macrophages 
and other resident inflammatory cells in the lung release profibrotic mediators may 
contribute to granuloma formation (Huizar et al. 2011), airway hyper-reactivity (Beamer et 
al. 2013), and impaired pulmonary and cardiovascular function (Wang et al. 2011b; Katwa et 
al. 2012). These pathological endpoints are associated with recruitment of innate immune 
cells, mast cell activation, and alternative macrophage activation associated with release of 
IL-13, IL-33, and osteopontin following exposure to CNTs in mice (Huizar et al. 2011; 
Katwa et al. 2012; Beamer et al. 2013; Wang et al. 2014b). The possible mechanistic links 
between these immunological responses associated with exposure to CNTs and development 
of cancer are unknown. However, in general during tumor development, macrophages in the 
tumor microenvironment shift their phenotype from an M1 proinflammatory phenotype to 
an M2 profibrotic phenotype (Sica & Mantovani 2012) with production of IL-10, an anti-
inflammatory cytokine, arginase, and TGF-β, which contribute to fibrosis as well as a local 
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immunosuppressive microenvironment (Hanahan & Coussens 2012; Multhoff et al. 2012). 
In vitro exposure to CNTs has been shown to induce co-expression of macrophage M1 
proinflammatory and M2 profibrotic markers (Sanchez et al. 2011; Meng et al. 2015). It has 
been postulated that IL-33 release from lung epithelial cells polarizes macrophages toward 
an M2 profibrotic phenotype (Kurowska-Stolarska et al. 2009). The contributions of acute 
inflammation (i.e., resolves after the end of exposure) versus chronic inflammatory or 
immune response (i.e., persists after the end of exposure, or with repeated exposures) to the 
development of fibrosis and other chronic pathological endpoints, including cancer have not 
been systematically investigated following exposure to CNTs.
In a recent review article, Vietti et al. (2016) discuss the key events involved in the lung 
fibrotic reaction induced by CNTs. These events can include the activation of fibroblasts 
indirectly through the release of pro-inflammatory and pro-fibrotic mediators by 
inflammatory cells, induction of oxidative stress, activation of inflammasome or NF-kB 
(Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells), or the direct 
induction of fibroblast proliferation, differentiation, and collagen production via signaling by 
ERK 1/2 (Mitogen-Activated Protein Kinases 1 and 2) or Smad (a family of proteins, named 
for their similarity to the Drosophila gene Mothers Against Decapentaplegic, Mad).
Pleural inflammation, fibrosis, and cancer associated with asbestos exposure
—Inhalation of asbestos or erionite fibers can induce both non-neoplastic and neoplastic 
pleural reactions (Broaddus et al. 2011). Pleural effusions, fibrotic parietal pleural plaques, 
and diffuse visceral pleural fibrosis occur in humans with variable latent periods following 
initial exposure (Chapman et al. 2003). In contrast to these nonneoplastic reactions, diffuse 
pleural malignant mesothelioma occurs less frequently and often requires a prolonged latent 
period (e.g., 30–40 years in humans). A causal relationship between these inflammatory and 
fibrotic pleural reactions and the development of asbestos-related malignant mesothelioma 
has not been established, although bilateral calcified pleural plaques are a biomarker for 
asbestos exposure (Nishimura & Broaddus 1998). However, a statistically significant 
association was observed between mesothelioma and pleural plaques in asbestos-exposed 
male subjects. The presence of pleural plaques may be an independent risk factor for pleural 
mesothelioma (Pairon et al. 2013).
A recent study in humans revealed potential molecular links between pleural inflammation 
and hyperplasia with tumorigenesis mechanisms in pleura (Ramírez-Salazar et al. 2014). 
This study examined micro-RNA expression in a small number of mesothelioma cases (n = 
5) compared to an equal number of cases with pleural fibrosis and chronic inflammation or 
atypical mesothelial hyperplasia. The targets of four down-regulated miRNAs in MPM 
(mir-181a-5p, miR-101–3p, miR-145–5p and miR-212–3p), one in PP (mir-101–3p) and one 
in HP (mir-494) were significantly enriched in “pathways in cancer”. The patients with 
mesothelial hyperplasia had a diagnosis of atypical mesothelial hyperplasia, which is 
considered by some pathologists to be a precursor lesion to malignant mesothelioma (it has 
some molecular changes characteristic of mesothelioma). However, no images were 
provided to confirm this diagnosis. Further studies are needed to determine the links 
between early changes and mesothelioma development.
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The specific physico-chemical characteristics to predict fiber-induced cancer are not known, 
although the number of longer and thinner structures has been strongly associated with 
cancer in humans and in animals. In workers with exposures to airborne chrysotile asbestos 
during textile manufacturing, the fiber dimensions that best predicted lung cancer were 
structures of >10 μm in length and <0.25 μm in diameter; however, other fiber dimensions 
were also significantly associated with lung cancer and with asbestosis in those workers 
(which could have been due, in part, to correlations in the fiber size categories across 
cumulative exposures) (Stayner et al. 2008). Similar findings were reported in earlier animal 
studies. In rats administered amphibole asbestos or other fibrous minerals (by pleural 
implantation, in 72 experiments) Stanton et al. (1981) reported that the best predictor of 
pleural sarcoma was the number of structures of >8 μm in length and <0.25 μm in diameter; 
however, a highly siginificant relationship was also found for fibers of >4 μm in length and 
<1.5 μm in diameter (Stanton et al. 1981). The authors noted that fibers of other dimensions 
could not be determined to be noncarcinogenic due to correlations in the number of particles 
in various size categories. In another study in rats (by inhalation or intraperitoneal injection), 
significantly elevated pulmonary tumors and pleural mesothelioma were associated with 
exposure to long amosite (30% fibers >5 μm) compared to rats exposed to short amosite (1% 
fibers >5 μm) (Davis et al. 1986). These authors suggested that although shorter (<5 μm) 
fibers could translocate to the pleura, they were less carcinogenic than the longer fibers (~8–
15 μm), and that the longest fibers (>25 μm) were unlikely to reach the pleura (Davis et al. 
1986). Other fiber dimensions and aspect ratios have been proposed by investigators (e.g., 
Pott et al. 1987; Lippmann 1990; Berman et al. 1995; Quinn et al. 2000).
The mechanism of carcinogenesis of biopersistent particles (both nonfibrous and fibrous) 
involves persistent inflammation and lung injury, which can trigger secondary genotoxicity 
due to oxidative stress. For long, rigid structures including nanostructures (e.g., asbestos 
fibers or MWCNT-7), incomplete uptake by macrophages and/or frustrated phagocytosis are 
hypothesized to be important drivers of persistent inflammation and lung or mesothelial cell 
injury (Nagai & Toyokuni 2012; Donaldson et al. 2013). The translocation of fibers or 
nanotubes to the pleura is also considered to be important in the development of 
mesothelioma. Direct instillation of carbon nanotubes into the peritoneal space of mice has 
been shown to induce similar acute inflammatory responses as asbestos fibers, although the 
intensity of this response depends on the dimensions and agglomeration state of the sample 
used (Poland et al. 2008). The causal association between these acute inflammatory 
responses and development of malignant mesothelioma following exposure to carbon 
nanotubes has not been critically investigated in rodents due to the difficulty in imaging this 
anatomic compartment and the long latent period before tumors develop (Broaddus et al. 
2011).
In vitro (cellular) responses associated with direct genotoxicity
Measurement of genotoxicity—DNA damage, chromosomal alterations, and cell cycle 
or centrosome disruption in vivo (rodents) or in vitro (human or rodent cells) are well-
established markers of direct genotoxicity in humans and animals and are therefore 
considered to be the most relevant precursor endpoints to assess the potential carcinogenicity 
of CNTs and CNFs. IARC emphasizes that biomarkers that measure irreversible effects 
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(e.g., chromosome aberrations and mutations) should be given higher weight than reversible 
effects (e.g., DNA damage measured by the comet assay) in the assessment of whether or 
not a specific mechanism of genotoxicity is operating in humans (IARC 2006). However, 
tests for irreversible effects are typically not suited for high through-put screening of many 
types of nanomaterials because they are laborious and there is an element of further 
exploration of test results (e.g., assessment of mutagenic spectrum after a positive test result 
on mutant frequency). One can expect that the development of genomic approaches to DNA 
repair and mutagenesis will be highly beneficial for finding relevant biomarkers (Wyrick & 
Roberts 2015). A correlation between aneuploidy in vitro and mesothelioma in vivo was 
found for asbestos and other fibers of dimensions reported by Stanton (length >8 um, 
diameter ≤0.25 um) in cultured rat pleural mesothelial cells and in rats by intrapleural 
injection, suggesting that chromosomal mis-segregation (resulting in aneuploidy) is a critical 
step in mesothelioma development (Yegles et al. 1995). Simple assays for DNA damage 
(e.g., comet assay) can be used to compare many types of nanomaterials within the same 
experimental setting of cell cultures and experimental animal models. The same is true for 
measurements of gene expression patterns where it principally should be possible to 
compare transcription profiles between benchmark carcinogenic CNTs (e.g., MWCNT-7) 
and other types of CNTs in attempt to bridge pathologic information and hazards.
The measurement of direct genotoxicity includes a number of endpoints, such as DNA 
strand breaks, including double strand breaks, and oxidatively damaged DNA base products. 
Measurement of oxidatively damaged DNA has mainly encompassed 8-oxo-7,8-dihydro-2′-
deoxyguanosine (8-oxodG) as determined by chromatographic techniques, antibody-based 
methods or comet assay modified with repair enzymes to detect oxidatively damaged DNA. 
This lesion is mutagenic in mammalian cells and gives rise predominantly to G to T 
transversions (Moriya 1993). Oxidatively damaged DNA (measured by the modified comet 
assay) has been observed in human bronchial epithelial, lung and mesothelial cells (Jacobsen 
et al. 2008; Pacurari et al. 2008; Lindberg et al. 2009, 2013), human colon carcinoma tissue 
(HT29) cells (Pelka et al. 2013), fibroblasts (Kisin et al. 2007, 2011; Yang et al. 2009), 
phytohemagglutinin-stimulated lymphocytes (Kim & Yu 2014), macrophages (Migliore et 
al. 2010; Di Giorgio et al. 2011), and human hepatocytes (Alarifi et al. 2014; Vesterdal et al. 
2014a). In principle, oxidatively generated DNA lesions can be repaired and, therefore, may 
not give rise to permanent genomic changes, such as cytogenetic lesions and mutations.
Misrepaired or unrepaired DNA double strand breaks and mitotic defects induce structural 
and numerical chromosome abnormalities, respectively. DNA damage at the chromosome 
level is measured by micronucleus assay, which may differentiate clastogenic (fragments 
without centromeres) and aneugenic (entire chromosomes with centromeres) effects, and by 
numerical changes in fluorescent in situ hybridization of inter-phase cells and chromosomal 
aberrations in mitotic cells. Micronuclei are chromosome fragments resulting from 
chromosome breakage and/or mitotic spindle damage, which are observed in interphase cells 
(Kisin et al. 2011).
The alkaline comet assay has been particularly popular for studying direct genotoxicity by 
exposure to CNTs as well as other types of engineered nanomaterials and particulate matter 
from combustion-derived air pollution (Møller et al. 2015a). The comet assay measures 
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DNA migration in an agarose gel by electrophoresis at either neutral or alkaline pH. DNA 
double strand breaks are detected by the neutral comet assay, whereas the alkaline comet 
assay (pH above 13) detects DNA strand breaks and lesions that are converted to DNA 
strand breaks by high pH conditions (so-called “alkaline labile sites”). The alkaline comet 
assay detects DNA damage; however, the damage is referred to as DNA strand breaks in this 
review to distinguish this type of damage from other lesions that are detected by modified 
versions of the assay. One such modified version of the comet assay uses a digestion step 
with DNA repair enzymes from bacterial or human cells. The enzymes encompass 
formamidopyrimidine DNA glysolase (FPG), endo-nuclease III (ENDOIII) or human 
oxoguanine DNA glycosylase (hOGG1). The FPG enzyme cleaves DNA at ring-opened 
formamidopyrimidine lesions, including 2,6-diamino-4-hydroxy-5-formamidopyrimidine 
(FapyGua) and 4,6-diamino-5-formamidopyrimidine (FapyAde). ENDOIII lesions 
encompass oxidized pyrimidines, such as uracil glycol, thymine glycol, 5-hydroxycytosine 
and 5-hydroxyuracil. hOGG1 can detect 8-oxo-7,8-dihydroguanine (8-oxoGua) or 8-oxodG. 
Results from these enzyme-modified comet assays are reported either as total sites (DNA 
strand breaks plus extra breaks generated by the enzyme) or enzyme-sensitive sites (breaks 
generated by the enzyme minus basal level of DNA strand breaks).
Concordance of approximately 80% has been reported between exposure to animal 
carcinogens and positive outcome in terms of elevated levels of DNA strand breaks (as 
assessed by the comet assay in cultured cells and animal tissues) (Anderson et al. 1998; 
Sasaki et al. 2000; Møller 2005). The alkaline version of the comet assay, for measurement 
of DNA strand breaks, complements the micronucleus assay as standard genotoxicity tests 
(Rothfuss et al. 2010). Indeed, a recently published critical review of studies on various 
types of engineered nanomaterials cites the concordance between comet assay results and 
micronuclei at approximately 80% (Karlsson et al. 2015).
The finding of genotoxicity by the comet and micronucleus assays suggests that genetic and 
related effects could occur in mammals. Comet assays indicates the occurrence of DNA 
breakage, either single or double strand, depending on the analytical method used. The 
detection of single strand breaks (SSB) depends on the location of the lesion on 
untranscribed (global genome Nucleotide Excision Repair, NER) or transcribed 
(transcription coupled-NER) regions of DNA (Hanawalt & Spivak 2008; Scharer 2013). 
Double strand breaks (DSB) can generate errors in DNA following repair by non-
homologous end-joining of breaks and may be a source of mutations (Malkova & Haber 
2012; Guirouilh-Barbat et al. 2014). A micronucleus is formed during anaphase in mitosis. It 
contains a whole or fragment of chromosome. This is indicative of defective chromosome 
segregation. In the next mitoses, a daughter cell may lack a whole chromosome or part of a 
chromosome. These mitotic defects contribute to chromosomal instability.
There are several methods to investigate mutations. Bacterial assays (Ames tests) are well 
known for studying mutations induced by chemicals and are done by determining the rate of 
histidine + auxotrophs revertants grown on glucose-minimal salts agar plates. However, the 
applicability of bacterial assays for studying mutation caused by particles is limited due to 
lack of particle uptake by bacteria (Jaurand et al. 2009). Mutation tests are available for 
studying eukaryotic cells. With mammalian cells, mutation is determined via the 
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hypoxanthine-guanine phosphoribosyltransferase (HGPRT) locus; the HGPRT gene plays a 
role in the purine salvage pathway for DNA synthesis. After treatment with a tested agent, 
mammalian cells are cultured in a medium containing 6-thio-guanine, which is metabolized 
to a toxic compound that kills the cells. However, if the HGPRT gene is mutated, the cells 
remain viable. Transgenic mice and cells from transgenic mice, such as guanine 
phosphoribosyltransferase (gpt) delta mice and Big Blue® mouse and Big Blue® rat models, 
are used to test mutagenicity. The mutations detected are principally base pair substitution, 
frameshift, and small insertions/deletions. The gpt delta mice carry the gpt gene of E. Coli 
and approximately 80 copies of phage lambda EG10 DNA. The lacI Big Blue® uses a 
lambda shuttle vector containing the bacterial lacI gene, which encodes the repressor protein 
of the lacZ gene. These assays are used to determine the number and type of mutations in 
target genes in different tissues (Environmental Health Criteria 233. Transgenic Animal 
mutagenicity assays. 2006. www.who.int/ipcs/publications/ehc/ehc233.pdf; Transgenic 
Rodent Gene Mutation Assays (OECD) by G. R. Douglas. http://www.oecd.org/
chemicalsafety/testing/46161373.pdf). Detection of mutations in mammalian cells and 
tissues can be also made directly by DNA sequencing analysis in specific genes, especially 
oncogenes. Transgenic rodent mutation assays allow the determination of mutations in 
different organs. There is no target tissue restriction since the mutations can be determined 
in tissues where the particles translocate, or even if an effect at a distant site occurs. The 
advantages (availability of different modes of administration and analysis of numerous 
tissues, assay focusing on gene mutations, correspondence with transgenic in vitro assays) 
and disadvantages (limited sensitivity to clastogens, spontaneous mutant frequency and cost) 
have been recently summarized (Lambert et. al. 2005). WHO considers that a positive study 
is predictive of carcinogenicity, and a negative result in a properly conducted transgenic 
mutation assay demonstrates that the agent is not a gene mutagen (WHO 2006).
Genotoxicity is an important endpoint related to potential carcinogenicity. In vivo 
genotoxicity data on CNTs and CNFs were limited at the time of the IARC Monograph 111 
meeting, and some targeted literature searches were subsequently performed for this review. 
A full systematic literature search was not performed; however, the following two regular, 
targeted literature searches were performed. One search strategy used PubMed, limited to 5 
years, with the keywords carbon nanotube (toxicity OR microarray). Publications on 
genotoxicity or gene expression were selected. Another search strategy used PubMed, 
EMBASE and Web of Science, with an approach similar to that described in Møller & Loft 
(2010). The search terms for materials (carbon nanotubes, SWCNT, MWCNT) were 
combined with those for endpoints (DNA damage, genotoxicity, strand breaks, oxidative 
DNA damage, micronuclei, micronucleus assay, comet assay, FPG, ENDOIII, 8-oxodG, 8-
OHdG, 8-oxoguanine, chromosome aberrations, mutations, Ames test). Publications were 
selected that reported results in mammalian species (the exception being Ames test or 
mutations in E. coli). A larger number of in vitro genotoxicity studies have been published, 
and the number is growing; similar literature search strategies were performed to update the 
available information in this area. Both positive and negative studies were evaluated for 
inclusion in this review. A few of the selected studies were excluded (as described in Tables 
S-1–S-4 in the online supplemental material).
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Inclusion criteria for DNA damage endpoints—Only studies that have used 
characterized materials have been included in the review. Information on dimensions, 
specific surface area and purity was considered necessary. The abstracted information in the 
tables is primarily fiber characteristics in dry form as supplied from the supplier. This 
inclusion criterion is pragmatic, as a very strict inclusion criterion would limit the number of 
studies in the review without promoting a better comparison of effects between studies.
The level of DNA damage in the comet assay is obtained by measuring the extent of DNA 
migration in a single nucleus in an agarose gel using fluorescence microscopy. It is standard 
practice in the comet assay to calculate the mean or median from 50 to 100 comets per gel 
and regard this as the experimental unit for statistical analysis (Møller & Loft 2014). 
However, a frequent flaw in comet assay studies has been to include all comets in the 
statistical analysis, sometimes even without independent replicates on different days, which 
gives rise to remarkably high statistical power (Møller et al. 2015a). This issue applies to all 
versions of the comet assay, although it seems most often to be observed in studies using the 
alkaline version for detection of strand breaks. The inclusion criterion for comet assay 
endpoints in the present critical review is from studies that report results from independent 
replication, typically on three different days in cultured cells or from different animals. The 
statistical analysis is based on the cell culture (not individual comets) or animals.
Another issue related to assessment of DNA damage by the comet assay is a lack of efficient 
blinding of samples before the inspection of slides in a microscope. It is sometimes 
suspected that the comet assay is a subjective technique for determination of DNA damage 
because it relies on the investigator finding the comets in the gel. Indeed, there is inter-
investigator variation in the scoring of comets by the comet assay, but a formal assessment 
of this type of process has shown that individual investigators display a remarkable 
consistency in scoring over time (Forchhammer et al. 2008). Thus, subjectivity related to 
selecting comets is not a problem if it is the same investigator who analyzes all blinded 
samples in a study. Still, it is not possible to assess whether or not samples have been 
properly blinded before analysis in the comet assay; a lack of clarity about blinding does not 
per se indicate that the samples have not been blinded before analysis. It should also be 
noted that a formal assessment of the effect of blinding in the comet assay in an inter-
laboratory validation trial with 12 laboratories did not indicate that investigators were biased 
when they knew the content of the samples (Forchhammer et al. 2012). Still, it should be 
stressed that the recent OECD guidelines for the in vivo comet assay specifically states that 
“all slides for analysis, including those of positive and negative controls, should be 
independently coded and scored “blinded” so the scorer is unaware of the treatment 
condition” (OECD 2014). The same applies to in vitro studies, although it should be 
acknowledged that efficient coding of samples can be a problem for high concentrations of 
certain types of nanomaterials because there can be residual particles left in the DNA or 
agarose gel despite repeated washings of the cells after the exposure in culture dishes. The 
complete blinding of samples can be a challenge in vivo as well since particles may be 
visible in tissues or BALF.
The inclusion criterion for studies on 8-oxodG by chromatographic or antibody based 
techniques is that levels of DNA lesions are less than 5 lesions/106 dG. The European 
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Committee on Oxidative DNA Damage recommends that studies with higher baseline levels 
of 8-oxodG than 5 lesions/106 dG in unexposed cells or animals should be interpreted with 
caution because of risk of flawed methodology (ESCODD 2003). This was clearly 
demonstrated by the fact that much higher values of 8-oxodG are obtained by ELISA 
techniques as compared to chromatographic assays (Barregard et al. 2013). Studies on 
particulate matter from air pollution or engineered nanomaterials with non-optimal assays 
for detection of oxidatively damaged DNA in animal tissues more often show increased 
genotoxicity than studies with optimal assays (Møller et al. 2013). In addition, studies with 
non-optimal detection of oxidatively damaged DNA report a larger effect size than studies 
with optimal assays (Møller et al. 2015b). Publication bias is a likely explanation for the fact 
that studies with positive test results on oxidatively damaged DNA are more likely to be 
reported in the literature because these assays are typically easy to perform and can be 
purchased as commercially kits. The consequence of using a poor method of 8-oxodG 
measurement and flawed statistical analysis can perhaps be appreciated by the fact that two 
papers on oxidative stress and genotoxicity in titanium dioxide exposed mice were retracted 
by the editor of Particle and Fiber Toxicology (see Pubmed identification number (PMID) 
26169674 and 26169780). Only studies that report levels of oxidatively damaged DNA as 
lesions/106 dG or have reported DNA damage levels in units that can be converted to 
lesions/106 dG are included in the review. In addition, only studies that investigated 
genotoxicity in lung tissue are included in the review.
The Supplementary material (Tables S-1 and S-3) provides information about studies that 
examine effects in tissues other than the lung. Studies that assessed genotoxicity in cultured 
cells are provided in Supplementary Tables S-2 and S-4. Some of the genotoxicity endpoints 
evaluated in IARC Monograph 111 are not included in this review paper, for the reasons 
discussed above. Genotoxicity endpoints from new studies were evaluated for inclusion in 
this review paper using the same criteria. In general, there is approximately 50% overlap 
between the genotoxicity endpoints included in the IARC Monograph 111 (IARC, in press) 
and in this review paper, for both in vitro and in vivo results.
Indirect genotoxicity of CNTs and CNFs: rodent studies
Evidence on possible steps in pathway(s) to mesothelioma
Overall evidence—For some MWCNTs, evidence is available on the translocation of 
MWCNTs from lungs to the pleural cavity, inflammation and fibrosis in the pleural cavity, 
and proliferation of mesothelial cells. These studies, which are summarized below, provide 
the current state of evidence to evaluate the potential for exposure of MWCNTs in the 
respiratory tract to cause possible precursor events related to the development of malignant 
mesothelioma.
There are no studies to date on the translocation of SWCNTs from the lungs into the pleural 
cavity, inflammation in the pleural cavity, fibrosis in the pleural cavity, or proliferation of 
mesothelial cells in experimental animals. No studies were found that had investigated these 
endpoints with SWCNT. No studies of these endpoints were found for CNFs.
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Translocation to pleura – MWCNT—Translocation of MWCNTs from the lungs to the 
pleural cavity was reported in several inhalation and intratracheal instillation studies. Mercer 
et al. (2010) performed a pharyngeal aspiration study in mice exposed to MWCNT-7 and 
showed that MWCNTs had penetrated the intrapleural space from the lungs 56 days post-
exposure (80 μg dose). The translocation was confirmed by morphological observation 
(Porter et al. 2010). MWCNTs were observed in rat pleural cavity lavage after 
administration of two types of MWCNTs – MWCNT-M (same as MWCNT-7); and 
MWCNT-N – at a total dose of 1.25 mg/rat by intrapulmonary spraying (Xu et al. 2012). 
The investigators found frequent deposition of MWCNTs in mediastinal lymph nodes but 
only a few MWCNTs penetrated through the visceral pleura, suggesting that translocation of 
MWCNTs from the lung into the pleural cavity occurs via lymphatic flow. However, the 
mechanism of translocation is not well known. Fibers could also reach the pleura via 
capillaries, and parietal lymphatic drainage may concentrate the fibers in areas of the parietal 
pleura (Miserocchi et al. 2008). Yet, in the Xu et al. (2012) study, no MWCNTs were 
observed in the parietal pleura. In another study, inhaled MWCNTs were located in the 
subpleural area 1 day after inhalation (Ryman-Rasmussen et al. 2009). Those researchers 
proposed that activated CNT-containing macrophages travel via pleural lymphatic drainage 
and stimulate mononuclear cell recruitment, thus increasing focal aggregates (Ryman-
Rasmussen et al. 2009).
When F344 rats were exposed by transtracheal spraying to a larger sized needle-like 
MWCNT (MWCNT-L) and a smaller sized MWCNT (MWCNT-S) that forms cotton-like 
aggregates over a period of 24 weeks, the MWCNT-L, but not the MWCNT-S, translocated 
into the pleural cavity, deposited in the parietal pleura, and was found in pleural lavage (Xu 
et al. 2014).
Pleural cavity inflammation – MWCNT—Inflammation following inhalation or 
intratracheal instillation of MWCNTs has been shown by some studies (Ryman-Rasmussen 
et al. 2009; Xu et al. 2012; Xu et al. 2014). Acute pleural mononuclear cell aggregates were 
found following inhalation of 30 mg/m3 of MWCNTs (6 hr in 1 day; examined up to 14 wk 
post-exposure); however, cell aggregates returned to control levels 6 weeks post-exposure 
(Ryman-Rasmussen et al. 2009). In a study of two types of MWCNTs (MWCNT-7 and 
MWCNT-N) administered using intrapulmonary spraying at a total dose of 1.25 mg/rat, the 
proportion of macrophages increased, while the proportion of neutrophils and lymphocytes 
decreased, in the pleural cavity lavage fluid compared to the vehicle control (Xu et al. 2012); 
a no treatment control was not included in that study. In a more recent study, rats were 
exposed to MWCNT-L and MWCNT-S over 24 weeks (total dose: 1.625 mg/rat; 0.125 mg/
dose once every 2 weeks, total 13 times). MWCNT-L induced stronger inflammatory 
reactions than MWCNT-S, including increased inflammatory cell number and cytokine / 
chemokine levels in the pleural cavity lavage (Xu et al. 2014). Inflammation in the pleural 
cavity to either MWCNT-S or MWCNT-L was significantly greater than that in the vehicle 
or no treatment controls (Xu et al. 2014). To date, a limited number of studies have been 
published on chronic pleural inflammation of MWCNT administered to the lungs (by 
inhalation, intratracheal instillation, or pharyngeal aspiration) (i.e., Xu et al. 2014 only is 
published at this time).
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Pleural cavity fibrosis – MWCNT—Pleural fibrosis following CNT exposure has been 
described by Ryman-Rasmussen et al. (2009) and Xu et al. (2012). Following an inhalation 
exposure of 30 mg/m3 of MWCNTs, subpleural fibrosis disappeared at 14 weeks post-
exposure (Ryman-Rasmussen et al. 2009). Xu et al. (2012) examined fibrotic changes by 
Azan-Mallory’s staining on lung tissue from rats exposed to two types of MWCNTs by 
intrapulmonary spraying. Subpleural collagenous fibrosis was found under mesothelial cell 
proliferation. However, pleural and alveolar fibrosis could not be readily distinguished. In 
the study by Xu et al. (2014) using intrapulmonary spraying, MWCNT-L, but not MWCNT-
S, induced fibrosis as assessed by a significant increase in parietal and visceral thickening as 
compared to controls.
Mesothelial cell proliferation – MWCNT—We have judged the proliferation of 
mesothelial cells as a marker of pleural injury. Xu et al. (2012) showed that MWCNTs 
induce visceral mesothelial cell proliferation by proliferating cell nuclear antigen (PCNA) 
immunostaining after acute exposure (five intratracheal doses over 9 days), accompanied 
with elevated pleural inflammation and fibrosis. MWCNTs and crocidolite each induced 
PCNA at approximately 10-fold that of the vehicle control. Patchy parietal mesothelial 
proliferation lesions were found in rats treated with MWCNT-L, but not MWCNT-S (Xu et 
al. 2014). However, limited data are available to date on chronic or persistent pleural injury 
following exposure to MWCNTs through inhalation.
Evidence on possible steps in pathway(s) to lung cancer
Overall evidence—A number of studies of various types of MWCNT, several studies of 
SWCNT, and a few studies of double wall CNT (DWCNT) or CNF have shown pulmonary 
inflammatory and fibrotic responses associated with exposure to these materials by various 
routes of exposure to the respiratory tract (Table 3). The observed endpoints include increase 
in proinflammatory cytokines, granulomas and granulomatous inflammation, persistent 
inflammation, and fibrosis. In some studies, these endpoints were not observed or were not 
persistent at post-exposure time points (Table 3). MWCNTs of various types are the most 
studied of these materials to date. The studies of SWCNT tend to show persistent 
inflammation and fibrosis, while the findings in the MWCNT studies were more mixed 
(Table 3). The influence of the various material-specific vs. experimental factors on these 
response endpoints has not been assessed, including the contribution of the dose and 
duration of exposure, the physical-chemical characteristics of the materials, and the 
experimental design factors including species and route of exposure.
Pulmonary inflammation
MWCNT: There are many studies in which investigators observed pulmonary inflammation 
following inhalation and intratracheal instillation of MWCNTs in rats or mice. Duration of 
exposure and post-recovery period for the inhalation exposure are indicated in Table 3.
Persistent inflammation was found in three 13-week inhalation studies of two MWCNTs and 
one CNF in rats. Ma-Hock et al. (2009) and Pauluhn (2010) detected inflammation in the 
lungs of both female and male rats. High concentrations of CNFs were found to induce 
inflammation (DeLorme et al. 2012), while persistent or moderate inflammation was found 
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to occur with exposure to minimum concentrations of 2.5 mg/m3 (Ma-Hock et al. 2009) or 
1.5 mg/m3 (Pauluhn 2010) MWCNTs and 25 mg/m3 (DeLorme et al. 2012) CNFs.
Two 4-week inhalation studies of Wistar rats exposed to MWCNTs resulted in no evidence 
of persistent inflammation (Morimoto et al. 2012b; Kim et al. 2014). The maximum 
concentrations tested, which did not induce significant inflammation, were 0.37 mg/m3 
(Morimoto et al. 2012b) and 0.96 mg/m3 (Kim et al. 2014). The lung burdens and retention 
kinetics were not reported in those studies. An acute (6-h) inhalation study of MWCNTs in 
rats provided evidence of persistent inflammation at the concentration of 241 mg/m3 at 3 
months post-exposure (Ellinger-Ziegelbauer & Pauluhn 2009); the deposited pulmonary 
dose at the end of the 6-h exposure can be estimated at approximately 840 μg (as described 
in NIOSH 2013, Section A.2.2, assuming a ventilation rate of 0.21 L/min and 0.046 alveolar 
deposition fraction), which is in the range of the minimum mass particle dose associated 
with overloading of pulmonary clearance in rats (Section “Clearance and Retention”) and 
would be a higher volumetric dose given the less than unit density of the MWCNT 
Baytubes® (Pauluhn 2010). Another acute (6-h) inhalation study of three types of MWCNTs 
in rats at 70 mg/m3 showed no inflammation on day 21 post-exposure; the estimated 
deposited dose was reported as 380 μg for each of the MWCNT materials inhaled, “as 
produced”, purified, or carboxylic acid functionalized MWCNT in dispersion media 
(assuming a ventilation rate = 0.15 L/min, and 0.1 alveolar and tracheobronchial deposition 
fraction) (Silva et al. 2014). In the same study (Silva et al. 2014), 200 μg of each MWCNT 
materials administered by intratracheal instillation resulted in inflammation on day 1 but 
resolved by day 21 post-exposure. The administered and estimated doses in Silva et al. 
(2014) were below the minimum rat overloading doses on a mass basis (Section “Clearance 
and Retention”); density was not reported, which is needed to estimate the equivalent 
volumetric doses.
There are many intratracheal instillation or pharyngeal aspiration studies of MWCNTs that 
report the development of persistent inflammation in the lungs of rats and mice (e.g., Han et 
al. 2010; Aiso et al. 2010; Cesta et al. 2010; Porter et al. 2010; Kobayashi et al. 2011; 
Morimoto et al. 2012b; Murray et al. 2012; Sager et al. 2013). On the other hand, several 
intratracheal instillation studies of MWCNTs showed only transient inflammation in the 
lungs of rats (Kobayashi et al. 2010; Silva et al. 2014). In a study by Xu et al. (2014), rats 
were exposed to MWCNT-L and MWCNT-S over 24 weeks (total dose: 1.625 mg/rat; 0.125 
mg/dose once every 2 weeks, total 13 times), and in contrast to the pleura, MWCNT-S 
induced stronger inflammation in the lung than MWCNT-L.
Exposure to MWCNTs has been found to induce expression of a variety of cytokines that 
trigger inflammation. When pulmonary and systemic immune responses induced by 
intratracheal instillation of MWCNTs were investigated in mice (Park et al. 2009), the total 
number of immune cells in BALF were significantly increased in treated groups (5, 20, and 
50 mg/kg doses of MWCNTs), and the distribution of neutrophils was elevated 1 day after 
instillation. Pro-inflammatory cytokines (IL-1, TNF-α, IL-6, IL-4, IL-5, IL-10, IL-12, and 
IFN-γ) were also increased in a dose-dependent manner in BALF. The highest levels of 
most cytokines occurred 1 day after instillation and thenceforward decreased. Th2-type 
cytokines (IL-4, IL-5, and IL-10) were elevated in mice exposed to MWCNTs compared to 
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Th1-type cytokines (IL-12 and IFN-γ). Mice that were intranasally instilled with 1.5 mg/kg 
of double walled carbon nanotubes (DWCNTs) displayed lung inflammation and a decrease 
in oxidative perturbations, which were investigated using electron spin resonance and spin 
trapping experiments (Crouzier et al. 2010). Poulsen et al. (2013) exposed C57BL/6 mice to 
a single intratracheal instillation of 18, 54, or 162 μg of MWCNT-7/mouse. BALF and lung 
tissue samples were collected 24 h post-exposure. The total number of inflammatory cells in 
BALF was significantly increased in all treated groups, and while the numbers of 
neutrophils and eosinophils were elevated, the number of macrophages was reduced. DNA 
microarrays, confirmed by gene-specific RT-qPCR (employed to study mechanistic 
responses), showed a dose-dependent inflammatory response was observed in BALF from 
the mouse lungs, even at the lowest dose of 2 μg/mouse.
There are reports of transient pulmonary inflammation that are not accompanied by 
increased cytokines in BALF. When biological responses to a single intratracheal instillation 
of MWCNTs were assessed in rats (Kobayashi et al. 2010), transient pulmonary 
inflammation was observed in the lungs of rats exposed to 1 mg/kg of MWCNTs. However, 
BALF cytokine levels did not significantly change at any time point.
SWCNT: A four-week inhalation study of Wistar rats exposed to SWCNTs revealed no 
evidence of persistent inflammation in the lung (Morimoto et al. 2012a). On the other hand, 
intratracheal instillation and pharyngeal aspiration studies demonstrated that exposure to 
SWCNTs did cause the development of persistent inflammation in the lung (Lam et al. 
2004; Shvedova et al. 2005; Morimoto et al. 2012c). One intratracheal instillation study 
reported that rats exposed to SWCNTs had transient inflammatory responses in the lung 
(Warheit et al. 2004).
SWCNTs have been found associated with altered expression of a variety of cytokines, 
including proinflammatory cytokines, with the advent of inflammation. Pulmonary and 
systemic responses were assessed in rats after intratracheal instillation of highly pure, well-
dispersed, and well-characterized SWCNTs (Kobayashi et al. 2011). The number of BALF 
inflammatory cells increased in a dose-dependent manner. Significant increases in IL-1β and 
IL-6 levels were observed at several time points. However, only small differences were 
observed for IL-1α, IL-2, IL-4, IL-10, GM-CSF, INF-γ, or TNF-α between SWCNT-
exposed groups and controls at any of the time points. Shvedova et al. (2005) demonstrated 
that pharyngeal aspiration of SWCNTs elicited acute inflammation with early onset and 
progressive fibrosis and granulomas. An early neutrophil accumulation, followed by 
lymphocyte and macrophage influx, was accompanied by early elevation of 
proinflammatory cytokines (TNF-α, IL-1β) and then by fibrogenic transforming growth 
factor, TGF-β1. Mice exposed by inhalation to the more dispersed, smaller SWCNT 
developed an approximately four-fold greater pulmonary inflammation, interstitial collagen 
deposition, and fibrosis, when compared with mice exposed by pharyngeal aspiration to the 
less dispersed, larger SWCNT. However, the effects of particle size and dispersion could not 
be entirely determined because of the different routes of exposure and iron content, which 
was 0.2% Fe in the purified SWCNT administered by pharyngeal aspiration (Shvedova et al. 
2005) and 17.7% Fe in the unpurified SWCNT used in the inhalation study (Shvedova et al. 
2008).
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Fibrosis and granulomas
MWCNT: Pulmonary fibrosis, as well as induction of lung granulomas, has been observed 
following inhalation and intratracheal instillation of MWCNTs in rats and mice. Studies of 
Wistar rats exposed to two different types of MWCNTs for 13 weeks via inhalation provide 
evidence of granulomatous inflammation and fibrosis (Ma-Hock et al. 2009; Pauluhn 2010). 
Fibrotic responses in rat lung were found following 0.4 mg/m3 MWCNT exposure by both 
sexes (Pauluhn 2010). Six-hour inhalation studies of MWCNTs (Ellinger-Ziegelbauer & 
Pauluhn 2009; Ryman-Rasmussen et al. 2009) also provide evidence of persistent fibrosis in 
male rats and mice. In contrast, in a 4-week inhalation study, Wistar rats exposed to 
MWCNTs showed no evidence of lung fibrosis (Morimoto et al. 2012b). The maximum 
MWCNT concentration that did not induce fibrosis was 0.37 mg/m3.
A number of intratracheal instillation studies using rats or mice reveal that following 
exposure to MWCNTs, animals develop persistent or progressive fibrosis in the lung (Muller 
et al. 2005; Aiso et al. 2010; Cesta et al. 2010; Porter et al. 2010; Mercer et al. 2011, 2013a; 
Murray et al. 2012; Sager et al. 2013). On the other hand, some intratracheal instillation 
studies of rats exposed to MWCNTs report only transient or minimum fibrosis in the lung 
(Kobayashi et al. 2010; Morimoto et al. 2012b). In the above-mentioned studies (Kobayashi 
et al. 2010; Morimoto et al. 2012b), MWCNT length was relatively short but within an 
appropriate range of airborne MWCNTs that may be found in a work environment (Han et 
al. 2008).
SWCNT: Some intratracheal instillation, pharyngeal aspiration, and inhalation studies show 
that exposure to SWCNTs causes persistent or progressive fibrosis in the lungs in mice (Lam 
et al. 2004; Shvedova et al. 2005, 2008). In those studies, SWCNTs containing certain 
metals (26% nickel and 5% yttrium) (Lam et al. 2004) or higher metal content (17.7% vs. 
0.2% iron) (Shvedova et al. 2005, 2008); or 27% vs. 2% iron (Lam et al. 2004) were more 
fibrogenic than SWCNTs with the lower metal content. In addition, the SWCNT containing 
nickel and yttrium resulted in high mortality; 5 of 9 mice died 4–7 days after intratracheal 
instillation of the 0.5 mg dose. Yet, SWCNT with either low or high metal content was 
associated with early onset and persistent pulmonary fibrosis, following exposure by either 
IT instillation, pharyngeal aspiration, or inhalation (Lam et al. 2004; Shvedova et al. 2005; 
2008).
Other studies did not observe transient or minimum lung fibrosis in rats exposed to 
SWCNTs by intratracheal instillation (Morimoto et al. 2012c; Fujita et al. 2015). In the 
Fujita et al. (2015) study, granuloma formation in the lungs did not disappear until 2-years 
post-exposure. SWCNTs used in the study were relatively short compared to those in other 
SWCNT studies.
Epithelial cell proliferation and hyperplasia
MWCNT: Some studies provide evidence of proliferation of bronchiolar and alveolar 
epithelial cells following exposure to MWCNTs or CNFs by inhalation or instillation. In a 
13-week inhalation study of CNFs in rats, cell proliferation in the terminal bronchiole, 
alveolar duct, and subpleural region of the respiratory tract was induced in the lungs of male 
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and female rats; however, proliferation was no longer significantly elevated in males at 3 
months post-exposure nor in females except in the subpleural tissue (DeLorme et al. 2012). 
An intratracheal instillation study of MWCNTs revealed that pristine (a.k.a. as produced) or 
functionalized MWCNT exposure induced proliferation of alveolar and bronchiolar 
epithelial cells and macrophages at 16 days post-exposure (Roda et al. 2011). Another 
intratracheal instillation study reported that MWCNT exposure did not induce hypertrophy 
of bronchial and alveolar epithelial cells up to 6 months post-exposure (Kobayashi et al. 
2010). An aspiration exposure of B6C3F1 mice to MWCNT-7 demonstrated bronchiolo-
alveolar hyperplasia and cellular atypia that were present at 2 days after exposure to 80 μg of 
MWCNT-7, and the hyperplasia persisted at 56 days post-exposure (Porter et al. 2010). 
When mice were exposed to MWCNT-7 (inhalation of 10 mg/m3, 5 h/d), bronchiolo-
alveolar hyperplasia was observed at all time points examined (Porter et al. 2013). An 
additional study reported bronchiolo-alveolar hyperplasia 28 days after C567BL/6 mice 
were exposed by aspiration or inhalation of SWCNT (Shvedova et al 2008).
In a cancer promotion study, mice were exposed to MWCNT-7 (MCA- or MCA+) by 
inhalation (5 mg/m3, 5 hr/d, for 15 d; 17 mo post-exposure) with or without pretreatment 
with cancer initiator 3-methylcholanthrene (MCA) by IP administration. The initial 
MWCNT lung burden was 31.2 ± 0.9 μg/lung. Focal adenomatous alveolar epithelial 
hyperplasia was observed at 17 months post-exposure in the terminal bronchiole/alveolar 
duct region (Sargent et al. 2014). In humans, atypical adenomatous hyperplasia (AAH) is the 
form of primary bronchoalveolar hyperplasia considered to be preneoplastic (Foley et al. 
1991; Malkinson 1991; Brambilla et al. 2001; Ress et al. 2003; Sargent et al. 2014; Pandiri 
2015). For this reason, Sargent et al. (2014) separated hyperplasia into general hyperplasia 
and focal adenomatous hyperplasia, which resembles human AAH and which was 
“characterized by an increase in the number of crowded alveolar epithelial cells that outlined 
contiguous alveolar septa in discrete, generally random locations” (Sargent et al. 2014).
The incidence of focal adenomatous alveolar hyperplastic lesions (all severity levels) was 
12, 15, 28, or 62%, respectively, for the air, MCA, MWCNT, and MCA + MWCNT exposed 
mice; and the incidence of those lesions of marked severity was 2, 2, 5, or 27%, respectively, 
at 17 months following a 3 week inhalation exposure to 5 mg/m3 MWCNT (Sargent et al. 
2014). The incidence of carcinoma (bronchiolo-alveolar and/or adenocarcinoma) was 13, 22, 
14, or 62%, respectively, for the same exposure groups (or, 23, 52, 27, 90% for all tumors, 
including adenomas). Thus, the focal adenomatous alveolar hyperplasia incidence was two-
fold higher than the cancer incidence in the mice exposed to MWCNT only. The mechanism 
of carcinogenesis induced by MCA is gene mutation (Maddox et al. 2008), which differs 
from that expected for CNTs. MWCNT-7 does not appear to be a strong mutagen, but 
induces chromosomal aberrations (aneugens and clastogens); it also stimulates cell growth 
in vivo, and stimulates proliferation of MCA-mutated cells.
In a subsequent study of the same groups of mice studied in Sargent et al. (2014), Snyder-
Talkington et al. (2016) observed increased expression of total mRNA and miRNA in the 
blood of the mice 17 months after exposure to MWCNT-7. In mice that developed 
pathological changes in the lungs – including hyperplasia, fibrosis, bronchiolo-alveolar 
adenoma, and bronchiolo-alveolar carcinoma – after the MCA/corn oil administration 
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followed by MWCNT/air inhalation, numerous mRNAs and miRNAs in the blood were 
significantly up- or down-regulated (Snyder-Talkington et al. 2016). For a given pathology, 
the expression profile was different between the exposure groups, suggesting a specific 
response to the different exposures. Moreover, in comparisons of mRNA and miRNA 
expression in mice with bronchiolo-alveolar adenoma versus bronchiolo-alveolar carcinoma, 
each exposure group showed different profiles, indicating different regulation of the 
transition from adenoma to adenocarcinoma. Pathway analyses (Ingenuity Pathway) allowed 
determination of the top five canonical pathways associated with this transition from 
adenoma to adenocarcinoma: (1) initiation and progression of inflammation, (2) loss of 
epithelial features with mesenchymal transition, (3) neuronal cell survival after injury, (4) 
cell growth and transformation, and (5) hematopoiesis. In the MWCNT exposed group, the 
observed pathways were: wound repair, fibrosis and tumorigenesis, cell growth, proliferation 
and invasion, and cell apoptosis owing to stress to the endoplasmic reticulum. In the MCA + 
MWCNT exposed group, the observed pathways were: lipid metabolism and glycolysis, 
inflammation, cell proliferation, invasion and tumor immune evasion, and leukocyte 
migration (Snyder-Talkington et al. 2016).
A study of two types of MWCNT – “long” and “short/tangled” – found type II hypertrophy 
but not hyperplasia in mice exposed to the “long” (but not “short/tangled”) MWCNT 
(Muhlfeld et al. 2012). The “long” MWCNT (from Mitsui & Co. Ltd., Japan, but apparently 
different than MWCNT-7 based on reported mean length) was produced by catalytic 
chemical vapor synthesis using the floating reaction method, and the “short/tangled” 
MWCNT (from NanoLab, Inc., MA, USA) was produced by catalytic vapor discharge with 
a ceramic oxide (alumino-silicate) catalytic support that was removed post-synthesis by acid 
treatment. “Long” MWCNT was 13 μm in length and 40–50 nm diameter, while “short/
tangled” MWCNT was 1–5 μm in length and 15 nm diameter (as reported by the 
manufacturers) (Muhlfeld et al. 2012). The dose was 10 μg/mouse (female C57BL/6) 
exposed by pharyngeal aspiration and examined 28 days post-treatment. The lack of 
observed alveolar epithelial type II hyperplasia or AHH in the Muhlfeld et al. (2012) study is 
not necessarily unexpected given the quantitative differences in the mouse lung doses used 
by Sargent et al. (2014) and Muhlfeld et al. (2012), with an initial lung dose of 31 vs. 10 μg 
and a post-exposure duration of 17 mo. vs. 1 mo., respectively. The two studies also differed 
by MWCNT materials and mouse strain and gender.
SWCNT: One intratracheal instillation study of SWCNTs in rats showed that exposure to 
SWCNTs did not induce the proliferation of lung parenchymal cells (assessed by 5-
bromo-2-deoxyuridine (BrdU) incorporation into dividing cells’ DNA) (Warheit et al. 2004).
Genotoxicity
In vivo studies in rodents
No studies have been conducted yet that investigate genotoxic endpoints in humans with 
exposure to CNTs or CNFs. Therefore, observations from studies of animal tissue and 
cultured cells (Section “In Vitro Studies in Cultured Cells”) presently provide the most 
relevant information with regard to mechanistic evidence of carcinogenicity. A summary of 
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in vivo data on genotoxicity and gene expression endpoints in lung tissue is provided in 
Table 4.
DNA damage in lung tissue following exposure to MWCNTs or SWCNTs—
Fifteen studies were found that assessed the levels of DNA damage in rodent pulmonary 
tissue after exposure to CNTs (Table S-1). Rats exposed to 330 nm long MWCNTs (0.17–
0.96 mg/m3, 6 h/days, 5 d/wk) by nose-only inhalation for 28 days had increased levels of 
DNA strand breaks in lung tissue (2.4-fold) at the end of exposure, which had decreased at 
90 days post-exposure (1.4-fold compared to the control group) (Kim et al. 2014). In a 
similar study by the same authors, rats exposed to 2.6 μm long MWCNTs (0.16–0.94 
mg/m3, 6 hr/d, 5 d) using whole-body inhalation exposure had increased levels of DNA 
strand breaks in lung tissue immediately after the exposure (1.5-fold) and 1-month post-
exposure (1.3-fold) (Kim et al. 2012). Inhalation of MWCNTs (1.1 μm long) for 90 days did 
not affect the level of DNA strand breaks or DNA lesions measured by the hOGG1-modified 
comet assay in lung tissue of rats (Pothmann et al. 2015). Kato et al. (2013) found that a 
single intratracheal instillation of MWCNT-7 in mice (50 or 200 μg/animal) caused 
increased DNA strand breaks in lung tissue 3 h post-exposure. Intratracheal instillation of 
0.7–3.0 μm long MWCNTs in mice (25.6 μg/wk, 5 wk) was associated with elevated DNA 
strand breaks in lung tissue, whereas there were unaltered levels of FPG-sensitive sites in the 
same tissue (Cao et al. 2014). In contrast to these studies, Ema et al. (2013b) found no 
difference in DNA strand breaks in lung tissue from rats after intratracheal instillation (0.2 
or 1 mg/kg body weight, or 0.04 or 0.2 mg/kg body weight, once a wk, 5 wk) of MWCNTs 
with a length of 2.7 μm. Intratracheal instillation of MWCNTs (“large” and “small” sample; 
3 doses; 24 h; 3 and 28 d post-exposure) resulted in DNA strand breaks (comet assay) in the 
lung. Small MWCNTs significantly enhanced DNA breakage at 54 and 162 μg/mouse on 
post-exposure day 3, and large MWCNT significantly enhanced DNA breakage at all doses 
but only after one day (Poulsen et al. 2015).
Following intratracheal instillation (0.2 or 1 mg/kg body weight, or 0.04 or 0.2 mg/kg body 
weight once a wk, 5 wk) of 4.4. μm long SWCNTs in rats, DNA strand breaks in lung tissue 
were unchanged (Naya et al. 2012). Intratracheal instillation of SWCNTs with a length of 
less than 1 μm (0.5 mg/kg bodyweight at 26 and 2 h before sacrifice, total dose = 1 mg/kg) 
did not increase the level of DNA strand breaks and FPG-sensitive sites (Vesterdal et al. 
2014b). However, intratracheal instillation of the same type of SWCNTs in mice (54 μg/
animal) increased DNA strand breaks in cells collected from BALF three hours post-
exposure (Jacobsen et al. 2009). The latter study is limited by the fact that cell composition 
in the BALF differed in exposed and control animals. Therefore, it is unknown whether the 
observed increase in DNA strand breaks was due to different cell compositions (with 
different basal levels of DNA strand breaks) or SWCNT exposure.
Genotoxicity studies are informative of the ability of CNT to cause DNA base oxidation. No 
evidence of oxidatively damaged DNA (i.e., FPG-sensitive sites) was found in a study of 
atherosclerosis-prone mice following pulmonary exposure to MWCNTs and SWCNTs, but 
the administered doses were low (maximal dose of 1 mg/kg after two intratracheal 
instillations (Vesterdal et al. 2014b) and 25.6 μg/mouse per week (Cao et al. 2014). 
Gastrointestinal exposure by gavage of this SWCNT material in either saline suspension or 
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corn oil (0.064 and 0.64 mg/kg bodyweight) was associated with increased levels of 8-
oxodG in lung and liver tissue from rats, whereas the same doses did not affect the level of 
8-oxodG in colon mucosa cells (Folkmann et al. 2009), suggesting a genotoxic mechanism 
arising as a consequence of oxidative stress, although it is impossible to distinguish between 
direct and indirect genotoxic mechanisms.
These studies show that increased levels of DNA strand breaks were found in lung tissue 
following exposure by intratracheal instillation or inhalation of MWCNTs, including 
MWCNT-7 (Kim et al. 2012, 2014; Kato et al. 2013; Cao et al. 2014; Poulsen et al. 2015). 
However, one study had negative results (Ema et al. 2013b), and two studies did not report 
increased DNA strand breaks in lung tissue after intratracheal instillation of SWCNTs (Naya 
et al. 2012; Vesterdal et al., 2014b), whereas one study showed increased levels of DNA 
strand breaks in cells from the BALF (Jacobsen et al. 2009). In summary, there is evidence 
suggesting that pulmonary exposure to different types of MWCNTs and SWCNTs is 
associated with increased levels of DNA damage in lung tissue. There does not appear to be 
a straightforward relationship between the fiber length and level of genotoxicity. In general, 
the MWCNTs and SWCNTs studied contained ~2–5% iron and had lengths of a few 
microns.
Chromosomal alterations, micronuclei and mutations in lung tissue following 
exposure to MWCNTs or SWCNTs—Table S-3 lists studies that assessed levels of 
micronuclei, chromosomal damage, and mutations in animal tissues after exposure to CNTs. 
It has been shown that intratracheal instillation of 0.7 μm long MWCNTs (0.5–2 mg/rat) 
increases micronuclei frequency in type II pneumocytes at 3 days post-exposure (Muller et 
al. 2008a). Intratracheal instillation of MWCNT-7 in mice (0.2 μg/animal, once a wk, 4 wk) 
enhanced gpt mutation frequencies in the lung, whereas there were no effects after 1 or 2 
instillations (Kato et al. 2013). The predominant type of mutation was G:C to C:G 
transversions, which may be caused by oxidation of DNA bases. The investigators reported 
increased levels of oxidatively generated DNA lesions in lung tissue, but the baseline levels 
of 8-oxodG in the control group was approximately 4.8 lesions/106 nucleotides, 
corresponding to 22 lesions/106 dG. This result suggests methodological problems related to 
spurious oxidation of DNA.
C57BL/6 mice that inhaled 5 mg/m3 of SWCNTs for 4 days (5 h/d) had an increased 
frequency of pulmonary mutation of the K-ras proto-oncogene (Shvedova et al. 2008). The 
same researchers demonstrated increased levels of K-ras mutations 1-year post-exposure in 
the lung tissue of mice that were exposed to SWCNTs via inhalation (5 μg/animal, 5 mg/m3, 
5 h/d, 4 d) or pharyngeal aspiration (40 μg/animal) (Shvedova et al. 2014).
The strongest evidence of mutagenesis comes from animal studies showing increased levels 
of gpt mutations in lung tissue after intratracheal exposure to MWCNT-7 (Kato et al. 2013) 
and K-ras mutations after inhalation exposure to SWCNTs (Shvedova et al. 2008, 2014). 
MWCNT (Nanolab, CVD produced, acid-washed; 1 μm length; 15 nm diameter) has been 
shown to be a strong anuegen and clastogen (Siegrist et al. 2014). Increased centromere 
positive micronuclei suggest that CNF is also an aneugen (Kisin et al. 2011). Aneuploidy is 
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an early event in the progression of many types of cancers (Pitot & Dragan 1993; Yegles et 
al. 1995; Sargent et al. 1996; Duesberg et al. 2011; Cortez et al. 2016).
In vitro genotoxicity in cultured lung cells
DNA damage—A substantial number of studies show positive associations between 
exposure to CNTs and genotoxicity in terms of DNA strand breaks. The studies indicate a 
similar ability of MWCNTs and SWCNTs to generate genotoxicity, and there appears to be 
no fiber characteristic uniquely associated with potency for DNA damage. The in vitro data 
on genotoxicity and gene expression of cellular transformation endpoints are provided in 
Table 5.
MWCNTs: Table S-2 lists studies that assess levels of DNA damage in cell culture after 
exposure to CNTs. In contrast to animal data, there is ample evidence of genotoxicity in 
cultured cells following exposure to MWCNTs. Of the studies on pristine (as produced 
CNTs), 14 were positive for DNA damage (Karlsson et al. 2008; Barillet et al. 2010; 
Migliore et al. 2010; Di Giorgio et al. 2011; Ghosh et al. 2011; Cavallo et al. 2012; 
Kermanizadeh et al. 2012, 2013; Aldeiri et al. 2013; Lindberg et al. 2013; Darne et al. 2014; 
Ursini et al. 2014; Visalli et al. 2015; Kim et al. 2016) and 4 studies showed unaltered levels 
of DNA strand breaks for some types of MWCNTs (Thurnherr et al. 2011; Aldeiri et al. 
2013; Darne et al. 2014; Jackson et al. 2015). In a large study with 15 different MWCNTs, 
DNA strand break induction was determined in FE1-Muta™ mouse lung epithelial cells (5 
concentrations, 12.5–200 μg/mL for 24 hr) (Jackson et al. 2015). Samples were grouped by 
physical characteristics (thin, thick, short: groups I, II, III, respectively), and each set 
included pristine, hydroxylated, and carboxylated MWCNTs (Jackson et al. 2015). 
MWCNTs were weakly genotoxic, including MWCNT-7 (referred to as NRCWE-006 in 
Jackson et al. 2015). Collectively, a significant dose-dependent increase in strand break 
levels was observed. However, when samples were analyzed individually, DNA strand 
breaks were significantly increased only following exposure to a COOH-functionalized 
material (Jackson et al. 2015). MWCNTs in Group II (thick, 50–80 nm; length 10–20 μm) 
showed significantly higher DNA strand breaks than MWCNTs in Group I (thin, 13–18 nm; 
length 1–12 μm). Moreover, OH-functionalized MWCNTs from Groups I–III together 
resulted in lower levels of DNA strand breaks than the pristine and COOH forms (Jackson et 
al. 2015). A principal component analysis did not show statistically significant associations 
when all of the physico-chemical characteristics of the MWCNTs and the biological effects 
were included in the analysis. MWCNTs in Group II (which induced DNA strand breaks) 
had a large diameter and were associated with increased levels of NiO.
However, MWCNT-7 and a number of other types of MWCNTs did not alter levels of DNA 
strand breaks in lung epithelial cells (Jackson et al. 2015). Thurnherr et al. (2011) found no 
alterations in the levels of DNA strand breaks in human alveolar basal epithelial 
adenocarcinomic (A549) cells after exposure to MWCNTs with a length of 2–5 μm and only 
0.4% impurities (Thurnherr et al. 2011). No alterations in the levels DNA strand breaks were 
reported in V79 lung fibroblasts from Chinese hamsters using the same samples as used in 
SHE cells (Darne et al. 2014). Darne et al. (2014) reported levels of strand breaks resulting 
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from exposure to three samples of double walled carbon nanotubes (DWCNTs) in SHE cells 
and V79 fibroblasts; only one sample produced strand breaks in SHE cells.
Presently, reliable measurements of oxidatively damaged DNA base products in cultured 
cells have only been assessed by the modified comet assay with use of repair enzymes. 
Exposure to MWCNT was found to increase ENDOIII- and FPG-sensitive sites in rat RAW 
264.7 macrophages (Migliore et al. 2010) and A549 cells (Visalli et al. 2015). However, 
unaltered levels of FPG-sensitive sites were found in A549 and BEAS-2B cells following 
exposure to MWCNTs (Karlsson et al. 2008; Cavallo et al. 2012; Ursini et al. 2014). 
Another group of investigators showed ambiguous results regarding the level of total sites 
after FPG treatment in human hepatoblastoma and renal cell lines (Kermanizadeh et al. 
2012, 2013) and in SHE cells and V79 fibroblasts (Darne et al. 2014).
The same type of MWCNT, NM400 and NM402, were used in a European study of 
Organization for Economic Co-operation and Development (OECD) materials in animals 
and cultured cells; an overall null effect was found for oxidatively damaged DNA 
(Kermanizadeh et al. 2012, 2013; Cao et al. 2014). Thus, presently there is weak evidence of 
a genotoxic mechanism of CNTs that generates oxidatively damaged DNA lesions.
With use of the neutral comet assay that detects double strand breaks, results have indicated 
unaltered levels of double strand breaks in A549 cells after exposure to MWCNTs (Ju et al. 
2014). Similarly, neither “short” (0.1–5 μm), nor “long” (0.1–20 μm) MWCNTs increased 
γH2AX immunostaining in rat kidney epithelial cells (Barillet et al. 2010). MWCNTs did 
not alter γH2AX immunostaining in Chinese hamster V79 cells (Mrakovcic et al. 2015). 
Other studies have assessed the presence of double strand breaks in cells via γH2AX 
immunostaining. Increased immunostaining for γH2AX in human endothelial cells was 
found following exposure to short MWCNTs (less than 1 μm in length) (Guo et al. 2011). 
Another study showed that MWCNTs increased the formation of γH2AX in human 
lymphocytes (Cveticanin et al. 2010).
These findings show that a number of studies have reported that exposure to various types of 
MWCNTs increase the levels of DNA strand breaks in human bronchial (BEAS-2B) and 
lung epithelial (A549) cells (Karlsson et al. 2008; Cavallo et al. 2012; Ursini et al. 2014), 
lymphocytes (Ghosh et al. 2011), murine macrophages (Migliore et al. 2010; Di Giorgio et 
al. 2011), human and rat renal epithelial cells (Barillet et al. 2010; Kermanizadeh et al. 
2013), human hepatocytes (Kermanizadeh et al. 2012), and Syrian hamster embryo cells 
(SHE) (Darne et al. 2014). MWCNT-7 was found to cause a 10-fold increase in macrophage 
DNA strand breaks following 24 h of exposure, whereas a treatment that decreased the iron 
content rendered MWCNT-7 non-genotoxic (Aldieri et al. 2013).
SWCNTs: Studies of SWCNTs predominantly show an association between exposure and 
increased levels of DNA strand breaks in cultured cells (Kisin et al. 2007, 2011; Pacurari et 
al. 2008; Yang et al. 2009; Lindberg et al. 2009, 2013; Migliore et al. 2010; Cicchetti et al. 
2011; Di Giorgio et al. 2011; Pelka et al. 2013; Alarifi et al. 2014; Kim & Yu 2014; 
Vesterdal et al. 2014a), whereas a few studies have shown null effect (Jacobsen et al. 2008; 
Darne et al. 2014; Bayat et al. 2015). Although these studies clearly show that exposure to 
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CNTs is related with increased levels of DNA strand breaks, an assessment of relevant fiber 
characteristics responsible for this effect remains inconclusive. This is exemplified in Table 
5 (and Tables S-2), where the individual studies in Table 5 are sorted with respect to the fiber 
length of the material in dry form (typically reported by the supplier). It should be 
emphasized that some studies have attempted to characterize the material in the suspension 
vehicle, but unfortunately this does not offer enough information to allow comparison of 
gentoxicity across studies.
FE1-MML mouse lung epithelial and human hepatoblastoma HepG2 cells exposed to 
SWCNTs were found to have increased levels of FPG-sensitive sites (Jacobsen et al. 2008; 
Vesterdal et al. 2014a). There were also increased levels of ENDOIII- and FPG-sensitive 
sites in rat RAW 264.7 macrophages after exposure to SWCNTs (Migliore et al. 2010). 
However, SWCNT exposure did not increase the level of extra FPG sites in human colon 
carcinoma cells (Pelka et al. 2013).
Studies of oxidatively generated DNA damage – essentially measured by the comet assay as 
FPG-sensitive sites – in cultured human cells indicate genotoxicity after SWCNT exposure 
(Jacobsen et al. 2008; Migliore et al. 2010; Vesterdal et al. 2014a). Identical SWCNTs were 
used in three in vivo studies (Jacobsen et al. 2009; Folkmann et al. 2009; Vesterdal et al. 
2014a, 2014b). This material was used by a number of other laboratories as part of a large 
European Sixth Framework Program (FP6) project on the risk of nanomaterials called 
Particle Risk (Johnston et al. 2013).
Exposure to SWCNTs has been associated with increased levels of double strand breaks 
(measured by γH2AX immunostaining) in human lymphocytes (Cveticanin et al. 2010) and 
A549 cells (Mrakovcic et al. 2015). Another study showed unaltered levels of γH2AX 
immunostaining in human mesothelial cells, although the levels were regarded to be 
nominally increased (approximately 1.2-fold) (Pacurari et al. 2008).
Chromosomal alterations, micronuclei, and mutations in cultured cells 
exposed to MWCNTs and SWCNTs
Micronuclei formation in cultured cells exposed to MWCNTs and 
SWCNTs: Chromosomal damage and alterations in chromosome number have been found 
in exposure studies of cultured primary human lymphocytes and SWCNTs (Catalán et al. 
2012), bronchial epithelial cell line BEAS-2B and MWCNTs (Siegrist et al. 2014), and 
murine macrophages (RAW 264.7) with both MWCNTs and SWCNTs (Di Giorgio et al. 
2011) (Table 5). In addition, 13 out of 18 studies report increased micronuclei frequency in 
human cell lines after exposure to MWCNTs, including three independent studies of 
MWCNT-7 (Muller et al. 2008a, 2008b; Asakura et al. 2010; Cveticanin et al. 2010; 
Migliore et al. 2010; Di Giorgio et al. 2011; Srivastava et al. 2011; Kato et al. 2013; Wu et 
al. 2013; Darne et al. 2014; Tavares et al. 2014; Visalli et al. 2015; Kim et al. 2016); five 
studies showed null effects (Szendi & Varga 2008; Thurnherr et al. 2011; Lindberg et al. 
2013; Ponti et al. 2013; Mrakovcic et al. 2015). Eight out of 13 studies report increased 
micronuclei frequency in human cell lines after exposure to either SWCNTs or MWCNTs 
(Cveticanin et al. 2010; Migliore et al. 2010; Cicchetti et al. 2011; Di Giorgio et al. 2011; 
Kisin et al. 2011; Manshian et al. 2013; Darne et al. 2014; Kim & Yu 2014; Kim et al. 
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2016); five studies showed null effects (Kisin et al. 2007; Lindberg et al. 2009; Lindberg et 
al. 2013; Pelka et al. 2013; Mrakovcic et al. 2015). Null effect studies used CNTs similar to 
the CNTs that caused micronuclei formation with respect to diameter, length, specific 
surface area and purity, although it should be emphasized that many publications contain 
insufficient information on fiber characteristics.
Table S-4 lists studies that assess chromosomal alterations, micronuclei and mutations in cell 
cultures after exposure to CNTs. Conflicting results are reported with regard to micronuclei 
induction in cultured cells after CNT exposure. There appears to be no difference between 
the distribution of studies showing increased formation of micronuclei and null effect with 
regard to the use of the cytokinesis-block micronucleus protocol or other protocols to score 
micronuclei. Therefore, specific assay protocols are not highlighted in descriptions of in 
vitro cell culture findings.
Human lymphocytes exposed to a panel of MWCNTs showed statistical differences in 
micronuclei frequency at all tested concentrations after exposure to MWCNTs with short 
fiber length (394 nm); two human lymphocyte samples generated micronuclei when exposed 
to 1–2 low concentrations (including MWCNT-7 and NM402), and three samples did not 
generate micronuclei (Tavares et al. 2014). The investigators concluded that tube diameter 
and length, surface area and transition metal content could not explain the observed results 
(Tavares et al. 2014).
MWCNT-7 has been shown to increase micronuclei frequency in hamster lung fibroblasts 
(Asakura et al. 2010) and human immortalized lung cancer epithelial cells (A549) (Kato et 
al. 2013), and human lymphocytes (Tavares et al. 2014). Increased frequency of micronuclei 
was observed in A549 cells and immortalized bronchial epithelial cells (BEAS-2B) that 
were exposed to MWCNTs (Srivastava et al. 2011; Wu et al. 2013; Visalli et al. 2015). 
Exposure to MWCNTs has been associated with increased frequency of micronuclei in 
lymphocytes (1–5 μm long, Cveticanin et al. 2010), murine macrophage cell lines (RAW 
264.7) (0.5–50 μm, Di Giorgio et al. 2011) and human breast cancer epithelial cells (MCF-7) 
(700 nm, Muller et al. 2008a). Another study showed increased micronuclei in BEAS-2B 
and immortalized human lymphoblastoid TK ± cells (MCL-5) cells after exposure to 
MWCNTs with short (400–800 nm), medium (1–3 μm) and long (5–30 μm) fiber length 
(Manshian et al. 2013). A sample of MWCNTs with relatively short fiber length (0.7 μm) 
and low transition metal content (0.48% Fe and 0.49% Co) was used to study the impact of 
MWCNT structural defects and metals on the formation of micronuclei in rat lung epithelial 
cell lines (RLE cells) (Muller et al. 2008b). Other short samples of MWCNTs produced a 
significant increase in micronuclei frequency in SHE cells and V79 fibroblasts (Darne et al. 
2014). MWCNTs with structural defects increased micronuclei frequency, whereas heated 
and ground MWCNTs were not as genotoxic in regards to micronuclei formation (Muller et 
al. 2008b). A number of studies have shown unaltered levels of micronuclei after MWCNT 
exposure in lung epithelial A549 cells (2–5 μm, Thurnherr et al. 2011; 0.5–2 μm, Mrakovcic 
et al. 2015), BEAS-2B (1–5 μm, Lindberg et al. 2013), Chinese hamster V79 fibroblasts 
(0.5–2 μm, Mrakovcic et al. 2015), and murine fibroblasts (1.5 μm, Ponti et al. 2013). 
Cultured lymphocytes exposed to 1–2 μm long MWCNTs were observed to have no change 
in micronuclei formation and sister chromatid exchange (Szendi & Varga 2008).
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Exposure to 20 μm long SWCNTs has been associated with increased frequency of 
micronuclei in phytohemagglutinin-stimulated human lymphocytes (Kim & Yu 2014). 
Increased levels of micronuclei formation were also observed in human lymphocytes (1–5 
μm, Cveticanin et al. 2010), gingival fibroblasts (760 nm, Cicchetti et al. 2011), 
immortalized murine macrophages (RAW 264.7) (2–5 μm and 0.5–100 μm, Migliore et al. 
2010; Di Giorgio et al. 2011), and V79 fibroblasts (>1 μm in length, Darne et al. 2014). 
Elevated levels of micronuclei were observed in hamster lung fibroblasts following exposure 
to SWCNTs 1–3 μm in length, crocidolite asbestos, or CNF (Kisin et al. 2011). An earlier 
study with the same SWCNT material resulted in a trend for increased micronuclei in 
hamster lung fibroblasts (Kisin et al. 2007). Likewise, a study using short SWCNTs (0.5–2 
μm) showed increased micronuclei formation in Chinese hamster V79 fibroblasts 
(Mrakovcic et al. 2015). However, a number of studies have not found increased formation 
of micronuclei following exposure to SWCNTs in hamster lung fibroblasts (0.5 μm, Pelka et 
al. 2013), BEAS-2B (1–5 μm or 0.5–100 μm, Lindberg et al. 2009, 2013), and SHE cells (>1 
μm in length, Darne et al. 2014). CNF induced micronuclei formation (primarily aneugenic) 
in primary human small airway epithelial cells (SAEC) (Kisin et al. 2011).
In summary, cell culture studies document the ability of MWCNT, SWCNT, and CNF to 
increase the frequency of micronuclei in proliferating cells. However, these effects may 
differ substantially between studies, possibly originating from differences in cell types, 
characteristics of CNTs, dispersion protocols and assay conditions.
Alterations in chromosome morphology and number, chromosomal aberrations in cells 
exposed to MWCNTs and SWCNTs: Table S-4 lists in vitro investigations in which 
primary cells as well as established cell lines were exposed to CNTs. Exposure to SWCNTs 
has been shown to be associated with aneuploidy in primary or immortalized human airway 
epithelial cells (Sargent et al. 2009, 2012). This mechanism is considered to result from 
physical interaction and interference between CNTs and the mitotic apparatus or 
fragmentation of the centrosome and is considered to be relevant for in vivo (airway) 
exposure in humans. As determined by analysis of chromosome number by fluorescence in 
situ hybridization (FISH), primary human small airway epithelial (SAEC) or immortalized 
BEAS-2B cells were found to have errors in chromosome number after exposure to 1 μm 
long MWCNTs (Siegrist et al. 2014). Three-dimensional reconstructions of 0.1 μm optical 
sections showed MWCNTs integrated with microtubules, DNA, and within the centrosome 
structure (Siegrist et al. 2014). Chromosome breakage and translocations between 
chromosomes as well as aneuploidy were observed in an immortalized mouse macrophage 
cell line (RAW 264.7 cells) following exposure to 0.5–100 μm long MWCNTs (Di Giorgio 
et al. 2011). There was an 8–34-fold increase in polyploidy in Chinese Hamster lung cells 
treated with 5 μm long MWCNT-7 (Asakura et al. 2010). Using phyto-hemagglutinin-
stimulated human lymphocytes, Catalán et al. (2012) demonstrated that 1–2 μm long 
MWCNTs increased chromosome and chromatid breakage. In another investigation of 
immortalized Chinese hamster ovary cells, no aneuploidy was observed following exposure 
to short (150 nm) or long (10 μm) MWCNTs (Kim et al. 2011). Short MWCNTs (0.2–1.0 
μm) were also found associated with unaltered levels of chromosome aberrations in Chinese 
hamster lung fibroblasts cells (Wirnitzer et al. 2009).
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Chromosome breakage and translocations between chromosomes as well as aneuploidy were 
observed in an immortalized mouse macrophage cell line (RAW 264.7 cells) following 
exposure to 2–5 μm long SWCNTs (Di Giorgio et al. 2011). The modal number of the 
macrophage cell line karyotype was 40 chromosomes; however, the number of 
chromosomes per cell after exposure to either SWCNTs or MWCNTs had a mean number of 
20–60 chromosomes/cell with no distinct modal number, indicating a high degree of 
aneuploidy in the original cell line (Di Giorgio et al. 2011). About 1–5 μm long SWCNTs 
were found to increase chromosome and chromatid breakage in phytohemagglutinin-
stimulated human lymphocytes (Catalán et al. 2012). Cultured primary human lung 
epithelial or BEAS-2B cells had errors in chromosome number after exposure to 1 μm long 
SWCNTs, as determined by analysis of chromosomes number by FISH (Sargent et al. 2009, 
2012). Mitotic disruption associated with SWCNT-treatment resulted in a G2/M block in the 
cell cycle, which was mechanistically different from MWCNT treated cells that had a block 
in G1/S (Sargent et al. 2009, 2012; Siegrist et al. 2014). When mammalian cells are exposed 
to agents that cause a block in S-phase, the DNA is repaired by homologous recombination. 
Further analysis by confocal microscopy and transmission electron microscopy 
demonstrated fragmented centrosomes following exposure to either SWCNTs or MWCNTs 
(Sargent et al. 2009; 2012; Siegrist et al. 2014). These investigations document the ability of 
CNTs to disrupt the mitotic spindle and fragment the centrosome. In acellular conditions, 
intercalation with DNA, as well as formation of a microtubule/carbon nanotube-hybrid, 
leads to physical interference with the mitotic apparatus and/or fragmentation of the 
centrosome in response to both SWCNTs and MWCNTs (approximately 1 μm) (Li et al. 
2006; Dinu et al. 2009). These interactions lead to aneuploidy in the daughter cells of 
exposed immortalized and primary human lung epithelial cells. However, some studies 
demonstrate unaltered levels of chromosome aberrations in immortalized Chinese hamster 
ovary cells after exposure to SWCNTs with a length of 1.2 μm (Naya et al. 2011), 20 μm 
(Kim et al. 2015) or a material where the length was not reported (Ema et al. 2013a).
In summary, in vitro investigations of immortalized and primary cells document the ability 
of CNTs to increase the frequency of chromosome damage and aneuploidy in proliferating 
cells. Similar to the results from studies of micronuclei frequency, these effects may differ 
substantially between studies, possibly originating from differences in cell types, CNT 
characteristics, dispersion protocols and assay conditions. The data demonstrating 
chromosome damage and errors in chromosomes following in vitro exposure with either 
SWCNTs or MWCNTs suggest an altered integrity of the mitotic spindle, which causes a 
block in the cell cycle of cultured cells.
Mutations: An unaltered mutation frequency was found in the hypoxanthine-guanine 
phosphoribosyltransferase (HGPRT) gene after Chinese hamster lung cells were exposed to 
MWCNT-7 (Asakura et al. 2010). Mutations in the HGPRT gene were increased in 
BEAS-2B cells after exposure to SWCNTs with a length of 1–5 μm, whereas shorter (0.4–
0.8 μm) and longer (5–30 μm) SWCNTs were not associated with mutagenicity (Manshian 
et al. 2013). Exposure to SWCNTs (0.5–2 μm) was associated with increased mutation 
frequency in the HGPRT gene in Chinese hamster V79 cells, whereas MWCNTs (0.5–2 μm) 
did not induce mutations (Mrakovcic et al. 2015). Long-term exposure (24 days) of FE1-
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Muta™Mouse lung epithelial cells to SWCNTs (less than 1 μm in length) showed no 
increase in mutation frequency in the cII locus (Jacobsen et al. 2008).
The mutagenic effect of CNTs has been evaluated with bacterial test systems using 
Salmonella typhimurium strains TA97, TA98, TA100, TA102, TA1535, TA1537, TA1538, 
YG1024, YG1029, and Escherichia coli strain WP2uvrA in the presence and absence of the 
metabolic activation system S9. These studies do not show mutagenicity after exposure to 
MWCNTs (Di Sotto et al. 2009; Wirnitzer et al. 2009; Kim et al., 2011; Taylor et al., 2014) 
or SWCNTs (Kisin et al. 2007; Naya et al. 2011; Ema et al. 2012, Kim et al. 2015). Thus, 
there is little evidence to suggest that exposure to MWCNTs or SWCNTs is associated with 
a strong mutagenic potential in mammalian cells or bacteria.
To summarize, mutagenesis in mammalian cells has been found negative, including one 
study of MWCNT-7 (Asakura et al. 2010) and two studies of SWCNTs (Jacobsen et al. 
2008; Manshian et al. 2013). Lack of mutagenetic activity in terms of frameshift and base 
pair substitutions has been shown following bacterial exposure to MWCNTs (Di Sotto et al. 
2009; Wirnitzer et al. 2009; Kim et al. 2011; Taylor et al. 2014) and SWCNTs (Kisin et al. 
2007; Ema et al. 2013a; Naya et al. 2011; Kim et al. 2015). The discrepancy between 
increased mutagenicity in animal models and lack of such an effect in cultured cells suggests 
that in vitro studies may not be a reliable experimental model of in vivo mutagenicity. 
Moreover, bacterial systems are not appropriate to evaluate the mutagenic potency of 
particles, and the large majority of mutation studies were carried out with prokaryotes.
Other indicative effects: gene expression and cell transformation—Genotoxic 
mechanisms of both MWCNTs and SWCNTs are supported by observations of modulated 
expression of genes encoding proteins involved in DNA repair, apoptosis and cell cycle 
control in animal models (eight studies [Snyder-Talkington et al. (2013a), Guo et al. (2012), 
Huang et al. (2014), Poulsen et al. (2013), Park et al. (2011a, 2011b, 2013)]) and human cell 
culture (six studies [Ravichandran et al. (2010), Srivastava et al. (2011), Kim (2012), Sarkar 
et al. (2007), Wang et al. (2011a), Pelka et al. (2013)]).
Guo et al. (2012) determined a set of 35 genes, constituting a MWCNT signature in mice 
exposed to MWCNT-7. Among these genes, several encode proteins involved in lung cancer 
development and progression (Guo et al., 2012). Gene expression studies in mice exposed 
by intratracheal instillation to MWCNT-7 revealed upregulation of genes involved in 
proliferation. At low dose (18 μg/mouse), there was an upregulation of genes associated with 
promoting cell cycle transitions and/or mitosis entry: Ccna2 (cyclin A2), Ccne (cyclin E) 
and Cdca3 (cell division cycle associated 3), in comparison with control mice (Poulsen et al. 
2013). There was an upregulation, in a dose-dependent manner, of Myc (V-myc avian 
myelocytomatosis viral oncogene homolog) in the lungs of exposed mice in comparison 
with control mice (Poulsen et al. 2013). MWCNT-7 administered to the mouse lung 
epithelial cell line FE1 resulted in differential gene expression compared to controls, 
including genes stimulating cell proliferation; upregulation of fos-like antigen 1 (Fosl1), 
(jun-protooncogene (Jun) and Myc and ER stress response, DNA-damage-Inducible 
transcript 3 (Ddit3/Gadd153), with potential oncogenic functions. Several genes play a role 
in the control of cell cycle progression as check points or repair systems (RAD1 checkpoint 
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DNA exonuclease, Rad1; N-myc downstream regulated gene 1, Ndrg1; centromere protein 
5, CenpV and RAD9 homolog A (S. Pombe), Rad9). A down regulation of growth-arrest-
specific 1 (Gas1) involved in growth suppression and blockage of entry in S phase was also 
observed (Poulsen et al. 2013). These findings show that MWCNT-7 exposure engages cells 
to control their DNA integrity and growth, and that cell growth may be activated by the 
overexpression of genes that activate growth and the underexpression of genes which 
normally exert a negative control. Snyder-Talkington et al. (2013b) reported alterations of 
genes associated to cellular growth and proliferation in telomerase immortalized-human 
small airway epithelial cells (SAEC) after in vitro exposure to MWCNT-7. Several of these 
genes, were upregulated such as V-Akt murine thymoma viral oncogene homolog 1 (AKT1), 
which is activated by growth factors; vascular endothelial growth factor A (VEGFA); 
smoothened, frizzled class receptor (SMO) and Sonic Hedgehog (SHH), involved in 
hedgehog signaling and carcinogenesis; as well as downregulation of B-cell CLL/lymphoma 
2 (BCL2), an apoptosis inhibitor. The expression of transcription factors CAMP responsive 
element binding protein 3 (CREB3) and E2F transcription factor 4 (E2F4), which regulate 
cell proliferation, were also enhanced. This may suggest a growth advantage of MWCNTs-
exposed SAEC. Moreover, these genes have a role in lung adenocarcinoma (Snyder-
Talkington et al. (2013b). Early passage immortalized cells are used in these studies to 
analyze genetic changes in a cell population in response to a toxic agent; these results are 
reliable because early passage immortalized cells have a stable genotype. This can be 
verified by assurance of the passage of the cells as well as genetic analysis of the untreated 
cells. As an example, studies of immortalized cells have been used in many investigations in 
liver and skin carcinogenesis to examine changes in mutations and gene expression that 
predict stage specific changes in primary liver and skin cancer (Sargent et al 1996).
In two studies in which primary and early passage immortalized cells and primary SAEC 
cells were exposed in vitro to 10–15 nm MWCNTs (Siegrist et al 2014) or to 1–4 nm 
SWCNTs (Sargent et al. 2012), increased colony formation was observed at the lowest dose 
of 0.024 μg/cm2 CNT. Clonal growth was considered to indicate increased cell proliferation. 
The lowest in vitro dose in Siegrist et al. (2014) was equivalent (on a cell surface area basis) 
to an in vivo dose of 10 μg in mice, which was estimated to be equivalent to 34 years of 
exposure of a human to the USA National Institute for Occupational Safety and Health 
recommended exposure limit (NIOSH REL) of 1 μg/m3 for CNT or CNF.
Neoplastic-like transformation – as indicated by anchorage-independent cell growth, 
increased cell invasiveness, apoptosis resistance, increased cell motility, and angiogenesis – 
was found after prolonged exposure of human mesothelial cells to SWCNTs (Lohcharoenkal 
et al. 2014). These traits are associated with autonomous cell proliferation. Also associated 
with the cell transformation was the up-regulation of H-Ras and activation of ERK1/2, a 
downstream effector of Ras that plays a pivotal role in the regulation of cell proliferation 
cells.
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Role of physico-chemical properties associated with genotoxic or 
carcinogenic effects
Comparison of properties among CNTs, CNFs, and asbestos
Considerable uncertainty remains in understanding the role of physico-chemical properties 
in the toxicity of CNTs and CNFs. Physico-chemical characteristics that can contribute to 
differences in pulmonary responses include the tube or fiber dimensions (length and width), 
structural defects, metal contaminants, post-synthesis treatments, and surface 
functionalization of the materials prepared and tested. CNTs and CNFs can vary in their 
physicochemical properties depending on the method of preparation and the application 
(e.g., industrial vs. biomedical). Most toxic particles, including silica and asbestos, are not 
single toxic entities, but rather materials for which toxicity varies by source and 
modifications at the particle surface. This is even more the case for CNTs. Although CNTs 
and CNFs have variable dimensions, most CNTs and CNFs fall within the World Health 
Organization definition of fibers. Because of their high aspect ratios and high durability, 
which suggests substantial biopersistence, CNTs have been compared to asbestos; and 
similarities in biological responses to some types of CNTs and asbestos have been reported 
in both in vitro and in vivo studies (e.g., Donaldson et al. 2011). CNFs and CNTs have 
similar basic physico-chemical properties (Fubini, et al. 2011, Table 2) and limited studies 
have shown qualitatively similar pulmonary effects (DeLorme et al. 2012; Murray et al. 
2012).
In addition to the properties of aspect ratio and durability, surface reactivity can modulate 
the toxicity of CNTs (e.g., Sanchez et al. 2009; Jaurand et al. 2009, Fubini et al. 2011). The 
surface chemistry of CNTs and asbestos in their native forms can be “quite different” 
(Fubini et al. 2011). One major difference is that unfunctionalized CNTs are highly 
hydrophobic, while asbestos is highly hydrophilic in all its forms. The surface charge of 
unfunctionalized CNTs is very low to negative at physiological pH, while asbestos has a 
high surface charge (i.e., negative for amphiboles, and positive for chrysotile). The types and 
amounts of bioavailable metals in unpurified CNTs can be highly variable, including 
metallic and/or ionic moieties (e.g., Co, Ni, Fe, agglomerated within the tube as residual 
catalyst). By comparison, asbestos typically occurs only with Fe ions present (i.e., mostly 
Fe2+/3+ in amphiboles, as stoichiometric complements that are regularly organized in the 
crystalline structure, and a few isolated Fe2+ions that are substituted for magnesium ions in 
all asbestos forms) (Fubini & Otero-Aréan 1999; Fubini et al. 2011). Agglomeration in 
aqueous media is much more pronounced for hydrophobic CNTs compared to asbestos, 
which can split longitudinally into fibrils. Enzymatic degradation has been reported for 
specific preparations of CNTs (with carboxyl functionalities at the surface obtained by 
oxidation) (Section “Solubility/Degradation in Body or Cellular Fluids”), while similar 
effects have not been reported for asbestos fibers, likely reflecting the difference between a 
carbon and a silica framework.
The variability among CNTs and CNFs in physico-chemical properties is the result of 
multiple factors, including the following: (1) wall number, e.g., preparation as SWCNT or 
MWCNT, which results in different diameters and flexibility; (2) presence of various metals, 
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which may have been used as catalysts and then remain within the carbon framework in 
trace or substantial amounts and may be fully or partially accessible by fluid molecules; (3) 
small or large number of framework defects, depending on the mechanical and thermal 
procedure to which CNTs have been submitted; (4) length and shape [straight, curled or 
entangled]; (5) “functionalization,” meaning that organic chains are linked to the carbon 
framework, a process usually done by oxidation to make CNTs more hydrophilic and easily 
dispersed in aqueous media, or to give them the potential to carry drugs, peptides or other 
groups of interest; and (6) formation of different types of protein corona in suspension 
vehicles (Shannahan et al. 2013).
A recent quantitative analysis of data across studies was used to examine the contribution of 
physico-chemical characteristics of CNTs on the dose–response relationship for pulmonary 
inflammation (Gernand & Casman 2014). Classification and regression tree methods were 
used since these methods are better able to handle statistical challenges in meta-analyses, 
such as missing data. Of note, classification and regression tree techniques are developed for 
prediction purposes, and causal interpretations have to be done with reservation. The results 
showed that the most important characteristics contributing to pulmonary toxicity were 
metallic impurity (positive association with cobalt and mixed effect of other metals), CNT 
length (negatively correlated with most toxicity indicators), CNT diameter (positively 
associated with toxicity), aggregate size (positive or negative correlations depending on the 
toxicity endpoint), and specific surface area (negatively associated with toxicity indicators). 
These results are somewhat unexpected based on evidence from the fiber and nanoscale 
particle paradigms. However, it must be mentioned that variables considered by the authors 
were endpoints measured in BALF extracted from the lungs of animals exposed by 
inhalation or instillation: increase of PMNs, macrophages, LDH, and total protein, which 
represent only some of the potential biological responses to CNTs. Closer examination of 
these associations may reveal reasons for the findings, such as that a given mass dose of 
shorter CNTs contains a higher concentration of reactive free ends. In addition, extension of 
such databases to examine pre-cancer endpoints could provide useful insights on the role of 
physico-chemical properties, assuming the data across studies are sufficient for meta-
analysis.
Few studies have purposely modified or prepared sets of CNTs for in vitro or in vivo testing 
in order to associate toxicity to particular physico-chemical properties (see, for instance, 
Muller et al. 2008b; Roda et al. 2011; Aldieri et al. 2013; Bonner et al. 2013; Hamilton et al. 
2013; Ponti et al. 2013; Sager et al. 2014). In most cases, the CNTs tested are based on the 
availability of materials as prepared for a given purpose or application (see for instance Li et 
al., 2013; Jackson et al., 2015). CNTs are used in a wide range of applications including in 
the areas of medicine (imaging, drug delivery), environment, and electrochemistry. Because 
of their hydrophobicity, pristine CNTs must be functionalized for certain applications. The 
large number of potential applications of CNTs and CNFs may result in a potentially wide 
variety of CNTs or CNFs that are produced for those purposes, resulting in potential 
differences in the biokinetics and toxicities of those materials. Thus, on the one hand, the 
responses to CNTs and CNFs could be expected to be similar to asbestos, while on the other 
hand, the potential differences in the surface properties of these materials (e.g., 
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agglomeration, scavenging, ion release, charge) may imply different molecular mechanims. 
The overall surface activity would be a combination of these properties.
At this time, it is not possible to define the specific characteristics that account for the 
reported differences in toxic responses to various types of CNTs and CNFs. Differences in 
the physico-chemical characteristics of the materials as prepared and tested (e.g., 
dimensions, structure, defects, functionalization, contaminants) clearly play a role, but the 
key parameters and their relative importance have not been definitively determined. A 
number of studies discussed below provide information on the properties that were shown to 
modulate the toxicity of CNTs.
Form, size, length and thickness
Long, rigid CNTs were observed to induce more inflammation in the abdominal cavity than 
tangled ones (Poland et al. 2008; Nagai et al. 2011). CNTs over 4 μm long were reported to 
be pathogenic to the pleura of mice, and a threshold length value (4–5 μm) was proposed by 
Schinwald et al. (2012) for inducing acute inflammation in a mouse model. The acute 
pleural inflammation was attributed to the longer fiber lengths regardless of the material 
composition (i.e., silver or nickel nanowires or amosite asbestos) (Schinwald et al. 2012). A 
similar size-dependent inflammatory response was observed in mice administered 
MWCNTs or Ni nanowires by intrapleural injection (5 μg/mouse) (Murphy et al. 2011). In 
the same study, pleural clearance of long fiber structures (13 μm mean length) was reduced 
in mice administered MWCNT, compared to the same mass dose of MWCNT consisting of 
shorter structures (0.5–5 μm lengths); and the mice administered the long MWCNT 
developed inflammation and fibrosis of the parietal pleura compared to “no or modest 
resolving inflammation, with no parietal pleural pathological features” in mice administered 
the shorter MWCNTs at the same mass dose (Murphy et al. 2011; Donaldson et al. 2013). In 
a recent two-year study of rats, four CNTs differing in shape caused mesotheliomas, but the 
appearance of the tumors occurred much earlier with long and straight CNTs than curled 
CNTs (Rittinghausen et al. 2014). This result is similar to asbestos, but a strict analogy 
between asbestos fibers and CNTs is questionable, considering their differences in chemical 
composition and structure (Fubini et al. 2010, 2011). Pleural inflammation and fibrosis are 
induced only by long (>10 μm) CNTs after IP (Kolosnjaj-Tabi et al. 2010) or intrapleural 
injection (Murphy et al. 2011). The adverse effects of exposure to long, rigid (>10 μm) 
CNTs have been related to their physical interaction with cells, resulting in incomplete 
internalization, frustrated phagocytosis, and length-limited clearance from pleura through 
lymphatic stomata. Manshian et al. (2013) found that SWCNTs significantly increased the 
micronucleus frequency in BEAS-2B and lymphoblastoid (MCL-5) cells at sub-cytotoxic 
concentrations, with potency markedly decreasing with length, but only the shortest 
SWCNTs being mutagenic in mammalian cells.
No mesothelioma was found in six rats 12 months after IP injection of 10 mg tangled 
MWCNT (dimensions not reported), although significant mesothelioma was reported in rats 
(n = 6–30) administered 1 or 10 mg of MWCNTs with diameters of 50 to 140 nm and 
lengths of approximately 5 μm (Nagai et al. 2011, 2013). Although the Nagai et al. (2011, 
2013) studies provide some data suggesting a lower carcinogenic potency of tangled carbon 
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nanotubes, the IARC monograph 111 Working Group concluded that the investigations had 
an insufficient number of animals to show a negative result (IARC, in press).
Thinner (diameter ≈ 50 nm) MWCNTs appear to be significantly more active than thicker 
(diameter ≈ 150 nm) or tangled (diameter ≈ 2–20 nm) CNTs in causing mesothelial toxicity 
and mesothelioma in rats, but thin and thick MWCNTs were found to affect macrophages 
similarly (Nagai et al. 2011). In contrast, thin MWCNTs (diameter 9.4 nm) were more toxic 
in vivo (rats, lung) and in vitro (murine alveolar macrophages) than thicker MWCNTs 
(diameter ≈ 70 nm) (Fenoglio et al. 2012). Thinner CNTs were also found to be more 
cytotoxic to EAhy926, A549, HepG2, DMBM-2 V79 and TK-6 cells than thicker CNTs 
(Frohlich et al. 2013). However, long and thick CNTs, but not short and thin MWCNTs, 
were shown to cause inflammation in mice (Yamashita et al. 2010). Longer SWCNTs (>10 
μm) induced granuloma formation, while shorter SWCNTs (<300 nm) were excreted from 
the body in mice (Kolosnjaj-Tabi et al. 2010).
Qualitatively, these animal IP studies suggest that the carcinogenic potency (e.g., proportion 
of animals with tumors at a given dose) of CNTs appears to follow the fiber paradigm, with 
greater cancer potency associated with longer, biopersistent structures. However, CNT and 
CNF materials typically consist of a distribution of sizes, and specific dimensions of CNT 
structures associated with the carcinogencity of CNTs could not be determined in the IARC 
monograph (IARC, in press). It should be noted that definitive sizes of asbestos and other 
fibers that are carcinogenic has also not been determined, although long fibers are more 
carcinogenic that short fibers, when using a cutoff at 5 μm (Boulanger et al 2014). 
Regulatory standards for asbestos are typically based on fiber counts of structures >5 μm in 
length with a 3:1 (length:width) aspect ratio, as measured by phase contrast microscopy (in 
which structures greater than approximately 250 nm are visible). Research is needed to 
determine which length limits, if any, would be applicable to CNTs.
Defects
An ideal CNT is formed only by hexagonal rings of sp2 hybridized carbons. CNTs currently 
produced are far from perfect as the graphene layers contain various degrees of defects that 
either arise directly from CNT synthesis or may be introduced post synthesis. Typical 
defects are non-hexagonal rings, atom vacancies, sp3 hybridized carbon, incomplete 
bonding, and/or oxygenated groups (Ebbesen & Takada 1995; Charlier 2002; Galano et al. 
2010). In a study of the same MWCNT specimen, with or without defects, studied by 
Raman spectroscopy, micronuclei formation in cultured cells and inflammation and 
fibrogenicity in vivo correlated with the presence of broken C-C bonding generated by 
grinding (Muller et al. 2008a). Unaltered levels of micronuclei frequency were observed 
when all defects were eliminated by thermal treatment (Muller et al. 2008a).
Surface functionalization
The effect of surface functionalization is controversial because both lower and higher 
toxicity have been reported when functionalized and unfunctionalized CNTs were 
compared. This may arise from two contrasting factors: (1) an improved dispersibility, 
which increases “the dose” by allowing direct contact of single CNTs with cells and tissues, 
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and (2) some surface functionalities, e.g., carboxyls, that reduce adverse effects. The latter 
case concerns effects that depend on the chemical nature of the functionality employed. 
Surface oxygenated functionalities increase CNT toxicity in some models (Bottini et al. 
2006; Vittorio et al. 2009; Pietroiusti et al. 2011). In contrast, Cheng et al. (2008) reported 
that purified PEGylated (polyethylen glycol) SWCNTs, albeit reversibly internalized and 
translocated into the nucleus, were non-genotoxic in mammalian cells in terms of cell cycle 
distribution and mitosis after 5 days of continuous exposure. Anionic functionalization 
(COOH and PEG) decreased pulmonary fibrogenic potential compared to prepared 
MWCNTs, whereas strong cationic functionalization (polyethyleneimine) induced more 
pulmonary fibrosis. Neutral (NH2) and weakly cationic (SW-NH2) functionalized CNTs 
have similar fibrogenic potential compared to as-produced CNTs. The mechanism of these 
effects involves differences in cellular uptake of MWCNTs, lysosomal damage, and 
cathepsin B release associated with NLRP3 inflammasome activation (Li et al. 2013).
Hamilton et al. (2013) examined alveolar macrophages from C57BL/6 mice exposed to four 
distinct MWCNTs: (1) poorly water soluble raw, (2) “as-received,” (3) purified, highly water 
soluble –COOH-terminated raw and (4) purified. While simple purification reduced cellular 
toxicity and inflammasome activation only slightly compared to raw MWCNTs, 
functionalization of MWCNTs with –COOH groups dramatically reduced both outcomes. 
All particles were taken up by alveolar macrophages; however, purified MWCNTs were 
taken up in large vacuoles or phagolysomes and did not appear to be free in the cytoplasm. 
In contrast, the two functionalized MWCNTs appeared not to be in large vacuoles but more 
evenly distributed in smaller phagolysosomal structures or free in the cytoplasm. The results 
confirm that MWCNTs activate the NLRP3 inflammasome through a process involving 
phagolysosomal permeabilization, release of cathepsin B, and activation of caspase-1. Sager 
et al. (2014) investigated the same set of MWCNT in vivo. Unmodified and surface 
functionalized with -COOH MWCNTs were instilled intratracheally into C57BL/6 mice. 
Biomarkers for pulmonary inflammation included cytokines (IL-1b, IL-18, IL-33), 
profibrotic mediators, inflammatory cells (neutrophils), lysosomal release of cathepsin B, 
and markers of injury (albumin and lactate desydrogenase). The results showed that surface 
modification by the addition of the -COOH group to the MWCNT significantly reduced 
bioactivity and pathogenicity. Difference in bioactivity correlated with the activation of the 
NLRP3 inflammasome.
Solubility/degradation in body fluids
In vivo—The graphitic structure of CNTs makes them highly insoluble, yet several studies 
report that the carbon structure may be attacked and biodegraded in the lung by endogenous 
oxidants, predominantly peroxidases (e.g., myeloperoxidase [MPO] or eosinophil 
peroxidase [EPO]) in biological simulation fluids or in vivo (MPO, Kagan et al. 2010, EPO, 
Shvedova et al. 2012). Using MPO-deficient mice, Shvedova et al. (2012) showed that MPO 
contributes to the pulmonary oxidative biodegradation of SWCNTs in vivo.
In vitro—Two different routes of attack and degradation of CNTs by endogenous oxidants 
have been reported. The first route is via peroxidation: several peroxidases, such as MPO 
(Kagan et al. 2010) and eosinophil peroxidase (EPO; Shvedova et al. 2012), can degrade 
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chemically cut, short CNTs. Andon et al. (2013) reported SWCNT degradation upon 
incubation with human EPO, lactoperoxidase, and hydrogen peroxide. Biodegradation of the 
SWCNTs was higher in the presence of sodium bromide, but neither EPO alone nor 
hydrogen peroxide alone caused the degradation of nanotubes. The second route is via 
nonenzymatic degradation, which can occur when CNTs are in contact with simulated 
phagolysosomal fluid (Liu et al. 2010; Stern et al. 2012; Elgrabli et al. 2015). Surface 
functionalization directly influences the degree to which CNTs can be biodegraded (Liu et 
al. 2010, Bianco et al., 2011). The rate of degradation is associated with both the extent of 
surface functional groups and type of CNTs. MWCNTs are more resistant to degradation 
than SWCNTs and, thus, take longer to degrade. However, workers may be less likely to be 
exposed to functionalized or cut CNTs than to the raw or pristine CNTs that potentially have 
longer retention half-lives.
Radical production in cells and cell-free systems
MWCNTs and SWCNTs have the ability to quench free radicals (Fenoglio et al. 2006, 2008; 
Galano 2010). In vitro, CNTs retard the oxidation of polystyrene, polyethylene, 
polypropylene, and polyvinylidene fluoride due to their strong radical accepting ability, 
which may interrupt chain propagation, leading to antioxidant effects in polymeric material 
(Watts et al. 2003). Lucente-Schultz and coworkers demonstrated that pristine SWCNTs are 
powerful antioxidants in a cell-free system (Lucente-Schultz et al. 2009). Various modified 
CNTs exhibit different chemical composition and structure at defective sites. Ultraviolet-
visible and Raman spectra revealed that the efficiency of hydroxyl or 2,2-diphenyl-1-
picrylhydrazyl to scavenge radicals increased with increasing number of defective sites on 
modified CNTs (Shieh & Wang 2014). In the absence of defects, the quenching potential is 
lost (Fenoglio et al. 2008; Muller et al. 2008b).
Discussion of review findings
Overview of mechanisms
CNTs and CNFs share some common attributes with poorly-soluble particles, which have 
been shown to induce persistent inflammation and lung cancer in rodents (IARC 1997; 
Borm et al. 2004). Many types of CNTs and CNFs also have fiber characteristics, and some 
fibers (e.g., asbestos) have been associated with elevated risk of lung cancer and 
mesothelioma in humans and animals (IARC 2012). Rodent studies of intraperitoneal 
injection of certain MWCNTs have shown elevated mesothelioma, and MWCNT-7 has been 
identified as a promoter of lung cancer in mice (Section “Rodent Cancer Data on CNTs”). 
The translocation of fibers or nanotubes to the pleura is considered an important factor in the 
development of mesothelioma following inhalation exposure (Sections “Translocation from 
the Lungs to Other Organs” and “In Vivo (Rodent) Effects Associated with Indirect 
Genotoxicity”) (Figure 3).
The mechanism for particle and fiber-induced lung cancer involves the deposition and 
retention of particles in the lungs, which at sufficient doses can trigger the persistent influx 
of neutrophils, generation of reactive oxygen and nitrogen species, cell injury, cell 
proliferation, fibrosis, DNA oxidation damage, mutation and/or chromosomal alterations, 
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and eventually cancer (Knaapen et al. 2006; Schins & Knaapen 2007; Baan et al. 2007; 
IARC 2010) (Figures 3 and 4). Fibrous structures (fibers or tubes) of sufficient length and 
rigidity can cause an elevated inflammatory response due to frustrated phagocytosis 
(Sections “Cell Uptake and Interaction” “In Vivo (Rodent) Effects Associated with Indirect 
Genotoxicity”; “Form, Size, Length and Thickness”). The mechanistic evidence is based 
primarily on studies in rodents, especially rats. The exact physico-chemical characteristics to 
predict particle- and fiber-induced cancers are not known, and multiple factors could be 
involved. Some evidence in humans and rodents on asbestos and other mineral fibers has 
shown that the longer and thinner structures (e.g., >5–10 μm in length and <0.25 μm in 
diameter) are strongly associated with lung cancer or mesothelioma; however, other fiber 
dimensions are also significantly associated with cancer (Section “In vivo (rodent) effects 
associated with indirect genotoxicity – Pleural inflammation, fibrosis, and cancer associated 
with asbestos exposure”).
Inflammation-mediated cancer is considered to be an indirect (secondary) cancer 
mechanism. In addition, asbestos fibers, MWCNT, and SWCNT have been shown to 
physically disrupt cells and cellular structures, resulting in DNA damage and chromosomal 
alterations in dividing cells (Section “Genotoxicity”). Genetic instability (due to DNA 
mutations or chromosomal alterations) and the selection and amplification of genomically 
unstable cells are considered to be key events in the development of lung cancer or 
mesothelioma from exposure to biopersistent fibers of various types, and potentially to 
CNTs and CNFs (Table 7) (Figure 4). However, the available evidence is too limited to link 
the key events in the hypothesized cancer pathway across the various types of CNTs and 
CNFs.
A summary of the available evidence – and gaps – for key events in possible carcinogenic 
pathways is shown in Table 6. Reducing uncertainty in the relationships between these 
events and carcinogenesis and validating the predictive endpoints would permit assessment 
of a larger set of substances than is currently available. Such evidence might be used in 
future IARC evaluations, in which mechanistic evidence can substitute for conventional 
cancer bioassays when there is less than sufficient evidence in experimental animals or in 
epidemiological studies (Figure 2) (IARC 2006; Cogliano et al. 2008). Mechanistic data are 
likely to become increasingly available, especially for new materials such as CNTs and 
CNFs; thus, gaining a better understanding of these mechanisms will improve the evidence 
basis in the future. In order to develop such mechanistic evidence, further research and 
validation is needed to link the cancer-related (precursor) responses in the in vitro studies 
and the short-term in vivo studies to the cancer findings in vivo, with regard to the dose 
across experimental systems and to the physico-chemical properties of the materials.
The goals of this critical review were to summarize and further examine the mechanistic 
evidence and data gaps on the potential carcinogenicity of CNTs and CNFs. We extended 
our evaluation from the original IARC evaluation to include published studies on CNFs, and 
additional published studies in key areas of evidence with limited data including studies of 
pulmonary responses in workers and experimental animal studies on genotoxicity and cell 
proliferation as follows (see also Section “Substances and Endpoints Evaluated”). Recently 
published biomonitoring studies in workers exposed to MWCNT are discussed in Section 
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“Worker Exposures and Lung Responses” (Fatkhutdinova et al. 2016; Shvedova et al. 2016). 
One two-year rodent cancer bioassay of four types of MWCNT was published after the 
IARC Monograph 111 meeting and added to this review (Rittinghausen et al. 2014) (Table 
1). A recent article (Suzui et al. 2016) showing mesothelioma in rats exposed to MWCNT-N 
by the pulmonary route is briefly discussed at the end of this section. One new subchronic 
inhalation study in rats of one type of MWCNT was published after the monograph meeting 
and added to this review (Pothmann et al. 2015). A recent study of pulmonary deposition 
and retention kinetics of MWCNT based on in aggregated vs. dispersed aerosolized 
MWCNT is included (Pauluhn & Rosenbruch 2015). Two rodent studies of CNF were added 
(Murray et al. 2012; DeLorme et al. 2012). One acute inhalation study in rats of three 
variations of a MWCNT was added (Silva et al. 2014). Several studies are cited that assessed 
in vivo genotoxicity, gene and miRNA expression and cell transformation endpoints, DNA 
damage, and micronucleus frequency in rodent lung issues, which included: Shvedova et al. 
2008, 2014; Kato et al. 2013; Snyder-Talkington et al. 2013a, 2016; Vesterdal et al. 2014b; 
Poulsen et al. 2015; (Table 4). Some studies were excluded following examination (as 
described in Tables S-1 and S-3). A number of in vitro geno-toxicity studies in human lung 
or mesothelial cells were added to this review (Tables S-2 and S-4) (as described in Section 
“In vitro (cellular) responses associated with direct genotoxicity–Measurement of 
genotoxicity”). Further discussion in this review on key events and mechanisms of carcino-
genesis provides additional relevant references since the monograph meeting. Quantitative 
estimates of total deposited doses in rodent studies and workers are compared (Sections S-1–
S-3 in online supplementary material). Finally, the currently available evidence and data 
gaps (Tables 6 and 7) are described in this critical review.
The scientific literature is moving rapidly on the potential carcinogenicity of CNTs. 
Illustrating this point, a recent article (Suzui et al. 2016) reported increased incidences of 
malignant mesothelioma (6/38) and bronchiolo-alveolar lung tumors (adenomas and 
carcinomas) (14/38) in rats (F344/Crj male) following trans-tracheal intrapulmonary 
spraying (TIPS) of three different fractions of MWCNT-N (NIKKISO Co., Ltd) compared to 
0/28 of either mesothelioma or lung tumor response in the controls (Suzui et al. 2016). The 
average lengths of the MWCNTs were 4.2 μm before filtration and 2.6 μm in the flow-
through fraction. The total dose was 1 mg/rat, administered during the initial two weeks of 
the experiment; and rats were observed up to 109 weeks. All malignant mesotheliomas were 
seen in the pericardial pleural cavity. This is apparently the second published study showing 
carcinogenicity of MWCNT-N in rats, which could provide adequate evidence to revise the 
IARC (2014) finding on that material. It is not our purpose in this review paper to reevaluate 
the evidence and findings of the IARC Monograph working group, although we cite this 
recent article as it may be a key development in the carcinogenicity literature of MWCNTs.
Evaluation of evidence at key steps in carcinogenesis
Inhalation, deposition, and retention—Data are on airborne exposures to CNTs and 
CNFs measured in the workers’ breathing zone (Section “Worker Exposures and Lung 
Responses”) indicate that these substances are inhalable and that some fraction of the 
inhaled mass would deposit in the respiratory tract, including the pulmonary (gas-exchange) 
region (Section “Inhalation and Deposition”). In rodents, reduced clearance has been 
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reported in some but not all studies of CNTs, and may depend on the dose and duration as 
well as the particle size (Section “Clearance and Retention”). Chronic exposure studies are 
lacking for all types of CNTs and CNFs, and the long-term retention of CNTs or CNFs in 
the lung and pleura tissues has not been measured in animals.
Studies with quantitative data on the kinetics and fate of CNTs in the respiratory tract and 
other organs provide information that can help to reduce the uncertainty in extrapolating 
animal study findings to humans. Such data are available for some MWCNTs (Pauluhn 
2010; Mercer et al. 2010, 2011, 2013b), but not for SWCNTs or CNFs.
No studies are available in humans on the inhalation, deposition, retention, or translocation 
of CNTs or CNFs. Nonetheless, uncertainty is low that airborne exposure to CNT and/or 
CNF could result in the inhalation and deposition of these substances in the respiratory tract 
given the established aerosol deposition models in human and rodent respiratory tracts. 
Uncertainty is also relative low in the quantitative estimation of the deposited mass dose, 
given exposure, since the aerosol deposition models for in animals and humans are expected 
to apply to CNTs and CNFs with similar aerosol characteristics. Uncertainty is moderate/
high on the CNT/CNF dose that is retained in the lungs or translocated to the pleura in 
humans because – although the currently available data on the short-term/subchronic 
clearance, retention, and translocation of CNT in rodents are expected to be useful in 
estimating those processes in humans – such models have not yet been developed/validated, 
and data on the long-term kinetics are still lacking in animals or humans.
Migration to the pleura—Evidence from studies in rodents that have observed MWCNTs 
in pleural tissues following inhalation exposure (Ryman-Rasmussen et al. 2009; Xu et al. 
2012; Mercer et al. 2013b) (Section “Translocation from the Lungs to Other Organs”), and 
from studies of other types of fibers (e.g., asbestos and man-made fibers) in pleural tissues in 
animals and humans following inhalation exposure, suggest that humans could receive 
pleural tissue doses of MWCNTs (e.g., from airborne exposure in the workplace). However, 
the uncertainty is moderate/high on the quantitative doses of CNTs that would reach the 
pleura at specific exposure scenarios. Section S-3 provides an example of using available 
data to estimate human-equivalent airborne exposures associated with pleural tissue doses 
associated with mesothelioma in rats. These estimates suggest that the IP doses in the rat 
studies were not exceptionally high compared to those estimated for repeated exposures over 
a working lifetime. The dose rate is clearly different, however, and the role of dose rate on 
the pleural response to CNTs is not known.
Although IP injection studies are widely used for cancer hazard evaluations (Pott et al. 1991; 
JRC 1999; SCOEL 2012), and the findings from IP studies are used by IARC and others in 
carcinogen classifications, including for MWCNTs (Grosse et al. 2014; IARC, in press), IP 
study results are typically not used in quantitative assessments (e.g., potency or risk) because 
of the nonphysiological routes of exposure resulting in higher dose rates in the animal IP 
studies compared to equivalent pleural tissue doses in humans over a working lifetime 
(Section S-3). The limited amount of quantitative data on the translocation of CNTs from the 
lungs to the pleura (e.g., Mercer et al. 2013b) could be useful in developing models to 
estimate the pleural tissue dose of CNTs, e.g., from occupational exposure, and the risk of 
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mesothelioma. Further data analyzes would also be useful to explore possible correlations in 
the cancer findings from in vivo studies (including IP) and possible precursor events in 
short-term in vivo or in vitro studies (e.g., Yegles et al. 1995, as shown for asbestos and 
other mineral fibers).
Lung inflammation and fibrosis—Acute exposure to CNTs (MWCNTs, SWCNTs, 
DWCNTs) is associated with transient inflammation that resolves over time, although CNTs 
may persist in the tissues. Long-term exposure to CNTs induces a sustained inflammatory 
response associated with granuloma formation, fibrosis, and subpleural thickening. Acute or 
persistent pulmonary inflammation, pulmonary granuloma or fibrosis, and other effects were 
observed in most of the studies with MWCNTs, SWCNTs, and other CNTs. Some of the 
pulmonary responses might be due to the overload or bolus effects of CNT. Regardless of 
the number of walls or extent of purification, statistically significant dose–response 
relationships were observed for these pulmonary endpoints. Inhalation exposures to other 
samples of short (<2 μm) MWCNTs or SWCNTs did not induce pulmonary inflammation in 
rats, and intratracheal instillation of the same MWCNTs induced reversible mild pulmonary 
fibrosis. (See Sections “Pleural cavity inflammation – MWCNT”; “Pleural cavity fibrosis – 
MWCNT”; “Pulmonary inflammation”; “Fibrosis and granulomas” and Table 3 for 
references). The uncertainties in using this evidence to evaluate the potential carcinogenicity 
of CNTs and CNFs pertain to: (1) fibrosis as a precursor event in carcinogenesis (Section “In 
Vivo (Rodent) Effects Associated with Indirect Genotoxicity” and “Fibrosis”); and (2) 
persistence of the inflammatory response across the various types of CNTs and CNFs with 
repeated or chronic exposures (Section “In vivo (rodent) effects associated with indirect 
genotoxicity–Inflammation”).
Cell proliferation, hyperplasia, and cell signaling—Very few studies have critically 
examined cell proliferation and hyperplasia in rodent lungs exposed to CNTs. Cell injury, 
which can lead to cell proliferation, and hyperplasia (which is due to increased cell 
proliferation) may occur in the early stages of carcinogenesis, but these responses are 
potentially reversible if the stimulus (e.g., CNTs) is removed. However, repeated exposures 
to biopersistent materials, such as CNTs, with repeated occupational exposure, has the 
potential for continual stimulation of cell proliferation. Fibro-proliferative effects that can 
occur from biopersistent particles include septal lung fibrosis, hyperplasia, cell injury and 
turnover, and ultimately lung cancer (Donaldson et al. 2011; DeLorme et al. 2012). Some 
MWCNTs have been shown to persist in the lungs following inhalation exposure in rodents 
(Pauluhn 2010; Mercer et al. 2013a). Lung epithelial cell proliferation was observed in two 
studies in mice exposed to SWCNTs by pharyngeal aspiration or short-term inhalation, and 
in rats exposed to MWCNT or to CNF by subchronic inhalation. (Sections “Mesothelial cell 
proliferation –MWCNT” and “Epithelial cell proliferation and hyperplasia” and Table 3).
The finding of significantly increased focal adenomatous alveolar hyperplastic lesions in 
mice (male, B6C3F1) following inhalation of MWCNT-7 (Sargent et al. 2014) provides 
evidence of pre-neoplastic changes similar to those observed in humans that have the 
potential to progress to bronchiolo-alveolar carcinoma or adenocarcinoma (Brambilla et al. 
2001; Pandiri 2015). Presently, the mechanism of the cell proliferation is not known. 
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Knowledge of mutations in target genes, and regulation of cell cycle and associated 
pathways would be necessary to understand the cell proliferation mechanism. The 
significantly increased incidence in focal adenomatous alveolar hyperplasia among mice 
exposed to only MWCNT-7 indicates the capability of MWCNT-7 to induce cell 
proliferation and pre-neoplastic lesions (Sargent et al. 2014).
Evidence of altered gene expression and activation of cell cycle signaling pathways was 
recently reported for SWCNTs in an in vitro study (Chen et al. 2015). The gene expression 
profile was examined in human bronchial lung epithelial cells (BEAS-2B) continuously 
exposed to low doses (0.02 μg/cm2) of SWCNTs for 6 months (Chen et al 2015). The 
authors found an increased expression of RAS family genes, and activation of WNT 
signaling pathway. The RAS family of genes encodes proteins involved in cellular signal 
transduction, which result in cell growth and division. RAS are common oncogenes, mutated 
in many cancers (Regad 2015). The WNT signaling pathway is activated in many cancers 
and regulates proliferation and metabolism (Sherwood 2015).
Genotoxicity in vivo and in vitro (epithelial or mesothelial cells)—SWCNTs and 
MWCNTs induce genetic lesions in experimental animals and cultured human and animal 
cells and have similar genetic injury end-points (Section “Genotoxicity”; Tables 4 and 5). 
Positive results were reported in human primary and immortalized lung and mesothelial cells 
in short-term assays in vitro. DNA strand breaks, oxidized DNA bases, mutations, 
micronucleus formation, and numerical and structural chromosome abnormalities have been 
reported. In vitro studies report increased micronucleus frequency and increased levels of 
sister chromatid exchange in cells exposed to MWCNT-7 (Kato et al. 2013) and other types 
of CNTs (Table S-4).
SWCNTs and MWCNTs interact with and perturb the cellular mitotic apparatus, including 
microtubules and centrosomes, in human lung epithelial cells. K-ras point mutations have 
been reported in lung tissue of mice 1 and 28 days and 1 year following a 4-day inhalation 
exposure to one type of SWCNT; at 1 year post-exposure, karyotypical changes were shown 
by micronuclei and multinucleated cells in type II pneumocytes. SWCNT was genotoxic in 
mice after inhalation exposure (5 mg/m3, 5 h/d for 4 days) to short (1–3 μm) CNTs (K-ras 
mutations 28 days and 1 year post exposure; micronuclei 1 year post-exposure) (Shvedova et 
al. 2008, 2014).
Consistent evidence indicates that SWCNTs and MWCNTs are genotoxic in vitro for the 
relevant human target cells in the lungs and pleura. In vitro studies that utilize the target 
tissue cell type (e.g., human epithelial type II cells) avoid some of the uncertainty inherent in 
inter-species extrapolation. The number of in vivo studies of genotoxity of CNTS or CNFs is 
currently limited, and future research is needed to investigate possible correlations in cancer-
related responses in vivo in rodents and in vitro in human lung and pleural cells (e.g., as 
shown for asbestos and other mineral fibers; Yegles et al. 1995). Such studies could 
substantially increase the evidence basis on which to evaluate the potential carcinogenicity 
across the various types of CNTs and CNFs. To date, experimental studies are too limited to 
predict genotoxicity of CNTs based on specific physico-chemical properties.
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Cancer—Although cancer studies are available for several types of MWCNTs (Section 
“Rodent Cancer Data on CNTs”), cancer studies are lacking for SWCNTs, CNFs, and many 
other types of MWCNTs. A limited number of studies of precursor steps (persistent 
inflammation, genotoxicity) are available for only a few types of MWCNTs. Even for the 
highly studied MWCNT-7, gaps in knowledge of the key events are apparent (e.g., no animal 
genotoxicity data for the lung).
Dose–response data are lacking for the development of lung cancer or mesothelioma, and so 
the shape of the dose–response relationships (including at low doses) is not known from 
inhalation studies. Dose–response relationships were reported in several IP injection studies. 
However, the IARC classifications are based on hazard and do not consider dose (unless the 
mechanisms at the doses in the experimental animal studies are not likely to operate in 
humans). Most of the rodent cancer studies of MWCNs were based on IP injection to deliver 
the dose directly to the peritoneum (vs. pleura). An inhalation study in mice showed that 
MWCNT-7 is a cancer promoter (of adenocarcinoma) in mice following a single IP injection 
of MCA (Sargent et al. 2014) (Table 3). Inadequate number of animals in some dose groups 
or controls reduced the statistical validity of results in some of those studies (Tables 2 and 
3).
Data are lacking on the dose of MWCNTs that would reach the pleura with chronic 
inhalation exposure at relatively low concentrations, such as have been measured in the 
workplace. As mentioned in the Section “Migration to the pleura”, rough estimates of the 
working lifetime equivalent airborne concentration of MWCNTs that would result in a 
human-equivalent pleural dose suggest that the IP doses are not unreasonably high (Table 
S-7). For example, at the lowest IP doses in rats (0.05 mg) and mice (0.003 mg) – which 
were associated with significant mesothelioma incidence (Table 1) –the equivalent working 
lifetime airborne exposure estimates were 18 and 13 μg/m3, respectively (Table S-7). These 
rough estimates are based on the estimated working lifetime total deposited lung dose of 
CNT (assuming no clearance) and the estimated fraction of that dose that translocates from 
the lungs to the pleura (Section S-3).
Weight of mechanistic evidence and key data gaps
Although a considerable body of experimental data on CNTs and CNFs exists, significant 
data gaps remain in the key steps related to the hypothesized carcinogenic mechanisms of 
specific types of CNTs and CNFs. These gaps are due to the heterogeneity of CNTs and 
CNFs, inadequate systematic evaluation, and limited chronic studies. Some mechanistic 
evidence is available for in vivo end-points related to mesothelioma for a few MWCNTs but 
is lacking for SWCNTs and other CNTs and CNFs. For in vivo end-points related to lung 
cancer, mechanistic evidence is available for some MWCNTs and SWCNTs (Table 6) but 
not for other types of CNTs or CNFs.
The most mechanistic evidence available is for MWCNTs of various types. Several studies 
have demonstrated epithelial cell proliferation and persistent pulmonary inflammation 
following MWCNT exposure by rodents (Ma-Hock et al. 2009; Pauluhn 2010; Aiso et al. 
2010; Porter et al. 2010; Kobayashi et al. 2011; Murray et al. 2012; Sager et al. 2013; Xu et 
al. 2014; Sargent et al. 2014). Persistent pulmonary fibrosis was shown in several rodent 
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studies of MWCNTs (Muller et al. 2005; Aiso et al. 2010; Cesta et al. 2010; Mercer et al. 
2011, 2013a; Pauluhn 2010; Murray et al. 2012; Porter et al. 2010; Sager et al. 2013). 
Sargent et al. (2014) found fibrosis in male B6C3F1 mice at 17 months following inhalation 
of MWCNT-7 (with or without MCA). Pleural penetration of two types of MWCNTs was 
shown by Ryman-Rasmusssen et al. (2009) and Mercer et al. (2013b), and Xu et al. (2012, 
2014) found mesothelial cell proliferation following MWCNT exposure. On the contrary, 
several studies have demonstrated transient or no pulmonary imflammation, fibrosis and 
proliferation following MWCNT exposure (Kobayashi et al. 2010; Morimoto et al. 2012a, 
2012b; Silva et al. 2014). Evaluation of the factors that contribute to the differences in 
pulmonary responses to various types of CNTs and CNFs is a critical research need, 
including the role of dose and duration, physical-chemical properties, species/strain/gender, 
and other experimental factors.
The diversity of CNTs and CNFs precludes a systematic analysis of individual materials 
with wide variability in the physico-chemical properties of the materials tested, including 
size of the individual and agglomerated structures. Inconsistencies are found in the available 
data for the various types of CNTs. For example, although long (>5 μm) fibers are typically 
associated with persistent inflammation (considered to be a key event in particle and fiber 
carcinogenicity), short MWCNT (<1 μm) cause DNA damage in the absence of persistent 
inflammation. Differences in experimental procedures (e.g., affecting CNT dispersion or 
agglomeration) can also influence results. Although CNTs are typically hydrophobic and 
tend to agglomerate, these structures have been effectively dispersed in a solution that 
mimics the components of the alveolar lining fluid (although at lower concentrations) 
(Porter et al. 2008). Well-dispersed SWCNTs or MWCNTs caused an enhanced pulmonary 
interstitial fibrotic response in mice compared to mice administered poorly-dispersed 
materials (Mercer et al. 2008; Shvedova et al. 2008). However, agglomerated CNTs have 
also been shown to cause pulmonary and pleural effects. For example, visceral pleural 
thickening was observed in rats following subchronic inhalation at 1.5 or 6 mg/m3 of 
agglomerated MWCNT (MMAD of ~3 μm) (Pauluhn 2010).
Studies of CNTs and CNFs in the workplace have reported that the airborne structures are 
generally agglomerated and short (less than approximately 5 μm in length) (Han et al. 2008; 
Birch et al. 2011; Dahm et al. 2012; Dahm et al. 2015), although individual structures were 
occasionally observed (Dahm et al. 2015). CNFs share some physico-chemical properties 
with MWCNTs; however, the different arrangements of the graphitic building blocks suggest 
differences in reactivity (e.g., due to the mechanisms of defect generation or retention of 
metallic impurities). Further study is needed to provide systematic evaluation of CNTs and 
CNFs that differ in defined physico-chemical properties in experimental systems in order to 
delineate the role of specific properties.
Standardized study designs and protocols would reduce variability due to experimental 
factors and facilitate comparative analyses across CNT and CNF materials. For example, 
subchronic inhalation study guidelines have been established by OECD (2009), and minimal 
data and dosimetric considerations have been discussed in a recent review (Oberdorster et al. 
2015). A core set of experimental assays and endpoints on a representative set of CNTs and 
CNFs would provide a set of reference materials for comparative analyses to a wider variety 
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of materials and assays. Guidance is needed to promote experimental design and data 
reporting that are useful for hazard and risk assessments. At the same time, flexibility to 
develop and incorporate new methods or approaches must be retained, for example, with 
regard to developing and validating high throughput systems. In addition to standard 
experimental designs, standardized criteria for interpreting the mechanistic evidence would 
facilitate cancer hazard evaluations. For example, the IARC (2006) guidance could be 
extended to include more specific criteria on evaluation of mechanistic evidence of 
carcinogencity. Such guidance would be especially useful given the increasing trend toward 
alternative testing strategies and reduction in chronic bioassays. In addition, dose–response 
data sufficient to develop and test predictive models are needed to provide the evidence basis 
for reliably interpreting the mechanistic data in the absence of chronic bioassay data.
Although recognizing certain data limitations, some coauthors consider that the collective 
evidence is sufficiently strong to consider all types of CNTs to be potentially carcinogenic to 
humans (as discussed in IARC Monograph 111) (IARC, in press). Occupational exposure 
studies have shown that airborne CNTs are inhalable and respirable; studies in human 
respiratory tract replicas, and in rodent studies, show that CNTs and CNFs can be deposited 
and retained in the respiratory tract; some studies in rodents have shown that MWCNT can 
translocate to the pleura. Persistent pulmonary inflammation and fibrosis have been shown 
in some (but not all) studies in rodents exposed to MWCNT or SWCNT by inhalation or 
other routes. Pleural inflammation and injury have been shown in a few studies of MWCNTs 
in rodents. Many types of CNTs have been shown to induce primary or direct genotoxicity –
including DNA and chromosomal damage and interference with mitosis – in a large number 
of in vitro studies and in the few in vivo studies that have examined these mechanisms. 
Several types of genetic damage (different mechanistic end points) have been demonstrated 
in independent experiments in numerous mammalian cells types (including human lung and 
mesothelial cells). If such DNA and chromosomal damage is not correctly repaired, 
additional genetic and epigenetic changes may accumulate leading to mutations in cell cycle 
regulatory genes, oncogenes, and tumor suppressor genes and development of cancer (Figure 
4). The weight of evidence in the different steps leading to cancer is not necessarily the 
same, but genomic damage is mandatory in the mechanistic process. Each type of CNT has 
not been tested for each step leading to cancer, except for genotoxicity. However, globally, 
each step has been demonstrated to occur among the various types of CNTs. For MWCNTs, 
each step is completed, by one or another MWCNTs subtype, and as documented by several 
independent studies (Muller et al. 2008a; Ryman-Rasmussen et al. 2009; Aiso et al. 2010; 
Porter et al. 2010, 2013; Mercer et al. 2011; Treumann et al. 2013; Sargent et al. 2014; Kasai 
et al. 2015). New reported studies extend these results to additional types of CNTs, 
including an IP study showing carcinogenicity of four samples of MWCNTs (Rittinghausen 
et al. 2014), and a recent article that reports malignant and nonmalignant lung tumors and 
mesothelioma in rats exposed by trans-tracheal intrapulmonary spraying to three different 
fractions of MWCNT-N (Suzui et al. 2016).
The majority of the IARC monograph 111 Working Group considered that the lack of 
coherent evidence among the various CNTs precluded the prediction of carcinogenicity for 
specific CNTs based on mechanistic evidence alone (Grosse et al. 2014; IARC, in press). 
Thus, the IARC classification was based on the animal cancer studies available at the time 
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(Section “Rodent Cancer Data on CNTs”). The relevance of the animal-based mechanisms 
to humans is an important criterion in evaluation of the mechanistic evidence (IARC 2006). 
For CNTs, the majority of the Working Group considered that the mechanistic evidence in 
animals is relevant to humans, including the potential for the deposition and retention of 
airborne CNTs in the lung, translocation beyond the lung, and the development of 
inflammation, lung and pleural injury, fibrosis, and genotoxicity (Grosse et al. 2014; IARC, 
in press). However, a substantial gap in the current data is the lack of relevant mechanistic 
information from exposed humans (Grosse et al. 2014; IARC, in press). Ongoing 
epidemiology studies in humans may provide data to evaluate whether particular 
mechanisms are likely to be operative in humans. IARC (2006) considers that the strongest 
mechanistic evidence would “derive from data on humans or biological specimens obtained 
from exposed humans.” The diversity of MWCNTs, SWCNTs, DWCNTs, and CNFs used in 
the workplace, and the generally limited number of exposed subjects in these environments, 
make these studies and data synthesis challenging.
Research needs and recommendations
One of the main objectives of this review was to identify the significant data gaps in the 
mechanistic evidence in evaluating the potential carcinogencity of CNTs and CNFs, and to 
suggest research to fill those gaps. This evaluation builds on our work during the IARC 
monograph 111 meeting (IARC, in press). The practical use of this information is to guide 
improvements in the evidence basis for future evaluations of the various types of these 
materials. Given the large variety of CNTs and CNFs, it is unlikely that the standard two-
year bio-assay will be performed for most of these materials, and increasing reliance will be 
placed on mechanistic data (IARC 2006; Cogliano et al. 2008). Consideration of the 
biological mechanisms related to dose and dose rate may require further investigation to 
better assess the cancer risk in humans (McClellan 1997; Oberdorster et al. 2005a).
The technological capability to modify CNTs or CNFs to have specific structural types (wall 
number), dimensions, and functional groups introduces the possibility to “engineer” 
materials that are safer (less biopersistent, less biolocially reactive) compared to other 
materials that may be used for similar applications. The physico-chemical characteristics 
which influence the safety or harm of these materials is an important question, which is not 
fully understood for inhaled particles in general, nor specifically for CNTs or CNFs.
The following research needs and recommendations were developed following the IARC 
monograph 111 meeting, during the development of this critical review paper. These 
recommendations focus on specific areas of experimental investigation or data analysis 
which would help to improve the evidence basis and reduce uncertainty in future evaluations 
of the carcinogencity across the range of the various types of CNTs and CNFs:
Clarify the role of cellular studies in an evaluation of the mechanistic evidence 
on carcinogenicity—Despite the large number of cellular studies that showed 
genotoxicity of CNTs according to standard tests (Table 5), these data did not carry much 
weight in the original evaluation (IARC, in press). The lack of evidence in vivo for many 
types of CNTs on several steps in the pathway (Table 6), including the lack of chronic 
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inhalation studies, was the basis for a majority finding that the evidence was not strong 
enough to support modifying the carcinogen classification for any specific CNT or group of 
CNTs based on the animal data. Other Mechanisms Subgroup experts considered that the 
positive genotoxicity findings in cultured cells for a wide variety of CNTs, in conjunction 
with animal evidence on genotoxicity and cell proliferation for some CNTs, provided strong 
mechanistic evidence for the potential human carcinogenicity of the broader category of 
CNTs. Supporting that view are the findings of elevated DNA strand breaks (assessed by 
comet assay in cultured cells or animal tissues), which have been shown to be a reliable 
predictor of animal carcinogens generally (i.e., ~80% concordance); a high level of 
concordance was also reported between the findings of comet assays and micronucleus 
assays for various types of nanomaterials (Section “Measurement of genotoxicity”). 
Evidence of increased DNA strand breaks, micronuclei, and other measures of genotoxicity 
and gene expression was found in most, but not all, of the in vivo and in vitro studies of 
CNTs and CNFs to date (Table 4 and 5).
Although some guidance is available on evaluating the results of various tests for genetic 
and related effects “in view of the relevance of gene mutation and chromosomal aberration/
aneuploidy to carcinogenesis” (Vainio et al. 1992; McGregor et al. 1999) (IARC 2006), the 
role of in vitro assays in the weight-of-evidence in the mechanistic data has not been well-
defined, including for cultured cells from animals or humans corresponding to the target 
tissues for cancer (e.g., bronchiolar or alveolar epithelial cells or pleural mesothelial cells) in 
the absence of human data for comparison. Moreover, the studies cited in the IARC (2006) 
guidance on the types of assays to be considered in an evaluation of the mechanistic 
evidence (Montesano et al. 1986; Vainio et al. 1992; McGregor et al. 1999) pre-date some of 
the more recent advances in experimental assays. For example, the comet assay and 
micronucleus assay to measure DNA damage (Section “Measurement of genotoxicity”) are 
now standard genotoxicity tests for which OECD guidelines have been developed. An 
updated assessment of the role of these assays in mechanistic evaluations may be useful, 
especially given the increasing reliance on mechanistic data that is anticipated in many 
evaluations of potential carcinogens (IARC 2006; Cogliano et al. 2008).
Also needed is an examination of the predictivity of the more recently developed cell 
transformation assays (e.g., Wang et al. 2014a) on the potential carcinogenicity of various 
types of CNTs and CNFs. Linking these experimental assays to biomarkers measured in 
epidemiological studies of workers with exposures to CNTs or CNFs would strengthen the 
mechanistic evidence for evaluation, although such analyses will require sufficient data and 
the development and validation of predictive models.
Recent technological advances in experimental systems have a high potential for providing 
insights into the mechanisms of carcinogenicity. “Omics” assays have high output for 
determining the cell responses to xenobiotics and for investigating the molecular 
characteristics of the resulting pathologies, including the progression from the preneoplastic 
to neoplastic state. Pathway analyses allow investigations to focus on specific physio-
pathological responses. For example, genomic approaches have been developed to study 
DNA repair and mutagenesis (Wyrick & Roberts 2015). In silico comparison using data 
obtained in human neoplasms, especially lung cancers and mesothelioma, provide 
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information on general mechanisms of carcinogenicity and on animal species specificities. 
Comparison of data between several types of CNTs or CNFs could also be done. Genomic 
studies can be performed, not only on cultured cells, but also on normal and pathological 
tissues. The comparison between both types of data is of high interest to validate the in vitro 
systems to screen a large number of CNTs and CNFs. These assays, although in their 
infancy in the toxicological field, can be anticipated to be available in future evaluations.
Evaluate the strength of evidence associated with preneoplastic events—To 
strengthen understanding of the linkages between early changes and cancer, further study is 
needed on the early biological events that are potentially predictive of lung cancer or 
mesothelioma development following exposure to CNTs or CNFs, e.g., screening assays 
based on experimental assays in cellular systems. If such assay data are shown to correlate 
well with in vivo responses, then such dose–response data, in combination with validated 
dosimetry models that predict tissue dose, could be used to predict lung cancer and 
mesothelioma risk depending on the exposure and the physico-chemical properties of the 
material.
A key research need is to determine the relationship between pre-neoplastic lesions, such as 
AAH, and carcinoma following subchronic or chronic inhalation exposure to various types 
of CNT or CNF. Such studies are needed to improve the mechanistic evidence for assessing 
the potential carcinogenicity of CNT and CNF, since it is not feasible to perform chronic 
rodent bioassays of each material. The focal adenomatous hyperplasia observed in alveolar 
epithelial tissues in mice exposed to MWCNT-7 (Sargent et al. 2014) is considered to 
resemble the preneoplastic lesion AAH in humans (Section “Epithelial cell proliferation and 
hyperplasia—MWCNT”) (Brambilla et al. 2001; Pandiri 2015). It would be useful to 
investigate any influence of the physico-chemical properties of the material on the dose–
response relationships for pre-neoplastic lesions. It would also be useful to further examine 
the characteristics of the hyperplastic lesions in animals with the characteristics of 
preneoplastic lesions (e.g., AAH) in humans (Section “Epithelial cell proliferation and 
hyperplasia—MWCNT”) (Brambilla et al. 2001, Pandiri 2015).
Investigate the dose–response relationships for precursor events and cancer 
in the respiratory tract—Currently available toxicological data (in vitro and in vivo) 
could be utilized to develop meta-data sets to examine possible correlations between various 
early events in cellular systems and in animals that may be predictive of lung cancer or 
mesothelioma. These meta-analyses could be updated as new information becomes 
available. In vitro and in vivo biomarkers and endpoints on the pathway(s) to cancer 
development could be examined for their relationship to genotoxic and carcinogenic events 
in vivo (Sections “Hypotheses on Mechanisms Related to Genotoxicity and Carcinogenicity 
of Inhaled Particles or Fibers”; “Indirect Genotoxicity of CNTs and CNFs: Rodent Studies”; 
“Genotoxicity”). Comparable biomarker data from ongoing epidemiology studies in workers 
could be added to these evaluations when such data become available.
Ideally, information on the dose–response relationships for cancer, and associated precursor 
events, would include data from a chronic inhalation study on a selected set of CNTs or 
CNFs in rats and mice, such as from the US NTP chronic bioassay protocol. Earlier time 
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points for examination of short-term and subchronic responses would provide data for 
comparison to chronic endpoints in the same study. Such a study would be technically and 
economically challenging to achieve, including technological changes in the generation and 
measurement of CNTs aerosols (e.g., as discussed in Chen et al. 2012). The potential for 
adverse effects in other tissues and organs beyond the respiratory tract should also be 
investigated in a chronic bioassay.
Determine the physico-chemical and other properties that influence the dose–
response relationships—A systematic investigation of a set of CNTs and CNFs that 
vary by specific physico-chemical properties would provide highly useful data for 
examining quantitative structure-activity relationships in conjunction with dose–response 
analyses. The influence of other experimental factors would also need to be evaluated, 
including the route of exposure, the duration of exposure and post-exposure, the rodent 
species/strain/gender, and other experimental study conditions. A subset of materials which 
are relatively well-studied in vivo should be included as control or reference/benchmark 
materials. MWCNT-7 and ultrafine carbon black are relatively well-studied materials that 
has been examined across various assays and experimental systems. The selected set of 
assays and endpoints would be those shown with other materials (e.g., poorly-soluble 
particles or fibers) to be relevant to cancer pathway events in vivo (Section “Hypotheses on 
Mechanisms Related to Genotoxicity and Carcinogenicity of Inhaled Particles or Fibers”). A 
tiered testing and benchmark approach (as described in Oberdorster et al. 2005b; Kuempel et 
al. 2012; Nel et al. 2013) would improve the efficiency of the experimental system for 
development of quantitative dose–response data for comparative studies across a set of 
materials and assays.
Quantitative analyses of dose–response relationships for malignant and related non-
malignant endpoints, with consideration of the various dose metrics (mass, volume, surface 
area, number) and physico-chemical properties that could modify the dose–response 
relationships, would provide key evidence for predicting the cancer risk of exposure to 
specific CNT or CNF materials. The establishment of these relationships could strengthen 
the evidence basis to evaluate other CNTs or CNFs that have not been studied in animals. 
Such quantitative analyses could provide estimates of relative potency and support the 
development of occupational health guidance. However, due to the varying nature of these 
structures, and the variety of experimental designs, it remains a challenge to obtain a large 
enough database needed for valid statistical inference. Experimental factors need to be 
accounted for in any meta-analysis in order to reliably characterize the dose–response 
relationships for CNTs and CNFs from different studies. Experimental factors include the 
animal species/strain and gender, route of exposure, number of dose groups, animals per 
dose group, material preparation procedures, dose levels, and dose rates. Few studies to date 
provide sufficient dose–response data for quantitative comparisons among CNTs or CNFs. 
Greater emphasis on providing quantitative dose and response in a core set of validated 
assays, as well as a basic set of physico-chemical descriptors, would go a long way to 
providing useable data for meta-analysis.
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Develop validated dosimetry models for CNTs and CNFs in the rodent and 
human respiratory tract—Current deposition models for inhaled particles or fibers in the 
respiratory tract may provide reasonable estimates of the deposition fractions of CNTs or 
CNFs based on the aerosol particle size. Verification that current deposition models can 
predict deposition of airborne CNTs and CNFs would reduce uncertainty in using those 
models to predict deposited dose.
In contrast to deposition, the clearance and retention kinetics are more uncertain for CNTs 
and CNFs; and the inhaled particle or fiber models of clearance retention, and translocation 
need to be evaluated and possibly revised or extended to estimate the retention and clearance 
kinetics of CNTs and CNFs. Although some studies are available on the disposition of 
inhaled MWCNTs, data are lacking on the disposition of inhaled SWCNTs or CNFs, 
including clearance, retention, and/or translocation. Data available for several types of 
MWCNTs indicate that MWCNTs can rapidly migrate from the lungs to the pleura, as well 
as to extrapulmonary organs. Agglomerated CNTs remain in the lungs, while single CNTs 
are found in other tissues. Currently available clearance and retention models developed 
from data of inhaled fibers could be evaluated for fit to the limited kinetics data for 
MWCNT in rodents. Further data on clearance, retention, and translocation of CNTs or 
CNFs with repeated exposures are needed to understand the fate of inhaled CNTs and CNFs 
over time. The ultimate goal of a validated dosimetry model (e.g., developed from rodent 
data and extrapolated to humans) is to estimate the pulmonary and pleural dose of CNTs and 
CNFs, e.g., in workers, in order to estimate the risk of adverse effects given exposure.
Expand the current biomonitoring studies in workers—Further studies in humans 
on exposure, dose, and biomarker response are needed to strengthen the mechanistic data 
regarding the potential carcinogenicity of CNTs and CNFs. The strength of the evidence that 
any carcinogenic effect observed is due to a particular mechanism is evaluated in the IARC 
evaluation using terms such as “weak”, “moderate,” or “strong” (IARC 2006), prior to 
assessing whether that particular mechanism is likely to be operative in humans. The most 
relevant evidence that a particular mechanism could operate in humans will be from data in 
exposed humans, or from biological specimens from exposed humans, that show “the agent 
in question has caused changes in exposed humans that are on the causal pathway to 
carcinogenesis” (IARC 2006). It is also relevant to note that many types of CNTs in 
develpment may not have resulted in much exposure to humans, and thus such mechanistic 
data may not be available for the evaluations (IARC 2006). This situation would also offer 
an opportunity to better understand the carcinogenic hazard potential before significant 
exposure to humans occurs (i.e., get ahead of the curve in protecting the health of workers 
and the general population).
Conclusions of review and next steps
This review provides an updated, somewhat broader, and more in-depth review of the 
literature assessed for the IARC Monograph 111 evaluation of the evidence for the 
carcinogenicity of CNTs (Grosse et al. 2014; IARC, in press). The subsequent studies 
strengthen the data basis that was evaluated in the IARC Monograph 111 regarding the 
carcinogenicity evidence for certain types of MWCNTs (Rittinghausen et al. 2014), yet 
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significant data gaps remain for other types of CNTs and CNFs. Certain aspects of DNA 
damage have been documented in lung tissue and cultured cells, especially comet assay 
endpoints, after exposure to a range of CNTs. However there is a paucity of studies on some 
of the endpoints in the pathway to lung cancer, including mutations and chromosomal 
damage. Also, genotoxic effects to mesothelial cells in vivo following inhalation exposure 
remain to be investigated. Most notably is of course the absence of data from exposed 
humans.
MWCNT-7 is the most studied type of CNT, including data on lung and pleural early effects 
as well as cancer studies. In the absence of those data for other types of CNTs, it is unclear 
to what extent the data on MWCNT-7 can be extended to other types of CNTs. Some studies 
have shown greater inflammatory responses for longer CNTs compared to shorter (or 
tangled) CNTs (Poland et al. 2008; Nagai et al. 2013; Xu et al. 2014). A thinner diameter 
was also associated with higher tumor induction (Nagai et al. 2013). Heterogeneity in the 
types of CNTs and CNFs (by structure, dimensions, functionalization, contaminants) studied 
in the various steps on the hypothesized carcinogenic pathways; limitations in the animal 
cancer studies (few CNT types and no CNF evaluted, inadequate experimental design); and 
key data gaps in hypothesized cancer pathways were the main sources of uncertainty in the 
evidence available on the potential carcinogenicity of CNTs and CNFs.
Systematic, targeted research is needed to reduce uncertainty evidence about the potential 
carcinogenicity of various types of CNTs or CNFs and to develop predictive models based 
on physico-chemical properties. The application of a consistent study design across a range 
of well-characterized CNTs differentiated from each other by a single physico-chemical 
feature would facilitate the pooling and comparison of data from multiple studies. These 
types of comparative studies are vital to make connections between new and existing data 
and build on current knowledge of inhaled particles and fibers.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Evidence considered in IARC two-tier cancer evaluation process (IARC 2006).
Source: IARC Monograph Program; IARC (2006); Cogliano (2011). [Copyright permission 
from IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: 
Volume 111. Some Nanomaterials and Some Fibres. IARC, Lyon (in press)].
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Figure 2. 
Role of mechanistic evidence in IARC cancer hazard classifications: possible modulation of 
default classification group based on human and animal evidence (IARC 2006). ESLC: 
Evidence suggesting lack of carcinogenicity.
Source: IARC Monograph Program; IARC (2006); Cogliano et al. (2008). [Copyright 
permission from John Wiley and Sons Inc. for Environmental and Molecular Mutagenesis].
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Figure 3. 
Key events in cancer pathways: Indirect genotoxicity of particles or fibers via persistent 
inflammation.
Source: Adapted from a figure developed by Y Morimoto and N Kobayashi for IARC 
Monograph 111. [Copyright permission from IARC. IARC Monographs on the Evaluation 
of Carcinogenic Risks to Humans: Volume 111. Some Nanomaterials and Some Fibres. 
IARC, Lyon (in press)].
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Figure 4. 
Mechanisms of genomic instability generated by fibres: Cancer arises from genomic 
instability (GIN), and the genotoxic effects of CNTs are consistent with an ability to 
generate GIN. Inhaled CNTs induce a local inflammation associated with the production of 
cytokines, growth factors (GFs), and reactive oxygen species (ROS) (see chapters on 
inflammation and Figure 4), which can induce genomic insult and stimulate cell growth. 
Otherwise, fibres can be internalised by many cell types, resulting in a physical insult due to 
fibre load. In these “targeted and/or fibre-loaded” cells, the lesions in DNA produce defects 
in DNA structure. DNA breakage is generated by replication stress, and mitosis stress 
generates both DNA breaks and chromosome defects. Various repair mechanisms and cell 
cycle checkpoints are then activated to control genome integrity. Unrepaired or error-prone 
repair processes can entail mutations, chromosomal rearrangements and variations in 
chromosome number or morphology, which are the causes of genomic instability (GIN). 
Selection and amplification of genomically unstable cells can progress to lung cancer and 
mesothelioma.
Source: Adapted from a figure developed by M-C Jaurand for IARC Monograph 111 
(IARC, in press). [Copyright permission from IARC. IARC Monographs on the Evaluation 
of Carcinogenic Risks to Humans: Volume 111. Some Nanomaterials and Some Fibres. 
IARC, Lyon (in press)].
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Figure 5. 
Schematic of the tracheobronchial and alveolar airway path to the pleura for the human lung. 
G1 and G2 signify the last two conducting airway generations prior to reaching the 
designated terminal bronchiole opening into respiratory bronchioles and alveolar ducts.
Source: Figure prepared by M-C Jaurand for this article. [Tracheobronchial and alveolar 
pathway is reprinted from Comparative Biology of the Normal Lung, 2nd ed., Plopper CG 
and Hyde DM, Epithelial cells of the bronchiole, pp. 83–92, 2015, with permission from 
Elsevier; while thoracic and pleural region is adapted from Sureka et al. (2013), with use 
permitted by the Indian Journal of Radiology].
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80
×1
09
86
 (2
07
)
45
/5
0 
(90
)
M
W
CN
T 
C 
(lo
w
)
4.
18
 ±
 2
.4
1†
0.
04
0 
± 
1.
57
†
Fe
0.
08
0.
87
×1
09
84
 (4
15
)
42
/5
0 
(84
)
M
W
CN
T 
C 
(hi
gh
)
10
.2
4 
± 
1.
64
‡
0.
4
4.
36
×1
09
94
 (2
65
)
47
/5
0 
(94
)
M
W
CN
T 
D
 (l
ow
)
2.
53
 ±
 2
.0
2†
0.
03
7 
± 
1.
45
†
Co
0.
05
1.
51
×1
09
40
 (6
66
)
20
/5
0 
(40
)
M
W
CN
T 
D
 (h
igh
)
7.
91
 ±
 1
.4
0‡
0.
25
7.
54
×1
09
70
 (5
85
)
35
/5
0 
(70
)
A
m
os
ite
 a
sb
es
to
s (
lon
g)
6.
22
 ±
 3
.1
2†
13
.9
5 
± 
2.
10
‡
3.
94
 ±
 1
.8
3†
n
a
1.
4
0.
14
×1
09
66
 (6
23
)
33
/5
0 
(66
)
IP
 (h
alf
 of
 th
e t
ota
l m
ass
 do
se 
wa
s 
de
liv
er
ed
 tw
o
 ti
m
es
 in
 o
ne
 w
ee
k)
Co
nt
ro
l
n
a
n
a
n
a
0
0
1*
*
*
 
(nr
)
0/
23
 (0
)
N
ag
ai
 e
t a
l. 
20
11
,
 
20
13
; r
at
, F
34
4/
B
ro
w
n
 N
or
w
ay
 F
1 
hy
br
id
, m
al
e 
&
 
fe
m
al
e;
 1
2 
m
o.
M
W
CN
T:
 N
T5
0a
††
†  (
-ag
g)
Fe
, C
u
2¶
¶
~
3 
× 
10
7¶¶
40
*
*
*
12
/1
5 
(80
)*
N
T5
0a
††
†  (
low
)
5.
29
 ±
 0
.1
2
0.
05
0 
± 
0.
00
06
1
n
r
70
*
*
*
13
/1
3(1
00
)*
N
T5
0a
††
†  (
hig
h)
10
n
r
>
72
*
*
*
43
/4
3 
(10
0)*
N
T5
0b
 (h
igh
)
4.
6 
± 
0.
1
0.
05
2 
± 
0.
00
07
Fe
10
n
r
>
54
*
*
*
6/
6 
(10
0)*
N
T1
45
 (l
ow
)
4.
6 
± 
0.
08
0.
14
 ±
 0
.0
01
6
n
o
n
e
1
~
3 
× 
10
7¶¶
1*
*
*
5/
29
 (1
7)*
N
T1
45
 (h
igh
)
10
n
r
>
59
*
*
*
28
/3
0 
(93
)*
N
Tt
ng
l
n
d§
§
n
d§
§
Fe
10
n
r
>
60
*
*
*
0/
15
 (0
)¶
In
tra
pe
rit
on
ea
l i
nje
cti
on
 (IP
), s
ing
le
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Ty
pe
 o
f C
N
T,
 v
eh
ic
le
 
co
n
tr
o
l, 
or
 c
om
pa
ri
so
n 
m
a
te
ri
al
C
N
T 
le
ng
th
 (μ
m)
C
N
T 
di
am
et
er
 (μ
m)
C
N
T 
ca
ta
ly
st
, 
m
et
al
 
co
n
te
nt
, 
tr
ea
tm
en
t
D
os
e 
–
 M
as
s 
(m
g)
D
os
e 
– 
Fi
be
r 
n
u
m
be
r
M
or
ta
lit
y 
(%
) 
du
ri
ng
 
st
ud
y;
 
m
ea
n
 
su
rv
iv
a
l 
(d
ay
s)
M
es
ot
he
lio
m
a 
pr
o
po
rt
io
n 
(%
)
R
ef
er
en
ce
; s
pe
ci
es
, 
st
ra
in
, g
en
de
r;
 
st
ud
y 
du
ra
tio
n
Ve
hi
cl
e 
co
nt
ro
l (
Ta
ka
gi
 e
t a
l. 
20
08
)
n
a
n
a
n
a
0
0
0
0/
10
 (0
)
Ta
ka
gi
 e
t a
l. 
20
08
,
 
20
12
; m
ou
se
, 
C5
7B
l/6
, P
53
+/
−,
 
m
al
e;
 2
5 
to
 5
2 
w
ks
Fu
lle
re
ne
n
r
n
r
n
r
3
n
r
0
0/
10
 (0
)
M
W
CN
T-
7
1–
19
 (2
 m
ed
ian
); 
27
.5
%
 >
5 
μm
0.
07
0–
0.
17
0 
(0.
09
0 m
ed
ian
)
Fe
0.
00
3
1×
10
6||
20
 (n
r)
5/
20
 (2
5)*
0.
03
1×
10
7
10
0
17
/2
0 
(85
)*
0.
3
1×
10
8
90
19
/2
0 
(95
)*
3
1×
10
9
90
14
/1
6 
(88
)*||
Cr
oc
id
ol
ite
 (U
IC
C)
3
1×
10
10
50
14
/1
8 
(78
)*
In
tra
pe
rit
on
ea
l i
nje
cti
on
 (IP
), s
ing
le
Ve
hi
cl
e 
co
nt
ro
l
n
a
n
a
n
a
0
n
r 
f
60
 (n
r)†
†
1/
26
 (3
.8)
M
ul
le
r e
t a
l. 
20
09
; 
ra
t, 
W
ist
ar
,
 
m
al
e;
 
24
 m
o.
M
W
CN
T 
(+
)**
 
(lo
w
)
~
0.
7
0.
01
1 
(±
0.0
03
9)
A
L,
 F
e,
 C
o
2
40
2/
50
 (4
)
M
W
CN
T 
(+
) (
hig
h)
20
50
0/
50
 (0
)
M
W
CN
T 
(−
) (
hig
h)
20
60
3/
50
 (6
)
Cr
oc
id
ol
ite
2
70
9/
26
 (3
5)
In
tra
pe
rit
on
ea
l i
m
pl
an
ta
tio
n 
of
 ca
ps
ul
e
Cr
ys
ta
lli
ne
 Z
nO
‡‡
n
r
n
r
0 
(al
l r
ats
 
su
rv
iv
ed
 to
 
en
d 
of
 
st
ud
y)
0/
6 
(0)
Va
rg
a 
an
d 
Sz
en
di
 
20
10
; r
at
, F
34
4,
 
(nr
); 
12
 m
o.
SW
CN
T
4–
15
<
0.
00
2
90
%
 p
ur
ity
10
0/
6 
(0)
M
W
CN
T
1–
2
0.
01
–0
.0
3
98
%
 p
ur
ity
10
0/
6 
(0)
In
tra
sc
ro
ta
l i
nje
cti
on
, si
ng
le
Ve
hi
cl
e 
co
nt
ro
l
n
a
n
a
n
a
0
n
a
0
0/
5 
(0)
Sa
ka
m
ot
o 
et
 a
l. 
20
09
; r
at
, F
34
4,
 
m
al
e
M
W
CN
T-
7
1–
4 
(2 
pe
ak
)
0.
07
0–
0.
11
0 
(0.
09
0 p
ea
k)
Fe
 (~
0.3
%)
0.
24
8.
52
×1
07
86
 (n
r)
6/
7*
 
(86
)
Cr
oc
id
ol
ite
0.
1–
5 
(1.
1–
1.2
 pe
ak
)
0.
03
–0
.4
 (0
.11
–0
.20
 pe
ak
)
Fe
 (2
6–
29
%)
0.
47
1.
38
×1
09
0
0/
10
 (0
)
So
ur
ce
: C
re
at
ed
 fo
r t
hi
s p
ap
er
.
 
So
m
e 
in
fo
rm
at
io
n 
is 
th
e 
sa
m
e 
as
 in
 T
ab
le
s 3
.1
–3
.6
 o
f M
on
og
ra
ph
 1
11
 (I
A
RC
, i
n 
pr
es
s);
 so
me
 ad
dit
ion
al 
inf
orm
ati
on
 is
 ad
de
d (
e.g
., m
ort
ali
ty 
pe
rce
nt)
; a
nd
 a 
ne
w
 s
tu
dy
 is
 
ad
de
d‡
‡‡
. n
a: 
no
t a
pp
lic
ab
le;
 nd
: n
ot 
de
ter
mi
ne
d; 
nr
: n
ot 
rep
or
ted
.
*
St
at
ist
ic
al
ly
 si
gn
ifi
ca
nt
 (p
 
<
0.
05
).
† A
ll 
fib
er
 si
ze
s.
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‡ W
H
O
 fi
be
r l
en
gt
h 
(>
5 μ
m 
len
gth
, <
3 μ
m 
dia
me
ter
; ≥
3:1
 le
ng
th:
wi
dth
 ra
tio
).
§ F
ib
er
s >
20
 μ
m
 (%
 of
 W
HO
 fib
er
s):
 3.
81
, 9
.35
, 1
1.7
7, 
2.1
3, 
an
d 2
8.5
5, 
res
pe
cti
v
el
y,
 
fo
r M
W
CN
T 
A
, B
, C
, a
nd
 D
, a
nd
 a
m
os
ite
 a
sb
es
to
s.
¶ N
Tt
ng
l: 
a 
se
co
nd
 g
ro
up
 o
f 6
 ra
ts 
fo
llo
w
ed
 fo
r 3
 y
ea
rs
 p
os
t-e
x
po
su
re
 h
ad
 0
/6
 m
es
ot
he
lio
m
a i
nc
id
en
ce
.
|| Po
st
-e
x
po
su
re
 d
ur
at
io
n 
of
 2
5 
w
ks
 (v
s. 
52
 w
ks
 fo
r o
the
r d
os
e g
rou
ps
).
*
*
M
W
CN
T(
+)
 de
no
tes
 m
ate
ria
l w
ith
 st
ruc
tur
al 
de
fec
ts;
 M
W
CN
T(
−)
 de
no
tes
 m
ate
ria
l w
ith
ou
t d
efe
cts
. T
he
 au
tho
rs 
no
ted
 th
at 
na
no
tub
e n
um
be
rs 
we
re 
no
t o
bta
ine
d b
ec
au
se 
ag
glo
me
rat
ion
 m
ad
e c
ou
nti
ng
 
in
di
v
id
ua
l n
an
ot
ub
es
 u
nr
el
ia
bl
e.
 T
he
 a
ut
ho
rs
 fu
rth
er
 n
ot
ed
 th
at
 th
e 
pr
op
or
tio
n 
of
 in
di
v
id
ua
l n
an
ot
ub
es
 >
5 
μm
 in
 le
ng
th
 w
as
 e
st
im
at
ed
 to
 b
e 
“e
x
tr
em
el
y 
lo
w
.
”
††
N
o 
sig
ni
fic
an
t d
iff
er
en
ce
 in
 su
rv
iv
al
 a
m
on
g 
gr
ou
ps
 (p
 
=
 0
.1
6).
‡‡
N
o 
ve
hi
cl
e 
co
nt
ro
l r
ep
or
te
d.
§§
M
an
uf
ac
tu
re
r r
ep
or
te
d 
le
ng
th
 3
 μ
m
 a
nd
 d
ia
m
et
er
 0
.0
15
 μ
m
 (T
ab
le
 S
1,
 N
ag
ai
 e
t a
l. 
20
11
). A
ll s
tru
ctu
re 
siz
es 
in 
Ta
bl
e 
2A
 fo
r N
ag
ai
 e
t a
l. 
(20
11
) a
re
 a
u
th
or
-
re
po
rte
d.
¶¶
Fi
be
r c
on
ce
nt
ra
tio
n 
of
 N
T1
45
 o
r N
T5
0a
(-a
gg
) w
as
 ~
15
 ×
 1
03
 
fib
er
s/μ
l (
Fig
ure
 6B
 of
 N
ag
ai
 e
t a
l. 
20
11
). S
inc
e 2
 m
l to
tal
 w
as
 in
jec
ted
 (i.
e.,
 1 
ml
, tw
o
 ti
m
es
 in
 o
ne
 w
k),
 th
is 
wo
u
ld
 b
e 
eq
ua
l t
o 
~3
0 
× 
10
6 
fib
er
s i
nje
cte
d o
f N
T1
45
 (a
t 0
.5 
mg
/m
l fo
r 1
 m
g t
ota
l) a
nd
 N
Ta
(-a
gg
) (
at 
1 m
g/m
l f
or 
2 m
g t
ota
l).
*
*
*
Ca
lc
ul
at
ed
 fr
om
 F
ig
ur
e 
6(E
) o
f N
ag
ai
 e
t a
l. 
(20
11
) f
or
 c
on
tro
l, 
N
T5
0a
(-a
gg
), N
T5
0a
 (1
 m
g) 
an
d N
T1
45
 (1
 m
g) 
ba
sed
 on
 su
rvi
v
al
 a
t 3
50
d 
po
st-
in
jec
tio
n. 
Ca
lcu
lat
ed
 fr
om
 Ta
bl
e 
S2
 in
 N
ag
ai
 e
t a
l. 
(20
11
) 
fo
r t
he
 1
0 
m
g 
do
se
 g
ro
up
s o
f N
T5
0a
, N
T5
0b
, N
T1
45
, a
nd
 N
Tt
ng
l, 
w
hi
ch
 is
 b
as
ed
 o
n 
su
rv
iv
al
 w
ith
in
 se
v
er
al
 d
ay
s (
~h
alf
 of
 th
e r
ats
 in
 th
ese
 gr
ou
ps
 di
ed
 w
ith
in 
sev
er
al
 d
ay
s);
 th
e s
urv
iva
l i
s n
ot
 re
po
rte
d 
fo
r 
th
e 
10
 m
g 
gr
ou
p 
at
 3
50
 d
 p
os
t-e
x
po
su
re
, b
u
t i
t i
s a
ss
um
ed
 th
at
 th
e 
m
or
ta
lit
y 
%
 is
 g
re
at
er
 th
an
 th
at
 a
t s
ev
er
al
 d
ay
s p
os
t-i
nje
cti
on
.
††
† N
Ta
 is
 th
e 
sa
m
e 
as
 M
W
CN
T-
7.
‡‡
‡ S
tu
dy
 p
ub
lis
he
d 
af
te
r t
he
 IA
RC
 m
on
og
ra
ph
 1
11
 m
ee
tin
g.
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Ta
bl
e 
2
St
ud
ie
s o
f l
un
g 
ca
nc
er
 in
 ro
de
nt
s a
dm
in
ist
er
ed
 m
ul
ti-
w
al
le
d 
or
 si
ng
le
-w
al
le
d 
ca
rb
on
 n
an
ot
ub
es
 (M
W
CN
T 
or 
SW
CN
T)
, b
y r
ou
te 
of 
ex
po
su
re
.
Ty
pe
 o
f C
N
T,
 v
eh
ic
le
 c
on
tr
o
l, 
o
r 
a
sb
es
to
s
C
N
T 
le
ng
th
 (μ
m)
C
N
T 
di
am
et
er
 (μ
m)
C
N
T 
ca
ta
ly
st
, m
et
al
 
co
n
te
nt
D
os
e 
– 
M
as
s (
mg
)
D
os
e 
– 
Fi
be
r 
n
u
m
be
r
M
or
ta
lit
y 
(%
) d
ur
ing
 
st
ud
y;
 a
ge
 a
t d
ea
th
Tu
m
o
r 
pr
o
po
rt
io
n‡
R
ef
er
en
ce
; s
pe
ci
es
, s
tr
ai
n,
 g
en
de
r;
 
st
ud
y 
du
ra
tio
n
In
ha
la
tio
n,
 5
 m
g/
m
3  
o
f M
W
CN
T,
 5
 h
r/d
, 1
5 
d 
(in
itia
tio
n-p
rom
oti
on
 st
ud
y) 
- B
ron
ch
iol
o-a
lve
o
la
r a
de
no
m
a o
r c
ar
cin
om
a
A
ir
n
a
n
a
n
a
n
a
n
a
5 
(11
.2 
mo
)*
13
/5
6 
(23
)
Sa
rg
en
t e
t a
l. 
20
14
; m
ou
se
, B
6C
3F
1,
 
m
al
e;
 1
7 
m
o.
 P
E
M
CA
8 
(12
.3 
mo
)
28
/5
4 
(52
)
M
W
CN
T-
7
4.
5
0.
04
9
Fe
n
r
n
r
11
 (1
0.6
 m
o)
13
/4
9 
(27
)
M
CA
 +
M
W
CN
T-
7
24
 (1
1.2
 m
o)
38
/4
2†
 
(90
)
In
tra
tra
ch
ea
l i
ns
til
la
tio
n,
 si
ng
le
 –
 L
un
g 
ad
en
om
as
 an
d 
ad
en
oc
ar
cin
om
a
Co
nt
ro
l, 
sa
lin
e
n
a
n
a
n
a
n
a
n
a
n
r
0/
3
Yu
 e
t a
l. 
20
13
; m
ou
se
, C
57
BL
/6
, m
al
e;
 
6 
m
o.
M
W
CN
T,
 
as
 p
ro
du
ce
d
7.
71
0.
01
35
0.
1
n
r
1–
3/
3‡
M
W
CN
T,
 
ac
id
-tr
ea
te
d
0.
56
7
0.
00
75
0.
1
n
r
1/
3
In
tra
tra
ch
ea
l i
ns
til
la
tio
n,
 si
ng
le
 –
 N
o 
tu
m
or
s
SW
CN
T
In
di
v
id
ua
l t
ub
es
: 1
.2
 (m
ax
. 
le
ng
th
)
A
gg
re
ga
te
s:
 0
.3
2
In
di
v
id
ua
l t
ub
es
: 0
.0
03
 
(±
0.0
01
1)
A
gg
re
ga
te
s:
 0
.0
12
 (±
0.0
06
5)
Fe
, N
i, 
Cr
,
 
A
l, 
M
n 
(0.
05
% 
tot
al 
me
tal
 
co
n
te
nt
)
Co
nt
ro
l (
sal
ine
), 0
.04
, 0
.2,
 
1,
 2
 m
g/
kg
 B
W
Co
nt
ro
l; 
1.
8×
10
12
; 
8.
8×
10
12
; 
4.
4×
10
13
; 8
.8
×1
01
3 
pa
rti
cl
es
/k
g 
BW
0 
(al
l m
ice
 su
rvi
v
ed
 to
 
en
d 
of
 st
ud
y)
0/
6,
 0
/6
, 0
/6
, 0
/6
, 0
/6
K
o
ba
ya
sh
i e
t a
l. 
20
11
; r
at
, C
rl:
 C
D
 
(S
D)
, m
ale
; u
p t
o 6
 m
o. 
PE
Su
bc
ut
an
eo
us
 in
jec
tio
n, 
sin
gle
 – 
Va
rio
us
 ty
pe
s o
f t
um
or
s
Co
nt
ro
l
10
 (m
ea
n)
0.
1 
(m
ea
n)
>
99
.9
%
 ca
rb
on
Co
nt
ro
l (
sal
ine
);
n
r
0
0/
10
Ta
ka
na
sh
i e
t a
l. 
20
12
; m
ou
se
, r
as
H
2 
(C
57
BL
/6)
; m
ale
; 2
6 w
k P
E
Ca
rb
on
 b
la
ck
~
75
 m
g/
kg
1 
(22
 w
k)
1/
10
 a
de
no
m
a
M
W
CN
T
~
75
 m
g/
kg
0
0/
10
M
N
U
§
~
75
 m
g/
kg
4 
(12
–2
1 w
k)
10
/1
0 
(va
rio
us
 o
rg
an
s)
So
ur
ce
: C
re
at
ed
 fo
r t
hi
s p
ap
er
.
 
So
m
e 
in
fo
rm
at
io
n 
is 
th
e 
sa
m
e 
as
 in
 T
ab
le
s 3
.1
–3
.6
 o
f M
on
og
ra
ph
 1
11
 (I
A
RC
, i
n 
pr
es
s),
 an
d s
om
e a
dd
itio
na
l in
for
ma
tio
n i
s a
dd
ed
 (e
.g.
, m
ort
ali
ty 
pe
rce
nt)
. n
a: 
no
t a
pp
lic
ab
le;
 nr
: n
ot 
rep
ort
ed
.
*
Es
tim
at
ed
 fr
om
 F
ig
ur
e 
7 
in
 S
ar
ge
nt
 e
t a
l. 
(20
14
). M
ea
n 
ag
e 
of
 d
ea
th
 a
m
on
g 
an
im
al
s e
ut
ha
ni
ze
d 
ea
rly
 (n
o s
ign
ifi
ca
nt
 d
iff
er
en
ce
).
† S
ta
tis
tic
al
ly
 si
gn
ifi
ca
nt
 (p
 
<
0.
05
).
‡ P
ro
po
rti
on
 o
f a
ni
m
al
s w
ith
 tu
m
or
s, 
ex
ce
pt
 in
 Y
u
 e
t a
l. 
(20
13
), w
hi
ch
 re
po
rte
d 
th
e 
tu
m
or
 in
ci
de
nc
e 
(2 
ad
en
om
as 
an
d 1
 ad
en
oc
ari
no
ma
 in
 th
e “
M
W
CN
T, 
as
 p
ro
du
ce
d”
 g
ro
up
; a
nd
 1
 a
de
no
m
a 
in
 th
e 
“M
W
CN
T,
 
ac
id
-tr
ea
te
d”
 g
ro
up
) b
u
t d
id
 n
ot
 re
po
rt 
th
e 
th
e 
nu
m
be
r o
f a
ni
m
al
s w
ith
 
tu
m
or
s.
§ N
-m
et
hy
l-N
-n
itr
os
ou
re
a 
(M
NU
) a
nd
 hi
gh
-de
ns
ity
 po
lye
thy
le
ne
34
.
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Table 4
Summary of in vivo data on genotoxicity and gene expression endpoints in lung tissue.*
Endpoint MWCNT study and tube length SWCNT study and tube length
DNA oxidation products − Cao et al. (2014): 0.7–3, 0.4–4 μm − Vesterdal et al. (2014b): 1 μm
− Pothmann et al. (2015): 1.1 μm + Folkmann et al. (2009): 1 μm (oral 
exposure)
DNA breaks (SB) + (2% Fe) Kim et al. (2012): 20 μm + Jacobsen et al. (2009): 1 μm (BALF cells)
+ Poulsen et al. (2015): 4.1 μm − Vesterdal et al. (2014b): 1 μm
+ Kato et al. (2013): 2 μm − Naya et al. (2012): 4.4 μm
+ Cao et al. (2014): 0.7–3, 0.7.4 μm
+ Poulsen et al. (2015): 0.85 μm
+ (2% Fe) Kim et al. (2014): 0.33 μm
− Ema et al. (2013b): 2.7 μm
− Pothmann et al. (2015): 1.1 μm
Micronuclei + Muller et al. (2008b): 0.7 μm + Shvedova et al. (2014): 1–3 μm (inhalation)
Mutations + Kato et al. (2013): 2 μm (gpt locus) + Shvedova et al. (2008): 1 μm (inhalation)
− Shvedova et al. (2008): 1 μm (aspiration)
Gene expression + Snyder-Talkington et al. (2013a) Egfr (downregul), Junb 
(upregul)
+ Park et al. (2011a) p53 protein upregulation
+ Guo et al. (2012) Bcl3 (slightly upregul), Egfr (downregul) + Park et al. (2011b) p53 protein upregulation, 
purified sample
+ Huang et al. (2014) Cdkn1 (upregul) + Park et al. (2013) p53 protein upregulation
+ Poulsen et al. (2013) Bcl3 (upregul), Aurka (upregul), Myb 
(downregul)
Source: Adapted from Tables 4.4.2 and 4.4.3 of IARC monograph 111 (IARC, in press), which was originally developed by authors on this paper. 
This current table has been restructured and includes only the results in lung issue (e.g., excludes information from IP or GI routes of exposure).
Bcl3: B-cell cll/lymphoma 3; Cdkn1a: cyclin-dependent kinase inhibitor 1a (P21, Cip1); Egfr: epidermal growth factor receptor; Junb: Jun-B proto-
oncogene; Myb: V-Myb avian myeloblastosis viral oncogene homolog.
*
Levels of DNA damage, mutations, chromosome damage and cellular transformation are increased (+) or unaltered (−) in exposed cells compared 
to unexposed controls. Gene expressions include oncogenes, tumor suppressor genes, and genes involved in DNA repair and cell cycle regulation. 
(+) means a differential expression between control (untreated) and treated cells.
Crit Rev Toxicol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Kuempel et al. Page 104
Table 5
Summary of in vitro data on genotoxicity, gene expression of cellular transformation endpoints.
Endpoint MWCNT study and tube length SWCNT study and tube length
DNA oxidation products 
(FPG) + Visalli et al. (2015): 10–20 μm
§§ + Migliore et al. (2010): 0.5–100 μm
+ Migliore et al. (2010): 5–9 μm + Vesterdal et al. (2014a): 1 μm
+ Kermanizadeh et al. (2012), 0.7–3 and 0.7–4 μm + Jacobsen et al. (2008): 1 μm
+ Darne et al. (2014) >0.8 μm − Pelka et al. (2013): 0.05 μm
− Cavallo et al. (2012): 0.5–200 μm
− Ursini et al. (2014): 0.07–7.8 μm
− Karlsson et al. (2008): 3–7 μm
− Kermanizadeh et al. (2013): 0.7–3 and 0.7–4 μm
DNA breaks (SSB) + Cavallo et al. (2012): 0.5–200 μm + Lindberg et al. (2009)*: 0.5–100 μm
+ Ghosh et al. (2011): 0.5–200 μm + Migliore et al. (2010): 0.5–100 μm
+ Di Giorgio et al. (2011): 0.5–50 μm + Kim & Yu (2014): 20 μm
+ Barillet et al. (2010): 0.1–20 μm† + Yang et al. (2009): 5 μm
+ Visalli et al. (2015): 10–20 μm§§ + Pacurari et al. (2008): 2–5 μm
+ Migliore et al. (2010): 5–9 μm + Di Giorgio et al. (2011): 2–5 μm
+ Ursini et al. (2014): 0.07–7.8 μm + Kisin et al. (2007): 1–3 μm
+ Karlsson et al. (2008): 3–7 μm + Kisin et al. (2011): 1–3 μm
+ Lindberg et al. (2013): 1–2 μm + Lindberg et al. (2013): 1–5 μm
+ Aldieri et al. (2013): 1.1 μm (pristine) + Vesterdal et al. (2014a): 1 μm
+ Darne et al. (2014) >0.8 μm + Pelka et al. (2013): 0.5 μm
+ Kermanizadeh et al. (2012): 0.7–3 and 0.7–4 μm + Cicchetti et al. (2011): 0.8 μm
+ Kermanizadeh et al. (2013): 0.7–3 and 0.7–4 μm + Alarifi et al. (2014): 0.3–0.5 μm
+ Kim et al. (2016): 0.2 μm − Bayat et al. (2015): 5 μm
− Jackson et al. (2015): 5.7, 0.3–7, 0.7.4 μm‡ − Darne et al. (2014) >1 μm
− Aldieri et al. (2013): 1.1 μm (purified) − Jacobsen et al. (2008): 1 μm
− Thurnherr et al. (2011): 2–5 μm
− Darne et al. (2014) >1.5 μm or <1 μm
DNA breaks (DSB) + Cveticanin et al. (2010): 1–5 μm + Cveticanin et al. (2010): 1–5 μm§
+ Guo et al. (2011): 1 μm − Pacurari et al. (2008): 2–5 μm
− Mrakovcic et al. (2015): 0.5–2 μm*** − Mrakovcic et al. (2015): 0.5–2 μm***
− Ju et al. (2014): 1 μm
− Barillet et al. 2010: 0.1–20, 1.5 μm
Chromosome damage + Di Giorgio et al. (2011): 0.5–50 μm + Di Giorgio et al. (2011): 2–5 μm
+ Asakura et al. (2010): 5 μm + Catalán et al. (2012): 1–5 μm
+ Catalán et al. (2012): 1–2 μm + Sargent et al. (2009): 1 μm
+ Siegrist et al. (2014): 1 μm + Sargent et al. (2012): 1 μm
− Kim et al. (2011): 0.15 or 10 μm − Kim et al. (2015): 20 μm
− Wirnitzer et al. (2009): 0.5–50 μm − Naya et al. (2011): 1.2 μm
− Ema et al. (2013a): not reported
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Endpoint MWCNT study and tube length SWCNT study and tube length
Micronuclei + Wu et al. (2013): 10–30 μm + Migliore et al. (2010): 0.5–100 μm
+ Di Giorgio et al. (2011): 0.5–50 μm + Kim & Yu (2014): 20 μm
+ Visalli et al. (2015): 10–20 μm††† + Manshian et al. (2013): 5–30, 1–3, 0.4–0.8 
μm
+ Migliore et al. (2010): 5–9 μm + Di Giorgio et al. (2011): 2–5 μm
+ Cveticanin et al. (2010): 1–5 μm + Cveticanin et al. (2010): 1–5 μm§
+ Asakura et al. (2010): 5 μm + Kisin et al. (2011): 1–3 μm
+ Kato et al. (2013): 1–4 μm + Cicchetti et al. (2011): 0.8 μm
+ Tavares et al. (2014): 4.4 μm, 1.1 μm, 394 nm¶ + Darne et al. (2014) >1 μm (+ in V79; − in 
SHE cells)
+ Srivastava et al. (2011): 0.3–2 μm
− Lindberg et al. (2009): 0.5–100 μm*
+ Darne et al. (2014) 1.5 μm or <1 μm − Lindberg et al. (2013): 1–5 μm
+ Darne et al. (2014) >0.8 μm − Kisin et al. (2007): 1–3 μm
+ Muller et al. (2008a): 0.7 μm (ground sample) − Mrakovcic et al. (2015): 0.5–2 μm
+ Muller et al. (2008b): 0.7 μm|| − Pelka et al. (2013): 0.5 μm
+ Kim et al. (2016): 0.2 μm
− Thurnherr et al. (2011): 2–5 μm
− Lindberg et al. (2013): 1–5 μm
− Szendi&Varga (2008): 1–2 μm
− Mrakovcic et al. (2015): 0.5–2 μm
− Ponti et al. (2013): 1.5 μm**
Mutations − Asakura et al. (2010) hgprt, 5 μm + Manshian et al. (2013) hprt, 1–3 μm††
− Taylor et al. (2014) Bacteria, 5–20 μm + Mrakovcic et al. (2015) hgprt, 0.5–2 μm¶¶
− Kim et al. (2011) Bacteria, 10 or 0.15 μm‡‡ − Jacobsen et al. (2008) cII, 1 μm
− Mrakovcic et al. (2015) hgprt, 0.5–2 μm¶¶ − Kim et al. (2016) Bacteria, 20 μm
− Di Sotto et al. (2009) Bacteria, 5–7 μm − Kisin et al. (2007) Bacteria, 1–3 μm
− Wirnitzer et al. (2009) Bacteria, 0.2–1 μm − Naya et al. (2011) Bacteria, 1.2 μm
− Ema et al. (2013a) Bacteria, not reported
Gene expression (or protein) + Ravichandran et al. (2010) Trp53, p21 protein (up) + Sarkar et al. (2007) Atm (up)
+ Srivastava et al. (2011) Trp53, Cdkn1a (up) Bcl2 (down) + Wang et al. (2011a) p53
+ Kim et al. (2012) Cdkn2A (down) Bcl2 (up) + Pelka et al. (2013) p53
+ Vankoningsloo et al. (2012) Bcl2 (down) + Wang et al. (2012) Bcl2 (down)
+ Poulsen et al. (2013) Jun (up), Cdkn2c (down)
+ Zhu et al. (2007) p53 (up)
+ Zhang & Yan (2012) p21Cip1 (up), pRb (increased 
phosphorylation)
− Zhang & Yan (2012) p53
In vitro cellular 
transformation
+Wang et al. (2011a) Morphologic 
transformation
+ Lohchanoenkal et al. (2014) Morphologic 
transformation, HRAS protein expression
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Source: Adapted, from Table 3 in Sections 4–6 of IARC monograph 111 (IARC, in press), which was originally developed by authors on this paper. 
This current table has been restructured and includes some different presentations of the data, such as indicating which material was tested for 
cancer in animals.
Abbreviations: Bcl2: B-cell cll/lymphoma 2; Bcl3: B-cell cll/lymphoma 3; Cdkn1a: cyclin-dependent kinase inhibitor 1a (P21, Cip1); Cdkn2a: 
cyclin-dependent kinase inhibitor 2a; Cdkn2c: cyclin-dependent kinase inhibitor 2c (P18, Inhibits CDK4); Egfr: epidermal growth factor receptor; 
Junb: Jun-B proto-oncogene; Myb: V-Myb avian myeloblastosis viral oncogene homolog; pRb: retinoblastoma protein; Trp53: tumor protein p53.
Notes: Levels of DNA damage, mutations, chromosome damage and cellular transformation are increased (+) or unaltered (−) in exposed cells 
compared to unexposed controls. Gene expressions include oncogenes, tumor suppressor genes, and genes involved in DNA repair and cell cycle 
regulation. (+) means a differential expression between control (untreated) and treated cells. Bold text refers to observation on materials that have 
been tested for carcinogenicity in animal models.
*Contains a mixed material with more than 50% SWCNTs and 40% other nanotubes.
†
MWCNTs defined as “long” (0.1–20 μm) was genotoxic, whereas a “short” type (1–5 μm) was not genotoxic.
‡
Included 15 different materials, only MWCNT-7 and OECD materials MN400 and MN402 have been highlighted.
§Same effect of pristine and amide-functionalized SWCNTs.
¶
Three materials did not generate micronuclei (369 nm, 726 nm, 3.4 μm).
||
Heating (2400 °C) of the ground sample abolished genotoxicity. Samples that were heated and subsequently ground increased the formation of 
MN.
**
Both pristine and functionalized forms.
††Only material with 1–3 μm in length.
‡‡
Includes both “long” (approximately 10 μm) and “short” (150 nm) types of fibers.
§§Also increased level of DNA strand breaks and FPG-sensitive sites after exposure COOH-functionalized MWCNTs.
¶¶Also increased mutation frequency of COOH-functionalized SWCNTs. No effect of COOH-functionalized MWCNTs.
***No effect of COOH-functionalized CNTs.
†††Unaltered micronuclei frequency of COOH-functionalized MWCNTs.
Crit Rev Toxicol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Kuempel et al. Page 107
Ta
bl
e 
6
O
ve
ra
ll 
su
m
m
ar
y 
of
 st
ud
ie
s o
f l
un
g 
an
d 
pl
eu
ra
l r
es
po
ns
es
 to
 sp
ec
ifi
c 
ty
pe
s o
f c
ar
bo
n 
na
no
tu
be
 o
r n
an
of
ib
er
 (C
NT
 or
 C
NF
) i
n a
nim
als
.
Ty
pe
 a
nd
 so
ur
ce
o
f c
ar
bo
n
n
a
n
o
tu
be
 o
r
n
a
n
o
fib
er
D
im
en
sio
ns
*
Lu
ng
 E
ffe
ct
s (
ra
t, m
ou
se)
Pl
eu
ra
l E
ffe
ct
s (
ra
t, m
ou
se)
D
ia
m
et
er
(n
m)
Le
ng
th
(μ
m)
Bi
op
er
sis
te
nt
,
in
te
rs
tit
ia
l
re
te
nt
io
n
Br
o
n
ch
io
l-
a
lv
eo
la
r 
hy
pe
rp
la
sia
G
en
ot
ox
ic
ity
Fi
br
o
sis
Pe
rs
ist
en
t i
nf
la
m
m
at
io
n
Tr
a
n
slo
ca
tio
n
fr
o
m
 lu
ng
s t
o 
pl
eu
ra
Pl
eu
ra
l 
in
fla
m
m
at
io
n,
in
jur
y, 
&
/o
r 
pr
o
lif
er
at
io
n
M
ul
ti-
wa
lle
d 
Ca
rb
on
 N
an
ot
ub
e (
MW
CN
T)
B
ay
tu
be
s®
 (B
ay
er)
10
0.
2
Pa
u
lu
hn
 2
01
0
Pa
u
lu
hn
 2
01
0
Pa
u
lu
hn
 2
01
0
M
W
CN
T-
7 
(M
its
ui)
50
4
M
er
ce
r e
t a
l. 
20
11
,
 
20
13
a;
 X
u 
et
 a
l. 
20
12
Po
rte
r e
t a
l. 
20
13
; S
ar
ge
nt
 e
t 
al
. 2
01
4
Po
rte
r e
t a
l. 
20
10
,
 
20
13
; K
as
ai
 e
t a
l. 
20
15
Po
rte
r e
t a
l. 
20
10
,
 
20
13
; A
iso
 e
t a
l. 
20
10
; M
er
ce
r e
t a
l. 
20
11
,
 
20
13
a;
 K
as
ai
 
et
 a
l. 
20
15
Po
rte
r e
t a
l. 
20
10
; 
M
er
ce
r e
t a
l. 
20
10
,
 
20
11
,
 
20
13
a,
b;
 X
u 
et
 
al
. 2
01
2
X
u 
et
 a
l. 
20
12
N
T l
on
g1
 
(M
its
ui)
40
–5
0
13
M
uh
lfe
ld
 e
t a
l. 
20
12
M
uh
lfe
ld
 e
t a
l. 
20
12
N
T t
an
g1
 
(N
an
ola
b)
15
1–
5
M
uh
lfe
ld
 e
t a
l. 
20
12
M
uh
lfe
ld
 e
t a
l. 
20
12
M
W
CN
T-
N
 (N
ikk
iso
)
n
r
3
X
u 
et
 a
l. 
20
12
X
u 
et
 a
l. 
20
12
X
u 
et
 a
l. 
20
12
63
1.
1
O
ya
bu
 e
t a
l. 
20
11
M
or
im
ot
o 
et
 a
l. 
20
12
b
H
el
ix
20
0.
5–
50
R
ym
an
-R
as
m
us
se
n 
et
 
al
. 2
00
9
R
ym
an
-R
as
m
us
se
n 
et
 
al
. 2
00
9
R
ym
an
-R
as
m
us
se
n 
et
 
al
. 2
00
9
N
an
oc
yl
10
5
M
ul
le
r e
t a
l. 
20
05
M
a-
H
oc
k 
et
 a
l. 
20
09
M
ul
le
r e
t a
l. 
20
08
 
(G
)
Tr
eu
m
an
n
 e
t a
l. 
20
13
M
a-
H
oc
k 
et
 a
l. 
20
09
; M
ul
le
r e
t a
l. 
20
08
 
(G
)
G
ra
ph
i-s
tre
ng
th
©
 C
10
0 
(A
rke
m
a)
12
~
1
Po
th
m
an
n 
et
 a
l. 
20
15
Po
th
m
an
n 
et
 a
l. 
20
15
Ca
o 
et
 a
l. 
20
14
; 
Po
th
m
an
n 
et
 a
l. 
20
15
Po
th
m
an
n 
et
 a
l. 
20
15
CM
-9
5/
10
0 
(H
an
wh
a N
an
ote
ch
)
12
0.
5 
(C
M
-95
) 2
.6 
(C
M
-10
0)
Yu
 e
t a
l. 
20
13
K
im
 e
t a
l. 
20
14
K
im
 e
t a
l. 
20
14
K
im
 e
t a
l. 
20
14
Si
ng
le-
wa
lle
d 
Ca
rb
on
 N
an
ot
ub
e (
SW
CN
T)
H
ip
co
1
0.
9
Sh
ve
do
v
a 
et
 a
l. 
20
05
,
 
20
08
,
 
20
14
Sh
ve
do
v
a 
et
 a
l. 
20
05
,
 
20
08
Sh
ve
do
v
a 
et
 a
l.,
 2
00
5,
 
20
08
Su
pe
r-g
ro
w
th
 C
V
D
3
0.
32
Fu
jita
 et
 al
. 2
01
5
K
o
ba
ya
sh
i e
t a
l. 
20
11
M
or
im
ot
o 
et
 a
l. 
20
12
a;
 F
uji
ta 
et 
al.
 20
15
N
ik
ki
so
1.
8
0.
69
M
or
im
ot
o 
et
 a
l. 
20
12
c
Ca
rb
on
 n
an
of
ib
er
 (C
NF
)
CN
F 
(P
yro
gra
ph
)
80
–1
60
5–
30
M
ur
ra
y 
et
 a
l. 
20
12
M
ur
ra
y 
et
 a
l. 
20
12
CN
F 
(S
ho
w
a 
D
en
ko
)
15
8 
(m
ea
n)
5.
8 
(m
ea
n)
D
eL
or
m
e 
et
 a
l. 
20
12
D
eL
or
m
e 
et
 a
l. 
20
12
D
eL
or
m
e 
et
 a
l. 
20
12
So
ur
ce
: C
re
at
ed
 fo
r t
hi
s p
ap
er
.
 
A
n 
ea
rli
er
 d
ra
ft 
of
 th
is 
ta
bl
e 
w
as
 d
ev
el
op
ed
 b
y 
th
e 
M
ec
ha
ni
sm
s s
ub
gr
ou
p 
m
em
be
rs
 a
nd
 u
se
d 
in
 so
m
e 
of
 it
s d
el
ib
er
at
io
ns
, b
u
t t
he
 e
ar
lie
r t
ab
le
 w
as
 n
o
t i
nc
lu
de
d 
in
 th
e 
m
on
og
ra
ph
.
Crit Rev Toxicol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Kuempel et al. Page 108
K
ey
:  P
os
iti
v
e 
st
ud
y 
(i.
e.,
 ad
ve
rs
e 
ef
fe
ct
 o
bs
er
ve
d 
on
 sp
ec
ifi
ed
 e
nd
po
in
t b
y 
ty
pe
 o
f C
N
T 
or
 C
N
F 
fo
r t
he
 d
os
es
 a
nd
 a
ss
ay
s u
se
d)
 
N
eg
at
iv
e 
st
ud
y 
(i.
e.,
 no
 ad
ve
rs
e 
ef
fe
ct
 o
n 
sp
ec
ifi
ed
 e
nd
po
in
t b
y 
ty
pe
 o
f C
N
T 
or
 C
N
F 
fo
r t
he
 d
os
es
 a
nd
 a
ss
ay
s u
se
d)
 
La
ck
 o
f d
at
a
A
bb
re
v
ia
tio
ns
: (
G)
: g
rou
nd
 C
NT
; n
r:
 n
ot
 re
po
rte
d
*
A
pp
ro
xi
m
at
e 
m
id
-p
oi
nt
, i
f n
ot
 st
at
ed
 o
th
er
w
ise
; v
al
ue
s w
er
e 
re
po
rte
d 
di
ffe
re
nt
ly
 a
cr
os
s p
ub
lic
at
io
ns
.
Crit Rev Toxicol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Kuempel et al. Page 109
Table 7
Key Characteristics of Dusts and Fibres Evaluated for Carcinogenicity by IARC, including Carbon Nanotubes 
and Nanofibers.
Characteristic Example of relevant evidence Carbon black† Asbestos fibers‡
Carbon 
nanotubes and 
nanofibers§
1. Is Electrophilic or Can Be 
Metabolically Activated
Compound or metabolite with electrophilic 
structure, forms DNA and protein adducts
nr nr nr
2. Is Genotoxic DNA damage, gene mutations, 
chromosomal alterations
+/− + +
3. Alters DNA Repair or Causes 
Genomic Instability
Alterations of DNA replication or repair nr nr nr
4. Induces Epigenetic Alterations DNA methylation, histone modification, 
micro RNA expression
nr nr nr
5. Induces Oxidative Stress Cell-derived oxygen radicals, oxidative 
damage to macromolecules, redox 
imbalance
+ + +/−
6. Induces Chronic Inflammation Elevated inflammatory cells, altered 
production of cytokines and chemokines
+ + +/−
7. Is Immunosuppressive Decrease immunosurveillance, immune 
system dysfunction
nr nr nr
8. Modulates Receptor-Mediated 
Effects
Receptor activation or modulation of 
endogenous ligands
nr nr nr
9. Causes Immortalization Inhibition of senescence nr nr nr
10. Causes Sustained Cell 
Proliferation, Cell Death, or Altered 
Nutrient Supply
Changes in growth factors, energetics and 
signaling pathways related to cell cycle 
control, angiogenesis
nr* +* −/+*
Source: Created for this paper. Derived from information in Smith et al. (2016) and applied to the authors’ understanding of the scientific literature 
for CNT and CNF, as well as for the comparison materials of ultrafine carbon black and asbestos.
Table 7 is modified from Smith et al. (2016) and applied to specific particles (nonfibrous and fibrous), Key characteristics of carcinogens as a basis 
for organizing data on mechanisms of carcinogenesis, IARC (in press).
Definitions: “nr” not reported; “− “studies that examined these characteristics reported no relationship with exposure to the material; “+” studies 
that have reported a relationship between these characteristics and exposure to the material.
*
It is recognized that exposure to a sufficient dose of biopersistent materials such as asbestos can cause chronic inflammation, resulting in 
disruption of local tissue homeostasis and altered cell signaling that involves persistent cell proliferation (Mossman et al., 2013; Smith et al., 2016). 
In addition, pathways that are initiated by proto-oncogenes in pre-neoplastic and neoplastic cells can also recruit inflammatory cells, resulting in 
accelerated tumor promotion and progression (Grivennikov et al. 2010; Smith et al. 2016). Thus, characteristics 6 and 10 can be inter-related, and it 
is not currently feasible to distinguish the specific mechanisms involved. For CNTs and CNFs, persistent cell proliferation has been observed in a 
number of studies (Section “Weight of Mechanistic Evidence and Key Data Gaps”; Table 6), and angiogenesis has also been observed (Section 
“Other indicative effects: Gene expression and cell transformation”). However, most of these published studies reporting cell proliferation have not 
critically examined the mechanisms of sustained proliferative signaling to the extent that has been reported in published studies with asbestos 
fibers.
†Carbon black was most recently evaluated by IARC as Group 2B (IARC, vol. 93, 2010). Carbon black represents a class of poorly-soluble 
particles with low toxicity that impairs alveolar macrophage clearance at sufficiently high doses in rodents leading to persistent inflammation. 
Carbon black comes in different particle sizes and purities (some samples have high content of PAHs); evidence of genotoxicity reported in 
Jacobsen et al. (2007, 2011); Kyjovska et al. (2015); in vitro evidence of proliferative signaling in epithelial cells exposed to ultrafine carbon black 
reported in Tamaoki et al. (2004); Weissenberg et al. (2010).
‡Asbestos and erionite fibres were most recently evaluated by IARC as Group 1 (IARC, vol.100C, 2012) supported by established evidence for 
induction of genotoxicity, oxygen radical-induced injury, oxidative stress, and chronic inflammation; evidence of persistent cell proliferation 
mechanism described in Adamson et al. (1993); Adamson (1997); Adamson and Bakowska (2001); Heintz et al. (2010); Mossman et al. (2013).
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§Carbon nanotubes were recently evaluated by IARC and one type of MWCNT was classified as Group 2B (IARC, vol. 111, in press). This paper 
reviews the available experimental evidence for induction of genotoxicity, oxidative stress, and chronic inflammation following exposure to diverse 
types of carbon nanotubes. Significant data gaps and conflicting results for the various SWCNT and MWCNT samples reported in the literature; 
see Table 6; evidence for persistent cell proliferation for MWCNT-7 in Sargent et al. (2014).
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